This is a Validated Antibody Database (VAD) review about human CD44, based on 742 published articles (read how Labome selects the articles), using CD44 antibody in all methods. It is aimed to help Labome visitors find the most suited CD44 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD44 synonym: CDW44; CSPG8; ECMR-III; HCELL; HUTCH-I; IN; LHR; MC56; MDU2; MDU3; MIC4; Pgp1

Knockout validation
Abcam
domestic rabbit monoclonal (EPR1013Y)
  • western blot knockout validation; human; 1:1000; loading ...; fig 5a
  • proximity ligation assay; human; 1:500; loading ...; fig 3f
Abcam CD44 antibody (Abcam, ab51037) was used in western blot knockout validation on human samples at 1:1000 (fig 5a) and in proximity ligation assay on human samples at 1:500 (fig 3f). elife (2020) ncbi
BioLegend
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig s5b
  • flow cytometry; mouse; 1:1000; loading ...; fig s4c
BioLegend CD44 antibody (BioLegend, 103012) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig s5b) and in flow cytometry on mouse samples at 1:1000 (fig s4c). Nat Commun (2021) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; loading ...; fig 2-5
BioLegend CD44 antibody (BioLegend, BJ18) was used in flow cytometry on human samples (fig 2-5). Cells (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b, 6d
BioLegend CD44 antibody (BioLegend, 103012) was used in flow cytometry on mouse samples (fig 2b, 6d). Antioxidants (Basel) (2020) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; 1:200; loading ...
BioLegend CD44 antibody (Biolegend, 103006) was used in immunohistochemistry on mouse samples at 1:200. elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:200; loading ...; fig 3a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on human samples at 1:200 (fig 3a). Cancers (Basel) (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD44 antibody (BioLegend, 103044) was used in flow cytometry on mouse samples (fig s2a). Cell (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s5c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s5c). Sci Adv (2020) ncbi
mouse monoclonal (BJ18)
  • other; human; 1:100; loading ...
BioLegend CD44 antibody (Biolegend, BJ18) was used in other on human samples at 1:100. elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:800; loading ...; fig 1f
BioLegend CD44 antibody (BioLegend, 103047) was used in flow cytometry on mouse samples at 1:800 (fig 1f). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on human samples . Theranostics (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on human samples . Int Immunopharmacol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:200; loading ...; fig s2c
BioLegend CD44 antibody (Biolegend, 103021) was used in flow cytometry on human samples at 1:200 (fig s2c). Cancers (Basel) (2020) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (BioLegend, IM7) was used . Nature (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5d). Nat Commun (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . BMC Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 2s1
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 2s1). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s18
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s18). Nat Commun (2020) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6a
BioLegend CD44 antibody (Biolegend, IM7) was used in immunohistochemistry - paraffin section on mouse samples (fig 6a). Sci Rep (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD44 antibody (Biolegend, 103006) was used in flow cytometry on mouse samples (fig 1c). Cell Rep (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend CD44 antibody (Biolegend, 103016) was used in flow cytometry on mouse samples (fig 3c). elife (2020) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - free floating section; mouse; 1:1000; loading ...; fig 2f
BioLegend CD44 antibody (Biolegend, 103059) was used in immunohistochemistry - free floating section on mouse samples at 1:1000 (fig 2f). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e, 1j
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1e, 1j). Sci Adv (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s1a). Aging (Albany NY) (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2s1b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2s1b). elife (2020) ncbi
rat monoclonal (IM7)
  • mass cytometry; mouse; 1:800; loading ...; fig s32a, s32c
BioLegend CD44 antibody (Biolegend, 103002) was used in mass cytometry on mouse samples at 1:800 (fig s32a, s32c). Nat Commun (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s9e
BioLegend CD44 antibody (Biolegend, 103005) was used in flow cytometry on mouse samples (fig s9e). Nat Commun (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s5a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s5a). Sci Adv (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s5b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s5b). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e4d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig e4d). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend CD44 antibody (Biolegend, 103028) was used in flow cytometry on mouse samples (fig s1c). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2c
BioLegend CD44 antibody (Biolegend, 103015) was used in immunohistochemistry - paraffin section on mouse samples (fig 2c). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1h
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s1h). Science (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3a). Aging (Albany NY) (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a, 5a, 6a, s4b
BioLegend CD44 antibody (BioLegend, 103059) was used in flow cytometry on mouse samples (fig 3a, 5a, 6a, s4b). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; mouse; loading ...; fig 2a
BioLegend CD44 antibody (Biolegend, IM7) was used in immunocytochemistry on mouse samples (fig 2a). Biol Sex Differ (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1b
BioLegend CD44 antibody (Biolegend, 103008) was used in flow cytometry on mouse samples (fig s1b). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend CD44 antibody (BioLegend, 103051) was used in flow cytometry on mouse samples (fig s1c). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5a
BioLegend CD44 antibody (Biolegend, 103039) was used in flow cytometry on mouse samples (fig 5a). Oncoimmunology (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4f
BioLegend CD44 antibody (Biolegend, 103031) was used in flow cytometry on mouse samples (fig s4f). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s4b). JCI Insight (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4d
BioLegend CD44 antibody (Biolegend, 103028) was used in flow cytometry on mouse samples (fig s4d). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s6a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s6a). Science (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 2a). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 4a
BioLegend CD44 antibody (BioLegend, 103026) was used in flow cytometry on mouse samples at 1:200 (fig 4a). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2e
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s2e). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1e
BioLegend CD44 antibody (Biolegend, 103030) was used in flow cytometry on mouse samples (fig s1e). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1e
BioLegend CD44 antibody (Biolegend, 103030) was used in flow cytometry on mouse samples (fig s1e). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 1bc
BioLegend CD44 antibody (BioLegend, 103021) was used in flow cytometry on mouse samples at 1:100 (fig 1bc). Exp Ther Med (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2b
BioLegend CD44 antibody (Biolegend, 103008) was used in flow cytometry on mouse samples at 1:100 (fig 2b). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2h
BioLegend CD44 antibody (Biolegend, 103057) was used in flow cytometry on mouse samples (fig 2h). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend CD44 antibody (BioLegend, 103028) was used in flow cytometry on mouse samples (fig s2b). Immunity (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8a). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1d
BioLegend CD44 antibody (Biolegend, 103030) was used in flow cytometry on mouse samples at 1:200 (fig 1d). elife (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8b
BioLegend CD44 antibody (BioLegend, 103054) was used in flow cytometry on mouse samples (fig s8b). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend CD44 antibody (Biolegend, 103039) was used in flow cytometry on mouse samples (fig 5c). Cell (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8c). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1f
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1f). J Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e1e
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig e1e). Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend CD44 antibody (Biolegend, 103043) was used in flow cytometry on mouse samples (fig 1e). Cell Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD44 antibody (Biolegend, 103047) was used in flow cytometry on mouse samples (fig 2b). Cell Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s4a). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s5d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s5d). JCI Insight (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 1c
BioLegend CD44 antibody (Biolegend, 103012) was used in flow cytometry on mouse samples at 1:400 (fig 1c). elife (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2b). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7a
BioLegend CD44 antibody (BioLegend, 103029) was used in flow cytometry on mouse samples (fig 7a). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b, 5c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2b, 5c). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 5d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:400 (fig 5d). Nat Commun (2018) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD44 antibody (Biolegend, 338802) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3f). PLoS ONE (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1c). J Exp Med (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s19
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s19). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e2e
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig e2e). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1d
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s1d). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3f). EMBO J (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2h
BioLegend CD44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig 2h). Nat Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD44 antibody (BioLegend, 103020) was used in flow cytometry on mouse samples (fig 2a). PLoS Pathog (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
  • immunocytochemistry; mouse; loading ...; fig 1c
BioLegend CD44 antibody (Biolegend, 103035) was used in flow cytometry on mouse samples (fig 1b) and in immunocytochemistry on mouse samples (fig 1c). Cell (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1h
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1h). Nat Commun (2018) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; loading ...; fig 3s1b
BioLegend CD44 antibody (BioLegend, 338806) was used in flow cytometry on human samples (fig 3s1b). elife (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s2a). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (IM7)
  • immunoprecipitation; human; loading ...; fig sf1
  • immunocytochemistry; human; 1:250; loading ...; fig sf2
BioLegend CD44 antibody (Biolegend, IM-7) was used in immunoprecipitation on human samples (fig sf1) and in immunocytochemistry on human samples at 1:250 (fig sf2). Oncotarget (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 5f). Nat Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4c). Front Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:1000; loading ...; fig s1a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:1000 (fig s1a). Nat Commun (2017) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD44 antibody (BioLegend, BJ18) was used in flow cytometry on human samples (fig 2c). Cytokine (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to study the role of lysine acetyltransferase GCN5 in iNKT cell development and its mechanism, BioLegend CD44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig 2c). Cell Rep (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8c
In order to evaluate mouse models of hepacivirus infection, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s8c). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2k
In order to investigate the role of dopamine in B cell maturation in germinal centres, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s2k). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
In order to characterize the regulatory T cells expressing T-bet transcriptional factor, BioLegend CD44 antibody (BioLegend, 103026) was used in flow cytometry on mouse samples (fig 3f). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s3b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s3b). Nat Commun (2017) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD44 antibody (BioLegend, BJ18) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1c
In order to investigate the effect of lymphatic endothelial S1P on mitochondrial function and naive T cell survival, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1c). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s3a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3a). Nature (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4f). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2b
In order to investigate the role of CRB3 downregulation in maintaining breast cancer stem cells, BioLegend CD44 antibody (BioLegend, 103008) was used in flow cytometry on human samples (fig 2b). Oncogenesis (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5b
In order to find factors that regulate follicular T helper cell migration and function, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 5b). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3c). Nat Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1b
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, BioLegend CD44 antibody (biolegend, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to assess the contribution of viral infection to the development of celiac disease, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s8a
In order to investigate how aging affects transcriptional dynamics in naive and CD4 positive T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s8a). Science (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; cat; loading ...; fig 1e
  • flow cytometry; human; loading ...; fig 1f
In order to compare human and feline adipose-derived mesenchymal stem cells, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on cat samples (fig 1e) and in flow cytometry on human samples (fig 1f). Stem Cell Res Ther (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 6b). Immunology (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to examine the contribution of T-bet-expressing B cells to autoimmune diseases, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 2b). Stem Cells Dev (2017) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; mouse; 1:100; loading ...; fig 6a
In order to report the expression pattern of Gpr182 during development and adulthood using knockin mice, BioLegend CD44 antibody (BioLegend, 338810) was used in flow cytometry on mouse samples at 1:100 (fig 6a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
In order to investigate DNA repair in CD44+/CD24- cells, BioLegend CD44 antibody (BioLegend, 103029) was used . elife (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
In order to elucidate how P2X7 regulates the contraction of intestinal CD4 positive effector T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5c). Mucosal Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine the effect of a high salt diet on intestinal immunity and the risk of inflammatory bowel disease, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). Oncotarget (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to report that differentiation and self-renewal arise as opposing outcomes of sibling CD4 positive T cells during challenge with influenza, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2b
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:100 (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1b). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to suggest that persistent immune activation causes impairment of lymphocytes to respond to chemotactic stimuli, preventing their trafficking from the blood stream to peripheral organs, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; loading ...; fig s1c
In order to demonstrate that neonatal CD8 positive T cells have a specific genetic program biased toward the innate immune response, BioLegend CD44 antibody (Biolegend, BJ18) was used in flow cytometry on human samples (fig s1c). Cell Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
In order to investigate strains of Listeria monocytogenes that activate necrosis, apoptosis, or pyroptosis and study the role of CD8 positive T cells in these processes, BioLegend CD44 antibody (biolegend, IM7) was used in flow cytometry on mouse samples (fig 5c). Infect Immun (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 6c
In order to characterize malaria-induced splenic monocyte-derived dendritic cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 6c). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6f
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6f). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4
In order to characterize systemic antimicrobial CD4 positive T cell reactivity, BioLegend CD44 antibody (Biolegend, Im7) was used in flow cytometry on mouse samples (fig s4). Immunology (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:800; loading ...; fig 5e
In order to test how inhibiting autophagy impacts antitumor immune responses in immune-competent mouse models of melanoma and mammary cancer, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:800 (fig 5e). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 5
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 5). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2d
In order to use a CRISPR-Cas9 system to screen for genes involved in B-cell activation and plasma cell differentiation, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2d). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (BioLegend, 103022) was used . Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s3
BioLegend CD44 antibody (BioLegend, 103008) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; loading ...; fig 3g
BioLegend CD44 antibody (BioLegend, IM7) was used in immunocytochemistry on human samples (fig 3g). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6d
In order to investigate allergic responses to food allergens in WASP-deficient animals, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6d). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BioLegend CD44 antibody (BioLegend, 103030) was used in flow cytometry on mouse samples (fig s1). Cell (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 2
BioLegend CD44 antibody (Biolegend, 103015) was used in flow cytometry on human samples (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig S1
In order to study the effect of IL-10 signaling in infectious neurological diseases, BioLegend CD44 antibody (BioLegend, clone IM7) was used in flow cytometry on mouse samples (fig S1). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to probe how neutrophil extracellular traps modulate the rheumatoid arthritis-associated autoimmune response, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Eur J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3d
In order to test if a combination of LYN and Aire defects result in organ-specific autoimmunity, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3d). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to elucidate how Zfp36l1 and Zfp36l2 regulate the thymic beta-Selection checkpoint, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to explore the role of exhausted CD8 positive CXCR5 positive T cells in mice chronically infected with lymphocytic choriomeningitis virus, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1c). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
In order to demonstrate that lymphotoxin beta receptor directly controls thymic endothelial cells to guide hematopoietic progenitor cell homing, BioLegend CD44 antibody (Biolegend, 103006) was used in flow cytometry on mouse samples (fig 1a). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:100 (tbl s2). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to assess how ABCG1 loss in T cells affects atherosclerosis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; fig 4
BioLegend CD44 antibody (Biolegend, 103015) was used in immunocytochemistry on human samples (fig 4). Biol Open (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 4
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on human samples (fig 4). J Virol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; fig 4
BioLegend CD44 antibody (BioLegend, 103008) was used in flow cytometry on mouse samples at 1:100 (fig 4). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:300; loading ...; fig 4f
In order to investigate the stromal contribution to the microenvironment of tumor-draining lymph nodes, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:300 (fig 4f). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; human; loading ...; fig 1a
  • immunohistochemistry; mouse; loading ...; fig 1a
BioLegend CD44 antibody (Biolegend, IM7) was used in immunohistochemistry on human samples (fig 1a) and in immunohistochemistry on mouse samples (fig 1a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6). Oncotarget (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to investigate how dopamine receptor D3 signaling affects the balance of effector T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2c). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
In order to study promotion of host immunity and protection against IL-12/23p40-dependent lung injury during hookworm infection by myeloid-restricted AMPK-alpha1, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 6). J Immunol (2016) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; mouse; 1:50; loading ...; fig 7f
In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., BioLegend CD44 antibody (Biolegend, 338807) was used in flow cytometry on mouse samples at 1:50 (fig 7f). Nat Cell Biol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to investigate the mechanism for adoptively transferred effector T-cell survival and memory formation, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2a). Cell Biosci (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1b
In order to demonstrate that Ndfip1/Ndfip2 regulate cross talk between T-cell receptor and cytokine signaling pathways, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 1b). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3e
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3e). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Oncoimmunology (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3c
In order to report how the parallel networks of necroptosis-induced CXCL1 and Mincle signaling promote pancreatic ductal adenocarcinoma progression, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s3c). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4b
In order to determine the effects of an altered intestinal microbiota and microbial metabolites on graft-versus-host disease, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 4b). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
In order to study the requisite for the function of regulatory T cells known as phosphatase PP2A, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2b
In order to elucidate the role of B cells in the initiation of central nervous system autoimmunity, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5f
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5f). Gastroenterology (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 1b
BioLegend CD44 antibody (Biolegend, 103029) was used in flow cytometry on human samples (fig 1b). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6s
In order to compare the capacity of induced T regulatory and T helper 17 cells to develop in a T cell model of colitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 6s). J Immunol (2016) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; fig 4
BioLegend CD44 antibody (Biolegend, BJ18) was used in flow cytometry on human samples (fig 4). Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). Mucosal Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5a
In order to demonstrate that control of acute infection with Trypanosoma cruzi is associated with development of systemic necrotizing vasculitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5a). Infect Immun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s5
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s5). EMBO Mol Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to study the effect of atypical protein kinase C i on asymmetric division and CD8(+) T Lymphocyte, BioLegend CD44 antibody (Biolegend, 1M7) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 2f
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, BioLegend CD44 antibody (BioLegend, 103016) was used in flow cytometry on mouse samples at 1:400 (fig 2f). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 5). Int J Oncol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
BioLegend CD44 antibody (Biolegend, 103026) was used in flow cytometry on mouse samples (fig 6). Nature (2015) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (Biolegend, 103030) was used . Sci Rep (2015) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; fig 8
In order to identify the source of obesity-induced MCP-1 and identify molecular regulators mediating MCP-1 production, BioLegend CD44 antibody (Biolegend, BJ18) was used in flow cytometry on human samples (fig 8). Mol Metab (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; cat; fig 2
In order to examine the effect of fresh, autologous, adipose-derived mesenchymal stem cells on feline chronic gingivostomatitis, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on cat samples (fig 2). Stem Cells Transl Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to research skin-resident memory T cell homeostasis and lymphoma mediated by hair follicle-derived IL-7 and IL-15, BioLegend CD44 antibody (BioLegend, IMF7) was used in flow cytometry on mouse samples (fig 1). Nat Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1b). Mucosal Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1d). Arthritis Rheumatol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s7
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s7). elife (2015) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (BioLegend, 103021) was used . Mol Med Rep (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3f). Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 3a). Cancer Res (2015) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; fig 4
In order to determine the differential regulation of the inflammatory phenotype of brain microvascular endothelial cells by pro-inflammatory TNFalpha and IL-1beta, BioLegend CD44 antibody (Biolegend, 338803) was used in flow cytometry on human samples (fig 4). J Neuroinflammation (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3a
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 3a). J Leukoc Biol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 7
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 7). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate the role of Treg during T. gondii infection, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Microbes Infect (2015) ncbi
rat monoclonal (IM7)
BioLegend CD44 antibody (Biolegend, IM7) was used . Nature (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s6
BioLegend CD44 antibody (Biolegend, 103024) was used in flow cytometry on mouse samples (fig s6). Proc Natl Acad Sci U S A (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). PLoS Pathog (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Oncotarget (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig 1
BioLegend CD44 antibody (Biolegend, 103006) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples (fig 1). J Clin Invest (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2
BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples (fig s2). Brain (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
BioLegend CD44 antibody (Biolegend, clone IM7) was used in flow cytometry on mouse samples (fig 3). Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, 103012) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Clin Invest (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to examine the role of interleukin-4 in relation to eomesodermin within CD8+ T cells, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate the role of T reg cells in exhaustion of lymphocytic choriomeningitis virus-specific CD8 T cells, BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
  • immunohistochemistry; human; fig 2
In order to study reprogramming of cells toward a metastatic-like state by p53 psi, a transcriptionally inactive p53 isoform, BioLegend CD44 antibody (Biolegend, IM-7) was used in flow cytometry on mouse samples (fig 1) and in immunohistochemistry on human samples (fig 2). Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate how Fbw7-mediated GATA3 regulation and CDK2-mediated phosphorylation of Cdc4 phosphodegron regulate differentiation of T-cell lineages, BioLegend CD44 antibody (Biolegend, IM7) was used in flow cytometry on mouse samples . Mol Cell Biol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, 103029) was used in flow cytometry on mouse samples . Ann Neurol (2014) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human
BioLegend CD44 antibody (BioLegend, 2BJ18) was used in flow cytometry on human samples . Cell Death Dis (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
BioLegend CD44 antibody (Biolegend, clone IM7) was used in flow cytometry on mouse samples (fig 4). Vaccine (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
mouse monoclonal (BJ18)
  • flow cytometry; human; 0.5 ug/ml; loading ...; fig st13
BioLegend CD44 antibody (Biolengend, BJ18) was used in flow cytometry on human samples at 0.5 ug/ml (fig st13). Nat Cell Biol (2014) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; 1:200; loading ...; fig st13
BioLegend CD44 antibody (Biolengend, IM7) was used in immunocytochemistry on human samples at 1:200 (fig st13). Nat Cell Biol (2014) ncbi
rat monoclonal (IM7)
In order to evaluate a coculture system for in vitro colonoid formation, BioLegend CD44 antibody (Biolegend, 103001) was used . Am J Physiol Gastrointest Liver Physiol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate the immunological pathways that lead to obesity-associated asthma, BioLegend CD44 antibody (BioLegend, 103009) was used in flow cytometry on mouse samples . Nat Med (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200
BioLegend CD44 antibody (BioLegend, IM7) was used in flow cytometry on mouse samples at 1:200. Cell Cycle (2012) ncbi
Invitrogen
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 5e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 5e). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen CD44 antibody (Thermo Fisher, IM7) was used in flow cytometry on mouse samples (fig 5d). Front Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; domestic horse; 1:100; loading ...; fig 1c
Invitrogen CD44 antibody (Invitrogen, IM7) was used in flow cytometry on domestic horse samples at 1:100 (fig 1c). Animals (Basel) (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 4b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on human samples (fig 4b). BMC Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:100; loading ...; fig 6a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on human samples at 1:100 (fig 6a). Front Immunol (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 2a
Invitrogen CD44 antibody (eBioscience, 48-0441) was used in flow cytometry on mouse samples at 1:200 (fig 2a). Nat Commun (2020) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 3h
  • western blot; human; 1:250; loading ...; fig 5d
Invitrogen CD44 antibody (Thermo Fisher, MA5-13890) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 3h) and in western blot on human samples at 1:250 (fig 5d). J Neuroinflammation (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1s2a
Invitrogen CD44 antibody (eBioscience, 25-0441-82) was used in flow cytometry on mouse samples at 1:200 (fig 1s2a). elife (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen CD44 antibody (Thermo Fisher, IM7) was used in flow cytometry on mouse samples (fig 6a). Front Immunol (2019) ncbi
rat monoclonal (IM7)
Invitrogen CD44 antibody (eBioscience, 12-0441-81) was used . Cell Rep (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig s1g
Invitrogen CD44 antibody (Thermo Fisher, IM7) was used in flow cytometry on mouse samples at 1:200 (fig s1g). Cell Rep (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2c). Science (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a, s1c
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1a, s1c). Sci Adv (2019) ncbi
mouse monoclonal (VFF-7)
  • flow cytometry; human; fig s1d
Invitrogen CD44 antibody (Thermo, MA5-16966) was used in flow cytometry on human samples (fig s1d). Oncogene (2020) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e10
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig e10). Nature (2019) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100; fig 8i
Invitrogen CD44 antibody (Invitrogen, MA5-13890) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 8i). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 7d
Invitrogen CD44 antibody (Ebioscience, 48-0441-82) was used in flow cytometry on human samples (fig 7d). Oncoimmunology (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:50; fig 3a, 3b
Invitrogen CD44 antibody (eBioscience/Thermo, 17-0441-83) was used in flow cytometry on human samples at 1:50 (fig 3a, 3b). Stem Cells (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s4b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s4b). J Clin Invest (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4). J Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen CD44 antibody (Invitrogen, 45-0441-82) was used in flow cytometry on mouse samples (fig 3b). Int Immunol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 3e, s4b
Invitrogen CD44 antibody (EBioscience, 61-0441-82) was used in flow cytometry on human samples (fig 3e, s4b). Breast Cancer Res (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). Stem Cell Res Ther (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 3k
Invitrogen CD44 antibody (eBioscience, 17-0441-82) was used in flow cytometry on mouse samples at 1:200 (fig 3k). Nat Commun (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2e
Invitrogen CD44 antibody (eBioscience, 47-0441) was used in flow cytometry on mouse samples (fig s2e). Science (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:100. Nature (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1f
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1f). J Exp Med (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). Oncoimmunology (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a, 8b
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a, 8b). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig 6d
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples at 1:400 (fig 6d). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:300; loading ...; fig 3s2a
Invitrogen CD44 antibody (eBioscience, 48-0441-82) was used in flow cytometry on mouse samples at 1:300 (fig 3s2a). elife (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1a). Blood (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig ex7g
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig ex7g). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD44 antibody (Thermo Fisher Scientific, IM7) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2018) ncbi
rat monoclonal (1M7.8.1)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1b
Invitrogen CD44 antibody (Invitrogen, MA4405) was used in immunohistochemistry - frozen section on mouse samples (fig 1b). Matrix Biol (2019) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen CD44 antibody (Thermo Fisher Scientific, IM-7) was used in flow cytometry on mouse samples (fig 2b). Eur J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:300; loading ...; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:300 (fig 1d). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s6a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s6a). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:600; loading ...; fig s12c
Invitrogen CD44 antibody (Thermo Fisher Scientific, 48-0441-80) was used in flow cytometry on mouse samples at 1:600 (fig s12c). Nat Commun (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen CD44 antibody (eBioscience, 17-0441-83) was used in flow cytometry on mouse samples (fig 4a). Cell Rep (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 5a
Invitrogen CD44 antibody (eBioscience, 11-0441-82) was used in flow cytometry on human samples (fig 5a). Oncotarget (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). Cell Death Dis (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig e3c
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig e3c). Nature (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s2j
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s2j). Science (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6a). Cancer Res (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD44 antibody (eBioscience, 17-0441-81) was used in flow cytometry on mouse samples (fig 1a). J Biol Chem (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7e
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 7e). J Exp Med (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s3). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5d). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; loading ...; fig 3a
Invitrogen CD44 antibody (Affymetrix/eBioscience, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 3a). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). Front Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3d
Invitrogen CD44 antibody (eBiosciences, 25-0441-82) was used in flow cytometry on mouse samples (fig 3d). Cell (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 2d
Invitrogen CD44 antibody (eBiosciences, 17-0441-82) was used in flow cytometry on human samples (fig 2d). Oncogene (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6b
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6b). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4f
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4f). J Immunol (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen CD44 antibody (eBioscience, 12-0441) was used in flow cytometry on mouse samples (fig 1d). J Clin Invest (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1f
  • immunocytochemistry; mouse; loading ...; fig s1b
Invitrogen CD44 antibody (ThermoFisher Scientific, 17-0441) was used in flow cytometry on mouse samples (fig 1f) and in immunocytochemistry on mouse samples (fig s1b). Cell Stem Cell (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3g
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s3g). Cancer Res (2018) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2b
Invitrogen CD44 antibody (Invitrogen, IM7) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5b
In order to investigate the role of protease-activated receptor 2 in lymphocyte development, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5b). Int J Biochem Cell Biol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3f
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 3f). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to study the role of lysine acetyltransferase GCN5 in iNKT cell development and its mechanism, Invitrogen CD44 antibody (eBioscience, 11-0441-81) was used in flow cytometry on mouse samples (fig 2c). Cell Rep (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3b
In order to study the involvement of the Ox40/Ox40 ligand pathway in systemic lupus erythematosus, Invitrogen CD44 antibody (eBioscience, 17-0441) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5c
In order to study the regulatory mechanism for the sex-dependent stroke mortality, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 5c). Cell Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
In order to investigate the role of Egr2 and 3 in adaptive immune responses and its mechanism, Invitrogen CD44 antibody (eBiosciences, 25-0441-81) was used in flow cytometry on mouse samples (fig 1e). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4a). Eur J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1a
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 8a
In order to determine the role of RelB in classical dendritic cell and myeloid development, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 8a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:200; fig s5e
In order to investigate how LACTB suppresses breast cancer cell growth, Invitrogen CD44 antibody (eBioscience, 25-0441-81) was used in flow cytometry on human samples at 1:200 (fig s5e). Nature (2017) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human; loading ...; fig 3b
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Invitrogen CD44 antibody (Invitrogen, MHCD4401) was used in flow cytometry on human samples (fig 3b). Cell Death Dis (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s3d
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, Invitrogen CD44 antibody (eBioscience, 12-0441-83) was used in flow cytometry on mouse samples (fig s3d). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (156-3C11)
  • immunocytochemistry; human; loading ...; fig 2e
In order to find RE1 silencing transcription factor regulates epithelial-mesenchymal transition and neuroendecrin cell stemness acquisition in hormone-refractory prostate cancer, Invitrogen CD44 antibody (Thermo Scientific, MA5-13890) was used in immunocytochemistry on human samples (fig 2e). Sci Rep (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1d
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2017) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human; fig s1a
Invitrogen CD44 antibody (Invitrogen, MEM-85) was used in flow cytometry on human samples (fig s1a). Int J Mol Sci (2017) ncbi
rat monoclonal (IM7)
  • blocking or activating experiments; human; loading ...
In order to implicate myeloid differentiation factor-2 as the high-affinity soluble CD83 binding partner, Invitrogen CD44 antibody (eBioscience, IM7) was used in blocking or activating experiments on human samples . J Immunol (2017) ncbi
mouse monoclonal (156-3C11)
  • blocking or activating experiments; human; loading ...; fig 4c
In order to implicate myeloid differentiation factor-2 as the high-affinity soluble CD83 binding partner, Invitrogen CD44 antibody (Invitrogen, 156-3c11) was used in blocking or activating experiments on human samples (fig 4c). J Immunol (2017) ncbi
mouse monoclonal (VFF-7)
  • blocking or activating experiments; human; loading ...
In order to implicate myeloid differentiation factor-2 as the high-affinity soluble CD83 binding partner, Invitrogen CD44 antibody (eBioscience, VFF-7) was used in blocking or activating experiments on human samples . J Immunol (2017) ncbi
mouse monoclonal (5F12)
  • blocking or activating experiments; human; loading ...
In order to implicate myeloid differentiation factor-2 as the high-affinity soluble CD83 binding partner, Invitrogen CD44 antibody (Invitrogen, 5F12) was used in blocking or activating experiments on human samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a). Blood (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 3e
In order to demonstrate that ADAM12 supports the cancer stem cell phenotype in claudin-low breast cancer cells via modulation of the epidermal growth factor receptor pathway, Invitrogen CD44 antibody (Affymetrix eBioscience, IM7) was used in flow cytometry on human samples (fig 3e). Mol Cancer (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to evaluate miR-29a in B cells as a potential therapeutic target in arthritis, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 2c). Cell Mol Life Sci (2017) ncbi
mouse monoclonal (VFF-327v3)
  • immunohistochemistry; human; loading ...; fig 1c
In order to assess the expression of Lrig1 in senescent atrophic human epidermis and in the epidermis of CD44 knockout mice, Invitrogen CD44 antibody (Bender MedSystems, BMS144) was used in immunohistochemistry on human samples (fig 1c). PLoS ONE (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
In order to show that ABCA7 regulates natural killer T cell development in a cell-extrinsic manner, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1). Sci Rep (2017) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human; loading ...; fig s1a
In order to assess the human hematopoietic stem cell self-renewal potential and quiescence in an in vitro leukemic niche without leukemic cells, Invitrogen CD44 antibody (Invitrogen, MEM-85) was used in flow cytometry on human samples (fig s1a). Exp Hematol Oncol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1C
In order to evaluate the potential role of the attachment of myristic acid to the N-terminal glycine of proteins on the activation of gamma delta T cells, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1C). J Leukoc Biol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2
In order to examine natural killer T cell development in mice deficient for SLAM family receptors, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to determine that NKG2C/E identifies the CD4 T cell effector subset ThCTL that develop in the lung during influenza A virus infection in mice, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2a
  • immunocytochemistry; mouse; fig 2h
In order to explore the role of PKCalpha-DOCK8-Cdc42 signaling in T cell migration, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a) and in immunocytochemistry on mouse samples (fig 2h). J Exp Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6a
In order to explore if the anti-diabetic sulphonylurea glibenclamide protects insulin-producing cells against conditions mimicking those expected at the onset of type 1 diabetes, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6a). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:400; loading ...; fig s4a
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples at 1:400 (fig s4a). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2c
Invitrogen CD44 antibody (Affymetrix eBioscience, 17-0441-81) was used in flow cytometry on mouse samples at 1:100 (fig 2c). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1
In order to discuss differences in eosinophil degranulation between humans and mice, Invitrogen CD44 antibody (eBiosciences, M27) was used in flow cytometry on mouse samples (fig s1). Am J Respir Crit Care Med (2017) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2
In order to assess the effect of adult Sertoli cell condition medium on the induction of germ cells from bone marrow mesenchymal stem cells, Invitrogen CD44 antibody (eBioscience, 12-0441-81) was used in flow cytometry on mouse samples (fig 2). Iran J Basic Med Sci (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to find a role for RAB43 in cross-presentation by classical dendritic cells, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to use knockout mice to determine if GRK6 contributes to hematopoiesis, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Cell Death Dis (2016) ncbi
mouse monoclonal (156-3C11)
  • flow cytometry; human; fig 2b
In order to explore how the CD74/CD44 MIF receptor contributes to rheumatoid arthritis, Invitrogen CD44 antibody (ThermoFisher Scientific, 156-3c11) was used in flow cytometry on human samples (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:800; loading ...; fig 2b
Invitrogen CD44 antibody (Thermo Fisher, MA5-13890) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 2b). Mol Med Rep (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 3a
In order to propose that CD44+/24- is a good prognostic marker for breast cancer, Invitrogen CD44 antibody (Thermo Fisher, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3a). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:100; loading ...; fig 1C
In order to investigate the roles of CD44s and CD44v in the development of bone metastases, Invitrogen CD44 antibody (eBioscience, 12-0441-81) was used in flow cytometry on human samples at 1:100 (fig 1C). Oncol Lett (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 5a
In order to describe the microRNA regulatory network that is activated in macrophages during infection with Mycobacterium tuberculosis, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 5a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3e
In order to characterize side population T cells, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 3e). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1d
In order to elucidate how CD4 positive T cells help regulate blood pressure, Invitrogen CD44 antibody (eBioscience, 12-0441-81) was used in flow cytometry on mouse samples (fig 1d). Nat Biotechnol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to investigate the contribution of TGF-beta to the eomesodermin-driven CD4 T cell program during viral infection, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1b). J Clin Invest (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to demonstrate that the negative regulation of T cell receptor signaling during natural killer T cell development regulates NKT1 and NKT2 differentiation and survival, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2c). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2c
In order to propose that loss of Llgl1 results in epidermal growth factor receptor mislocalization and leads to pre-neoplastic changes, Invitrogen CD44 antibody (eBioscience, 17-0441) was used in flow cytometry on human samples (fig 2c). Oncotarget (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; pigs ; fig 1b
  • immunocytochemistry; pigs ; 1:100; fig 1a
In order to assess the presence of vitamin D machinery on porcine adipose-derived MSCs, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on pigs samples (fig 1b) and in immunocytochemistry on pigs samples at 1:100 (fig 1a). Stem Cell Res Ther (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s4
In order to demonstrate that OTULIN is essential for preventing TNF-associated systemic inflammation in humans and mice, Invitrogen CD44 antibody (eBioscience, 12-0441-81) was used in flow cytometry on mouse samples (fig s4). Cell (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 1
Invitrogen CD44 antibody (eBioscience, 25-0441) was used in flow cytometry on human samples (fig 1). Stem Cell Res Ther (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the role of galectin-3 in gastrointestinal cancer stem cells, Invitrogen CD44 antibody (bd, 47044182) was used in flow cytometry on human samples (fig 1a). Cell Death Dis (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1e
In order to implement lck-cre transgenic mice to study the role of loxP-targeted genes in T cell development and function, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1e). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 6f
In order to demonstrate that Blimp-1 controls CD4 T cell exhaustion, Invitrogen CD44 antibody (Affymetrix eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6f). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Am J Pathol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (156-3C11)
  • immunocytochemistry; human; loading ...; fig 1d
  • western blot; human; loading ...; fig 2b
In order to investigate the roles of CD44v3 and CD44v6 in endocrine-resistant breast cancer, Invitrogen CD44 antibody (Thermo Fisher Scientific, 156-3C11) was used in immunocytochemistry on human samples (fig 1d) and in western blot on human samples (fig 2b). Front Oncol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:500; fig st1
Invitrogen CD44 antibody (eBioscience, 25-0441) was used in flow cytometry on mouse samples at 1:500 (fig st1). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; 1:50; fig 6
Invitrogen CD44 antibody (eBioscience, 48-0441-82) was used in immunocytochemistry on human samples at 1:50 (fig 6). BMC Biol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 0.5 ul/ml; fig 3
In order to assess targeting of tumor-initiating cells through down-regulation of stemness genes expression by cryptotanshinone, Invitrogen CD44 antibody (eBioscience, 12-0441-82) was used in flow cytometry on human samples at 0.5 ul/ml (fig 3). Oncol Lett (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). J Clin Invest (2016) ncbi
rat monoclonal (HERMES-1)
  • blocking or activating experiments; human; fig 3a
Invitrogen CD44 antibody (Thermo Fisher Scientific, Hermes-1) was used in blocking or activating experiments on human samples (fig 3a). PLoS Pathog (2016) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human; fig 1b
In order to assess the use of human adipose-derived stem cells to treat cancer, Invitrogen CD44 antibody (Invitrogen, MHCD4401) was used in flow cytometry on human samples (fig 1b). Cytotherapy (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 3d). PLoS ONE (2016) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; 1:500; loading ...; fig s10
In order to elucidate cellular mechanisms that regulate the formation of clusters of circulating tumor cells, Invitrogen CD44 antibody (eBioscience, IM7) was used in immunocytochemistry on human samples at 1:500 (fig s10). J R Soc Interface (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
In order to examine the effects of mesenchymal stromal cell-derived extracellular vesicles on bone marrow radiation damage, Invitrogen CD44 antibody (eBioscience, 12-0441-82) was used in flow cytometry on mouse samples (fig s1). Leukemia (2016) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human; tbl 1
In order to research adipose tissue-derived mesenchymal stem cell proliferation and death with oxysterols, Invitrogen CD44 antibody (Invitrogen, MHCD4401-FITC) was used in flow cytometry on human samples (tbl 1). J Steroid Biochem Mol Biol (2017) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry; human; fig 1
In order to analyze the impact of breast cancer stem cell marker expression on clinical outcome and trastuzumab response in human epidermal growth factor receptor 2-positive breast cancer, Invitrogen CD44 antibody (Thermo Fisher Scientific, 156-3C11) was used in immunohistochemistry on human samples (fig 1). Br J Cancer (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen CD44 antibody (eBioscience, 25-0441) was used in flow cytometry on mouse samples . Biol Open (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2c
Invitrogen CD44 antibody (eBiosciences, 17-0441-81) was used in flow cytometry on mouse samples (fig 2c). Nature (2016) ncbi
mouse monoclonal (VFF-7)
  • flow cytometry; human; loading ...; fig 2a
In order to study Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis, Invitrogen CD44 antibody (Thermo Fisher, VFF-7) was used in flow cytometry on human samples (fig 2a). Am J Physiol Lung Cell Mol Physiol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (156-3C11)
  • flow cytometry; human; 1:200; fig 3
In order to characterize colonic cells treated with 4-methylnitrosamino-1-3-pyridyl-1-butanone, Invitrogen CD44 antibody (Thermo, MS-668) was used in flow cytometry on human samples at 1:200 (fig 3). Oncotarget (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig cd44
In order to propose that neuronal autoimmunity is a pathogenic feature of type 1 diabetes, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig cd44). Diabetes (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 7
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 7). elife (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig 5
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:200 (fig 5). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
Invitrogen CD44 antibody (eBioscience, 61-0441) was used in flow cytometry on mouse samples (fig 6). Clin Cancer Res (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:200; fig s6b
In order to suggest that locally synthesized C1q promotes tumor growth, Invitrogen CD44 antibody (eBioscience, IMF) was used in flow cytometry on mouse samples at 1:200 (fig s6b). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1a
In order to report that the majority of microbe-specific naive T cells produced memory cells during infection, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1a). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1). Dis Model Mech (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry; human; fig 1
In order to assess CD44 expression in different grades of mucoepidermoid carcinoma, Invitrogen CD44 antibody (Thermo Scientific, 156-3C11) was used in immunohistochemistry on human samples (fig 1). Head Face Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s12
Invitrogen CD44 antibody (ebioscience, 15-0441-83) was used in flow cytometry on mouse samples (fig s12). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:800; fig 1
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:800 (fig 1). Nat Commun (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
In order to examine the contribution of Foxo1 to activated T cells, Invitrogen CD44 antibody (eBiocience, IM7) was used in flow cytometry on mouse samples (fig 3). Nature (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; domestic horse; 1:200; fig 1
Invitrogen CD44 antibody (eBioscience, 17-0441-81) was used in immunohistochemistry on domestic horse samples at 1:200 (fig 1). Stem Cell Reports (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry; human; 1:100; fig e5
In order to study triple-negative breast cancer and BET bromodomain inhibitor response and resistance, Invitrogen CD44 antibody (NeoMarkers, MS-668-P1) was used in immunohistochemistry on human samples at 1:100 (fig e5). Nature (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of miR-34a in efferocytosis, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 2a
In order to find that breast cancer stem cells isolated with CD44(+)CD24(-/lo)SSEA-3(+) or ESA(hi)PROCR(hi)SSEA-3(+) markers have higher tumorigenicity than those with conventional markers, Invitrogen CD44 antibody (eBioscience, IM-7) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen CD44 antibody (eBioscience, 11-0441-81) was used in flow cytometry on mouse samples . Sci Rep (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig s1
In order to study the polysialylation of CCR7, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
In order to research the connection between oligodendrocyte death and immune-mediated CNS demyelination, Invitrogen CD44 antibody (eBioscience, 17-0441) was used in flow cytometry on mouse samples (fig 4). Nat Neurosci (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
Invitrogen CD44 antibody (eBioscience, 48-0441-82) was used in flow cytometry on mouse samples (fig 6). Nature (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of TfR1 in adaptive immunity, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Nat Genet (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry; mouse; 0.2 ug/ml; fig 2
In order to investigate how CD44 modulation induced resistance to type 1 diabetes in NOD mice, Invitrogen CD44 antibody (Thermo Scientific, MA1-10225) was used in immunohistochemistry on mouse samples at 0.2 ug/ml (fig 2). PLoS ONE (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 2e
  • flow cytometry; human; 1:100; fig 2g
  • immunocytochemistry; human; 1:100; fig 3e
In order to study the differentiation of oral mucosa stromal cells into neural crest stem cells and assess their therapeutic value, Invitrogen CD44 antibody (eBioscience, IM7) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2e), in flow cytometry on human samples at 1:100 (fig 2g) and in immunocytochemistry on human samples at 1:100 (fig 3e). Stem Cells Transl Med (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; rat; fig 2
Invitrogen CD44 antibody (eBioscience, 12-0441) was used in flow cytometry on rat samples (fig 2). Mol Med Rep (2016) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse
In order to study hepatocellular carcinoma and ectopic lymphoid structures function as microniches for tumor progenitor cells, Invitrogen CD44 antibody (eBioscience, IM7) was used in immunohistochemistry - paraffin section on mouse samples . Nat Immunol (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to examine CD44 and MMP-9 expression in different ulcerative colitis lesions, Invitrogen CD44 antibody (Thermo-Lab Vision, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Ann Diagn Pathol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to explore the impact of chronic antigenic stimulation on CD4(+) T cell dynamics, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
mouse monoclonal (5F12)
  • blocking or activating experiments; human; loading ...; fig 2e
In order to elucidate how group A Streptococcus modulates neutrophil responses via Siglec-9, Invitrogen CD44 antibody (Thermo Scientific, MS-178-PABX) was used in blocking or activating experiments on human samples (fig 2e). J Mol Med (Berl) (2016) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100-1:200; fig 2
In order to discuss thymic involution, Invitrogen CD44 antibody (Thermo Scientific, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:100-1:200 (fig 2). Int J Clin Exp Pathol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 1
In order to report a role for effector T helper type 2 cells during T cell receptor-independent innate-like immune responses, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study PI3Kdelta in CD8+ T cells during infection with Listeria monocytogenes, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry; human; 1:25
In order to evaluate the expression of CD24, CD44, CD133 and ALDH1 in invasive ductal carcinoma of the breast, Invitrogen CD44 antibody (Thermo-Labvision, MS-668-R7) was used in immunohistochemistry on human samples at 1:25. Pathol Res Pract (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100; loading ...; fig 1c
Invitrogen CD44 antibody (eBioscience, (48-0441-82) was used in flow cytometry on mouse samples at 1:100 (fig 1c). Stem Cell Reports (2015) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human; fig 1
In order to assess the effects of palladium(II) and niclosamide on the Wnt signaling pathway associated with breast cancer stem cells, Invitrogen CD44 antibody (Thermo Scientific, MEM-85) was used in flow cytometry on human samples (fig 1). Bioorg Med Chem (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig 4). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 2e
In order to assess surface expression of C-type lectin-like receptor 2 on hematopoietic cells from peripheral blood and secondary lymphoid organs, Invitrogen CD44 antibody (eBiosciences, 1M7) was used in flow cytometry on mouse samples (fig 2e). Eur J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). Immunity (2015) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; human; fig s8
In order to describe the use of CCR9 expression to create primary gastrointestinal tumors in immunodeficient mice by tail-vein injection, Invitrogen CD44 antibody (ebiosciences, IM7) was used in immunohistochemistry - paraffin section on human samples (fig s8). Nat Biotechnol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s1
Invitrogen CD44 antibody (eBioscience, 17-0441-82) was used in flow cytometry on mouse samples (fig s1). Cell Death Dis (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; loading ...; fig 7b
In order to find that lymph node-like vasculature in melanoma and lung carcinoma murine models is both a consequence of and key contributor to anti-tumor immunity, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 7b). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 1
Invitrogen CD44 antibody (eBioscience, 47-0441-80) was used in flow cytometry on human samples (fig 1). Stem Cell Res Ther (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 3). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1b
In order to assess a CD 4 T-cell population during tuberculosis that has memory-like properties maintained by Bcl6 and ICOS-dependent pathways, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human
In order to study the breast tumor microenvironment and interleukin-6 and pro inflammatory status, Invitrogen CD44 antibody (Neomarkers, 156-3C11) was used in immunohistochemistry - paraffin section on human samples . World J Surg Oncol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; tbl 5
In order to test if platelet-derived growth factor receptor-alpha inhibition reduces proliferation of mutant KIT-expressing gastrointestinal stromal tumor cells via ETV1, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on human samples (tbl 5). Gastroenterology (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:1000; fig 4
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:1000 (fig 4). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
Invitrogen CD44 antibody (eBioscience, 11-0441) was used in flow cytometry on mouse samples (fig 4). EMBO Mol Med (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; fig 2
Invitrogen CD44 antibody (eBioscience, 48-0441) was used in flow cytometry on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry; human; fig 9
In order to study promotion of collective invasion by an epigenetically distinct breast cancer cell subpopulation, Invitrogen CD44 antibody (Thermo Fisher Scientific, 156-3C11) was used in immunohistochemistry on human samples (fig 9). J Clin Invest (2015) ncbi
rat monoclonal (HERMES-1)
  • blocking or activating experiments; human
In order to study the role of MMP and ADAM in the temozolomide-induced recurrence of glioblastoma, Invitrogen CD44 antibody (Thermo Scientific, MA4400) was used in blocking or activating experiments on human samples . Neuro Oncol (2015) ncbi
mouse monoclonal (MA54)
  • immunocytochemistry; human; 1:5
  • immunohistochemistry; human; 1:50
Invitrogen CD44 antibody (Invitrogen, clone MA54) was used in immunocytochemistry on human samples at 1:5 and in immunohistochemistry on human samples at 1:50. Mol Cell Proteomics (2015) ncbi
mouse monoclonal (156-3C11)
  • immunocytochemistry; human; 4 ug/ml
In order to determine the role of CD9 in adhesion, migration and invasiveness of breast cancer cells, Invitrogen CD44 antibody (ThermoScientific, MA5-13890) was used in immunocytochemistry on human samples at 4 ug/ml. Oncotarget (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human
Invitrogen CD44 antibody (Ebioscience, 11-0441) was used in flow cytometry on human samples . Cancer Lett (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s2). Nat Immunol (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:2000; tbl 2
In order to identify biomarkers using HER2-positive advanced breast cancer samples from patients treated with trastuzumab and paclitaxel combination chemotherapy, Invitrogen CD44 antibody (Thermo Fisher Scientific, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (tbl 2). Tumour Biol (2015) ncbi
rat monoclonal (IM7)
  • western blot; mouse; 1:100; fig 5,6
Invitrogen CD44 antibody (eBioscience, IM7) was used in western blot on mouse samples at 1:100 (fig 5,6). Nat Commun (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; tbl s3
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (tbl s3). PLoS ONE (2015) ncbi
rat monoclonal (IM7)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse
Invitrogen CD44 antibody (e-Bioscience, IM7) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples . Oncogene (2015) ncbi
mouse monoclonal (VFF-18)
  • flow cytometry; human; 1:100; fig 1
In order to assess the contribution of c-Met signaling to dissemination of medulloblastoma, Invitrogen CD44 antibody (eBioscience, BMS125) was used in flow cytometry on human samples at 1:100 (fig 1). Springerplus (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Sci Rep (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 5). Nat Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:50; fig 1
In order to characterize human tracheal basal cells, Invitrogen CD44 antibody (eBioscience, 14-0441-81) was used in flow cytometry on human samples at 1:50 (fig 1). Respir Res (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Immunol Lett (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 3
In order to investigate the role of Rpl22 during early B cell development, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to examine the role of lymph node stromal cells in immune responses, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . elife (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1). J Leukoc Biol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study CD4 and CD8 responses to L. monocytogenes using GZMB-Tom knock-in mice, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Immunology (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6c
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6c). Nat Immunol (2014) ncbi
mouse monoclonal (SFF-2)
  • immunohistochemistry; human; 1:500
Invitrogen CD44 antibody (eBiosciences, SFF-2) was used in immunohistochemistry on human samples at 1:500. Proc Natl Acad Sci U S A (2014) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human
In order to determine if human adult dental pulp stem cells can be induced to express retinal neuronal markers, Invitrogen CD44 antibody (Invitrogen, MHCD4401) was used in flow cytometry on human samples . Neuroscience (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 5 ul per test
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on human samples at 5 ul per test. Cytometry B Clin Cytom (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2a
In order to investigate the role of DUSP6 in colonic CD4 positive T-cell function, differentiation, and inflammatory profile, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2a). Mucosal Immunol (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to assess the diagnostic role of CD44 and E-cadherin in atypical leiomyoma and leiomyosarcoma, Invitrogen CD44 antibody (Thermo Scientific, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). J Obstet Gynaecol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; tbl 3
In order to study miR-9, and miR-155 expression in breast cancer and how their expression correlates with different features of breast cancer, Invitrogen CD44 antibody (Thermo Scientific, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 3). Breast Cancer Res Treat (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; human
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to assess the contribution of Tbx1 to thymus and parathyroid development, Invitrogen CD44 antibody (eBioscience, clone IM7) was used in flow cytometry on mouse samples . Development (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study Bacillus Calmette-Guerin DeltaureC::hly and the superior protection against tuberculosis caused by central memory CD4+ T cells, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Infect Dis (2014) ncbi
mouse monoclonal (MA54)
  • immunohistochemistry - paraffin section; human; 1:50
In order to determine whether co-expression of CD133, CD44v6, and human tissue factor are associated with metastasis and overall prognosis in pancreatic carcinoma, Invitrogen CD44 antibody (Invitrogen, 33-6700) was used in immunohistochemistry - paraffin section on human samples at 1:50. Oncol Rep (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study the immunogenicity and immunomodulatory properties of bone marrow-derived mesenchymal stem cells using an allogeneic mouse model, Invitrogen CD44 antibody (Invitrogen, IM7) was used in flow cytometry on mouse samples . J Tissue Eng (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate the role of thoracic thymus in T cell development and homeostasis, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen CD44 antibody (eBioscience Inc., IM7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:600
In order to demonstrate the heritable downregulation of CD8 during type 2 polarization of murine CD8 positive effector T cells is associated with CpG methylation of the Cd8a locus, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:600. Nat Commun (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100
In order to study the involvement of endothelium in efficient Treg T cell recruitment in vivo, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; bovine
Invitrogen CD44 antibody (eBioscience, 12-0441) was used in flow cytometry on bovine samples . Tissue Eng Part A (2014) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; 1:10
Invitrogen CD44 antibody (eBioscience, 45-0441-80) was used in flow cytometry on human samples at 1:10. Odontology (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; 1:100
Invitrogen CD44 antibody (eBioscience, 12-0441-81) was used in flow cytometry on mouse samples at 1:100. Cell Transplant (2015) ncbi
mouse monoclonal (VFF-14)
  • flow cytometry; human
In order to study the presence in a sarcomatoid renal carcinoma cell line of both epithelioid and fibroblastoid cells, Invitrogen CD44 antibody (Biosource, VFF-14) was used in flow cytometry on human samples . Anticancer Res (2013) ncbi
mouse monoclonal (VFF-17)
  • flow cytometry; human
In order to study the presence in a sarcomatoid renal carcinoma cell line of both epithelioid and fibroblastoid cells, Invitrogen CD44 antibody (Biosource, VFF-17) was used in flow cytometry on human samples . Anticancer Res (2013) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human
In order to assess the susceptibility of fetal membranes-derived mesenchymal stromal/stem cells to all members of the human Herpesviridae family, Invitrogen CD44 antibody (Caltag Laboratories, clone MEM 85) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s9
In order to generate and characterize Hoxb8-FL cells, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples (fig s9). Nat Methods (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5a
In order to report the development of dendritic cells and other lineages in Bcl11a knockout mice, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5a). PLoS ONE (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig s2
In order to use a mouse model to examine the link between the microbiota and atopic dermatitis, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig s2). J Invest Dermatol (2013) ncbi
mouse monoclonal (VFF-7)
  • flow cytometry; human; 1:100
Invitrogen CD44 antibody (Bender Medsystems, clone VFF7) was used in flow cytometry on human samples at 1:100. Stem Cells (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Biomed Res Int (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study the impact of mesenchymal stem cells to experimental allergic encephalomyelitis, Invitrogen CD44 antibody (eBioscience, IM-7) was used in flow cytometry on mouse samples . Front Immunol (2013) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate the role of BTB-ZF factors in lymphoid effector programs, Invitrogen CD44 antibody (e-Bioscience, IM7) was used in flow cytometry on mouse samples . Nature (2012) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate how TGF-beta signaling regulates the self-reactivity of peripheral T cells, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Nat Immunol (2012) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to suggest that CD80 and CD86 contribute to polyclonal B cell activation mediated by Lat(Y136F) CD4 positive T cells, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Front Immunol (2012) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100
In order to identify diagnostic and prognostic markers for glioblastoma, Invitrogen CD44 antibody (Lab Vision, MS-668) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Oncol (2012) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to investigate age- and antigen-specific CD8 T cell responses, Invitrogen CD44 antibody (e-Bioscience, IM-7) was used in flow cytometry on mouse samples . PLoS Pathog (2011) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human; fig 3
In order to investigate how mesenchymal stem cells improve hematopoietic stem cell transplantability, Invitrogen CD44 antibody (Caltag, MEM85) was used in flow cytometry on human samples (fig 3). Int J Hematol (2011) ncbi
rat monoclonal (1M7.8.1)
  • flow cytometry; mouse
In order to determine the role for DOCK8 in peripheral CD8 T cell survival and function, Invitrogen CD44 antibody (Invitrogen, 1M7) was used in flow cytometry on mouse samples . J Exp Med (2011) ncbi
rat monoclonal (IM7)
  • western blot; mouse; fig 4b
Invitrogen CD44 antibody (eBioscience, 14-0441) was used in western blot on mouse samples (fig 4b). Leukemia (2011) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human; fig 3
In order to characterize stem cells isolated and expanded from the human dental pulp, Invitrogen CD44 antibody (Invitrogen, MEM 85) was used in flow cytometry on human samples (fig 3). J Biomed Biotechnol (2010) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 5, 6
In order to report that NAD(+) regulates the survival, phenotype, and function of T regulatory cells via the ART2-P2X7 pathway, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 5, 6). J Exp Med (2010) ncbi
mouse monoclonal (MA54)
  • immunocytochemistry; human; 1:100; fig 3
  • immunohistochemistry; human; 1:200; fig 4
In order to examine the mRNA splicing pattern of CD44 in normal stomach and gastric cancer cell lines, Invitrogen CD44 antibody (Invitrogen, clone MA54) was used in immunocytochemistry on human samples at 1:100 (fig 3) and in immunohistochemistry on human samples at 1:200 (fig 4). Lab Invest (2010) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 6
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 6). J Immunol (2010) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to elucidate the role of AUF1 in the immune system, Invitrogen CD44 antibody (eBioScience, IM7) was used in flow cytometry on mouse samples (fig 1). BMC Immunol (2010) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
In order to determine the roles of c-Myb during lymphocyte development, Invitrogen CD44 antibody (eBioscience, 1M7) was used in flow cytometry on mouse samples (fig 4). J Immunol (2009) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to determine the contribution of CD4+ T cells in the generation of CD8+-T-cell responses following acute infection with HSV-1, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Virol (2009) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to elucidate the role of IL-17 in influenza A infection, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
In order to study how multifactorial adjuvants show reduced toxicity and enhanced efficacy compared to unitary adjuvants as cancer vaccines, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2). Blood (2008) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study the strength and duration of an antigenic signal at initial stimulation and the development and response of effectors and memory cells to secondary stimulation with the same antigen, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Immunology (2008) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; tbl 1
In order to elucidate the role of IL-10 in regulating hepatic injury using IL-10 knockout mice infected with Trichinella spiralis, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2007) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2B
In order to discuss the development and functions of effector and memory Foxp3+ T cells, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 2B). J Immunol (2007) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to evaluate the use of biodegradable poly(D,L-lactic-co-glycolic acid) nanoparticles as a vaccine delivery system, Invitrogen CD44 antibody (E-Bioscience, 1M7) was used in flow cytometry on mouse samples . J Biomed Mater Res A (2007) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4
In order to assess how FTY720-treatment affects T cell populations, Invitrogen CD44 antibody (ebiosciences, IM7) was used in flow cytometry on mouse samples (fig 4). Int Immunopharmacol (2006) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to propose that memory T cells respond to alloantigens initially but fail to fully develop functionally, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1). Blood (2007) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human; tbl 1
In order to characterize B cells in human tonsils, Invitrogen CD44 antibody (Caltag, MEM-85) was used in flow cytometry on human samples (tbl 1). Blood (2007) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human
In order to report the expression of chemokine receptors on FOXP3+ T cells, Invitrogen CD44 antibody (Caltag, MEM-85) was used in flow cytometry on human samples . J Immunol (2006) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to study recent thymic emigrants in aged mice, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2006) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to demonstrate that software designed for transcriptomics applications can be used in multiparameter flow cytometry, Invitrogen CD44 antibody (ebiosciences, IM7) was used in flow cytometry on mouse samples . Cytometry A (2006) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human
In order to use flow cytometry to characterize mesenchymal stromal cell subsets and abnormalities, Invitrogen CD44 antibody (Caltag, MEM 85) was used in flow cytometry on human samples . Haematologica (2006) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to examine the role of T-bet in Valpha14i natural killer T cell function, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 1). Blood (2006) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to evaluate the tuberculosis vaccine candidate Mtb72F, Invitrogen CD44 antibody (eBiosciences, IM7) was used in flow cytometry on mouse samples . Infect Immun (2005) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 4A
In order to test if a pre-existing antigen-specific Th1 response affect the development of Th2 cells in vivo, Invitrogen CD44 antibody (eBioscience, IM7) was used in flow cytometry on mouse samples (fig 4A). J Immunol (2005) ncbi
mouse monoclonal (VFF-7)
  • immunohistochemistry - paraffin section; human; 1:80; fig 2
In order to determine the role of immunohistochemical markers in the differential diagnosis of follicular lesions of the thyroid, Invitrogen CD44 antibody (Biosource International, VFF-7) was used in immunohistochemistry - paraffin section on human samples at 1:80 (fig 2). In Vivo (2004) ncbi
mouse monoclonal (MEM-85)
  • flow cytometry; human
In order to test if human fetal liver cells expressing CD34 and CK7/8 represent a common stem cell for both the hematopoietic and hepatic systems, Invitrogen CD44 antibody (Caltag, MEM85) was used in flow cytometry on human samples . J Hepatol (2004) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse
In order to report two Treg subsets with distinct phenotypes and homeostasis in normal unmanipulated mice, Invitrogen CD44 antibody (Zymed, IM7) was used in flow cytometry on mouse samples . J Exp Med (2003) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to characterize murine tumor-infiltrating lymphocytes, Invitrogen CD44 antibody (CalTag, IM7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2001) ncbi
rat monoclonal (1M7.8.1)
  • flow cytometry; mouse; fig 2
In order to report that the lymphoid environment limits T cell proliferation in response to high superantigen levels, Invitrogen CD44 antibody (Caltag, 1 M.781) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2001) ncbi
mouse monoclonal (VFF-17)
  • immunohistochemistry - paraffin section; human; fig 1
In order to test if CD44, CD44v6, and CD44v7-8 are useful markers of squamous differentiation in epithelial tumors, Invitrogen CD44 antibody (Biosource, VFF-17) was used in immunohistochemistry - paraffin section on human samples (fig 1). Arch Pathol Lab Med (2000) ncbi
mouse monoclonal (VFF-7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to test if CD44, CD44v6, and CD44v7-8 are useful markers of squamous differentiation in epithelial tumors, Invitrogen CD44 antibody (Biosource, VFF-7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Arch Pathol Lab Med (2000) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 1
In order to study CD44 and hyaluronic acid interactions, Invitrogen CD44 antibody (noco, IM7) was used in flow cytometry on mouse samples (fig 1). J Exp Med (1992) ncbi
Abcam
domestic rabbit monoclonal (EPR18668)
  • immunocytochemistry; human; 1:500; loading ...; fig 5b
Abcam CD44 antibody (Abcam, ab189524) was used in immunocytochemistry on human samples at 1:500 (fig 5b). elife (2020) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot knockout validation; human; 1:1000; loading ...; fig 5a
  • proximity ligation assay; human; 1:500; loading ...; fig 3f
Abcam CD44 antibody (Abcam, ab51037) was used in western blot knockout validation on human samples at 1:1000 (fig 5a) and in proximity ligation assay on human samples at 1:500 (fig 3f). elife (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; rat; 1:2000; loading ...
Abcam CD44 antibody (Abcam, ab157107) was used in immunohistochemistry on rat samples at 1:2000. Biol Proced Online (2020) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1a
Abcam CD44 antibody (Abcam, ab51037) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1a). Cancer Manag Res (2020) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; rat; 1:1000; loading ...; fig s1b
Abcam CD44 antibody (Abcam, ab157107) was used in immunocytochemistry on rat samples at 1:1000 (fig s1b). J Neuroinflammation (2020) ncbi
domestic rabbit monoclonal (EPR18668)
  • western blot; human; 1:1000; loading ...; fig 4c
Abcam CD44 antibody (Abcam, ab189524) was used in western blot on human samples at 1:1000 (fig 4c). BMC Gastroenterol (2019) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot; human; loading ...; fig s2a
Abcam CD44 antibody (Abcam, ab51037) was used in western blot on human samples (fig s2a). BMC Cancer (2019) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s3d
Abcam CD44 antibody (Abcam, ab6124) was used in immunohistochemistry - paraffin section on mouse samples (fig s3d). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot; human; 1:1000; loading ...; fig 2s1d
Abcam CD44 antibody (AbCam, ab51037) was used in western blot on human samples at 1:1000 (fig 2s1d). elife (2019) ncbi
domestic rabbit monoclonal (EPR18668)
  • western blot; human; 1:3000; fig 1d
Abcam CD44 antibody (Abcam, ab189524) was used in western blot on human samples at 1:3000 (fig 1d). Mol Med Rep (2019) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; human; loading ...; fig 2b
  • immunohistochemistry; human; loading ...; fig 2h
Abcam CD44 antibody (Abcam, ab6124) was used in immunocytochemistry on human samples (fig 2b) and in immunohistochemistry on human samples (fig 2h). Cancer Res (2018) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot; human; loading ...; fig 1c
Abcam CD44 antibody (Abcam, ab51037) was used in western blot on human samples (fig 1c). Oncol Lett (2018) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot; human; fig 1d
Abcam CD44 antibody (Abcam, ab51037) was used in western blot on human samples (fig 1d). Stem Cell Reports (2017) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • flow cytometry; human; 1:50; loading ...; fig 1c
  • immunohistochemistry; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 2c
Abcam CD44 antibody (Abcam, ab51037) was used in flow cytometry on human samples at 1:50 (fig 1c), in immunohistochemistry on human samples (fig 4b) and in western blot on human samples (fig 2c). J Biol Chem (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:100; loading ...; fig 5f
  • immunohistochemistry; rat; 1:200; loading ...; fig 9a
In order to develop and characterize a rat model of glioma, Abcam CD44 antibody (Abcam, ab157107) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 5f) and in immunohistochemistry on rat samples at 1:200 (fig 9a). PLoS ONE (2017) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot; human; loading ...; fig 5a
Abcam CD44 antibody (Abcam, ab51037) was used in western blot on human samples (fig 5a). Oncol Lett (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig s4g
In order to elucidate novel functions of the senescence-associated secretory in promoting a proregenerative response through the induction of cell plasticity and stemness, Abcam CD44 antibody (Abcam, ab157107) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s4g). Genes Dev (2017) ncbi
mouse monoclonal (B-F24)
  • flow cytometry; human; fig 2a
Abcam CD44 antibody (Abcam, ab27285) was used in flow cytometry on human samples (fig 2a). Exp Ther Med (2016) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; human; 1:100; loading ...; fig 4a
In order to find that TrpC5 regulates differentiation in colorectal cancer, Abcam CD44 antibody (Abcam, ab6124) was used in immunocytochemistry on human samples at 1:100 (fig 4a). Clin Sci (Lond) (2017) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • immunohistochemistry - paraffin section; human; fig 4
  • immunoprecipitation; human; fig 7
Abcam CD44 antibody (Abcam, ab51037) was used in immunohistochemistry - paraffin section on human samples (fig 4) and in immunoprecipitation on human samples (fig 7). Oncogene (2017) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot; human; fig 2
Abcam CD44 antibody (Abcam, ab51037) was used in western blot on human samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry; human; fig 4a
In order to perform Raman-encoded molecular imaging with five nanoparticle flavors, Abcam CD44 antibody (Abcam, ab6124) was used in immunohistochemistry on human samples (fig 4a). PLoS ONE (2016) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; human; 1:100; fig 2
In order to investigate the contribution of DNA methyltransferase 1 to the epithelial-mesenchymal transition and cancer stem cells, Abcam CD44 antibody (Abcam, ab6124) was used in immunocytochemistry on human samples at 1:100 (fig 2). Neoplasia (2016) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • immunohistochemistry - paraffin section; human; fig 6b
Abcam CD44 antibody (Abcam, ab51037) was used in immunohistochemistry - paraffin section on human samples (fig 6b). Oncotarget (2016) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry; human; 1:400; fig 1b
Abcam CD44 antibody (Abcam, F10-44-2) was used in immunohistochemistry on human samples at 1:400 (fig 1b). Oncogene (2017) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry - paraffin section; human; 1:100; fig 4c
Abcam CD44 antibody (Abcam, ab6124) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4c). Biochem Pharmacol (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:10,000; loading ...; fig 5d
Abcam CD44 antibody (Abcam, ab24504) was used in western blot on rat samples at 1:10,000 (fig 5d). Int J Mol Sci (2016) ncbi
mouse monoclonal (MEM-85)
  • immunocytochemistry; human; fig 2b
Abcam CD44 antibody (Abcam, ab2212) was used in immunocytochemistry on human samples (fig 2b). BMC Biol (2016) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • immunocytochemistry; human; fig 7
In order to investigate cell stemness and pluripotency and differentiation of cells from human testicular sperm extraction, Abcam CD44 antibody (Abcam, ab51037) was used in immunocytochemistry on human samples (fig 7). Mol Reprod Dev (2016) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; human; fig 3
Abcam CD44 antibody (Abcam, ab6124) was used in immunocytochemistry on human samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (VFF-18)
  • western blot; human; loading ...; fig 2a
Abcam CD44 antibody (Abcam, ab78960) was used in western blot on human samples (fig 2a). Oncol Lett (2016) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; domestic rabbit; 1:200; fig 5b
  • immunohistochemistry; domestic rabbit; 1:200; fig 5b
Abcam CD44 antibody (abcam, ab6124) was used in immunocytochemistry on domestic rabbit samples at 1:200 (fig 5b) and in immunohistochemistry on domestic rabbit samples at 1:200 (fig 5b). J Transl Med (2016) ncbi
mouse monoclonal (MEM-85)
  • western blot; human; 1:400; fig 4
Abcam CD44 antibody (Abcam, ab2212) was used in western blot on human samples at 1:400 (fig 4). elife (2016) ncbi
domestic rabbit polyclonal
  • flow cytometry; rat; fig 1
  • flow cytometry; domestic rabbit; fig 1
Abcam CD44 antibody (Abcam, ab157107) was used in flow cytometry on rat samples (fig 1) and in flow cytometry on domestic rabbit samples (fig 1). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Abcam CD44 antibody (Abcam, ab51037) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Oncol Rep (2015) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot; human
Abcam CD44 antibody (AbCam, ab51037) was used in western blot on human samples . elife (2015) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot; human
Abcam CD44 antibody (Abcam, ab51037) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry - paraffin section; human; fig 1a
Abcam CD44 antibody (Abcam, AB6124) was used in immunohistochemistry - paraffin section on human samples (fig 1a). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot; human; loading ...; fig 1a
Abcam CD44 antibody (Abcam, 51037) was used in western blot on human samples (fig 1a). Oncotarget (2015) ncbi
mouse monoclonal (F10-44-2)
  • immunocytochemistry; human; 1:400; fig 3
In order to study the nuclear translocation of Atox1, Abcam CD44 antibody (Abcam, ab6124) was used in immunocytochemistry on human samples at 1:400 (fig 3). Protein Pept Lett (2015) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry; mouse; 1:100; fig 5
Abcam CD44 antibody (abcam, ab6124) was used in immunohistochemistry on mouse samples at 1:100 (fig 5). Hypertension (2015) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot; human; 1:5000
In order to determine the prognostic role of the Wnt-signaling antagonist SFRP1 in bladder cancer, Abcam CD44 antibody (Abcam, ab51037) was used in western blot on human samples at 1:5000. J Cancer Res Clin Oncol (2015) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • western blot; human; fig 6
  • western blot; mouse; fig 6
Abcam CD44 antibody (Abcam, ab51037) was used in western blot on human samples (fig 6) and in western blot on mouse samples (fig 6). PLoS Pathog (2015) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry; human
Abcam CD44 antibody (Abcam, Ab6124) was used in immunohistochemistry on human samples . Circulation (2015) ncbi
mouse monoclonal (F10-44-2)
  • western blot; human; 1:3000
Abcam CD44 antibody (Abcam, ab6124) was used in western blot on human samples at 1:3000. Nitric Oxide (2015) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • immunohistochemistry - paraffin section; human; 1:50
In order to investigate the effect of neoadjuvant chemoradiotherapy on pancreatic adenocarcinoma cancer stem cell markers, Abcam CD44 antibody (Abcam, ab51037) was used in immunohistochemistry - paraffin section on human samples at 1:50. BMC Cancer (2014) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • flow cytometry; human; fig 1
Abcam CD44 antibody (Abcam, ab51037) was used in flow cytometry on human samples (fig 1). J Biomed Mater Res A (2015) ncbi
domestic rabbit monoclonal (EPR1013Y)
  • flow cytometry; human; loading ...; fig s8
Abcam CD44 antibody (abcam, ab51037) was used in flow cytometry on human samples (fig s8). Int J Cancer (2014) ncbi
mouse monoclonal (F10-44-2)
  • immunohistochemistry - frozen section; human; 1:100
  • immunohistochemistry - frozen section; mouse; 1:100
Abcam CD44 antibody (Abcam, ab6124) was used in immunohistochemistry - frozen section on human samples at 1:100 and in immunohistochemistry - frozen section on mouse samples at 1:100. Stem Cells (2013) ncbi
Abcam CD44 antibody (Abcam, ab45912) was used . PLoS ONE (2012) ncbi
Santa Cruz Biotechnology
rat monoclonal (IM7)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 5e
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotechnology, sc-18849) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 5e). J Clin Invest (2019) ncbi
mouse monoclonal (DF1485)
  • immunoprecipitation; human; loading ...; fig s2c
  • immunocytochemistry; human; loading ...; fig s2a
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotechnology, sc-7297) was used in immunoprecipitation on human samples (fig s2c), in immunocytochemistry on human samples (fig s2a) and in western blot on human samples (fig 5a). Oncotarget (2016) ncbi
mouse monoclonal (DF1485)
  • other; human; 1:100; loading ...; fig 1a, 1c
Santa Cruz Biotechnology CD44 antibody (Santa Cruz, sc-7297) was used in other on human samples at 1:100 (fig 1a, 1c). Oncotarget (2015) ncbi
mouse monoclonal (DF1485)
  • immunohistochemistry - paraffin section; human; fig s5d
Santa Cruz Biotechnology CD44 antibody (Santa Cruz, sc-7297) was used in immunohistochemistry - paraffin section on human samples (fig s5d). Oncotarget (2015) ncbi
mouse monoclonal (DF1485)
  • flow cytometry; human; fig 1
Santa Cruz Biotechnology CD44 antibody (santa Cruz, sc-7297) was used in flow cytometry on human samples (fig 1). Biomed Res Int (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; mouse; fig 2
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotechnology, sc-18849) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2015) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 3
Santa Cruz Biotechnology CD44 antibody (santa Cruz, sc-18849) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 3). Int J Mol Med (2015) ncbi
mouse monoclonal (DF1485)
  • western blot; human; 1:500
In order to study the tissue factor protein and metastasis initiating cell markers during thrombocytosis, Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotechnology, sc-7297) was used in western blot on human samples at 1:500. BMC Cancer (2015) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; 1:500; loading ...; fig 6d
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotechnology, sc-59909) was used in western blot on human samples at 1:500 (fig 6d). Int J Oncol (2015) ncbi
rat monoclonal (IM7)
  • flow cytometry; human; loading ...; fig 3a
Santa Cruz Biotechnology CD44 antibody (Santa Cruz, sc-18849) was used in flow cytometry on human samples (fig 3a). Cancer Res (2015) ncbi
mouse monoclonal (DF1485)
  • western blot; human
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotechnology, sc-7297) was used in western blot on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (DF1485)
  • western blot; human
Santa Cruz Biotechnology CD44 antibody (Santa Cruz, sc-7297) was used in western blot on human samples . J Biomed Mater Res A (2015) ncbi
mouse monoclonal (DF1485)
  • western blot; human; fig 5
Santa Cruz Biotechnology CD44 antibody (Santa Cruz, sc-7297) was used in western blot on human samples (fig 5). Cell (2014) ncbi
mouse monoclonal (Bu52)
  • immunocytochemistry; human; 1:100; loading ...; fig 2c
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotechnology, sc-65265) was used in immunocytochemistry on human samples at 1:100 (fig 2c). Biomed Res Int (2014) ncbi
mouse monoclonal (VFF-7)
  • western blot; human
In order to investigate the role of TMPRSS4 in colorectal cancer, Santa Cruz Biotechnology CD44 antibody (Santa Cruz, sc-65412) was used in western blot on human samples . Cancer Biol Ther (2014) ncbi
mouse monoclonal (DF1485)
  • immunohistochemistry - paraffin section; human; 1:50; fig 5
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 4
Santa Cruz Biotechnology CD44 antibody (Santa, sc-7297) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 5) and in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 4). Proc Natl Acad Sci U S A (2012) ncbi
rat monoclonal (IM7)
  • immunocytochemistry; mouse; 1:50
Santa Cruz Biotechnology CD44 antibody (Santa Cruz Biotech, sc-18849) was used in immunocytochemistry on mouse samples at 1:50. Reproduction (2010) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 1b
MilliporeSigma CD44 antibody (Sigma, HPA005785) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1b). Gastric Cancer (2018) ncbi
mouse monoclonal (A3D8)
  • immunocytochemistry; human; loading ...; fig s1a
In order to study brain apoE regulation, MilliporeSigma CD44 antibody (Sigma, C7923) was used in immunocytochemistry on human samples (fig s1a). Cell Chem Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
MilliporeSigma CD44 antibody (Sigma-Aldrich, HPA005785) was used in western blot on human samples (fig 5). Molecules (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:500; fig 7
MilliporeSigma CD44 antibody (Sigma, HPA005785) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 7). Clin Sci (Lond) (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:500; fig 7
MilliporeSigma CD44 antibody (Sigma, HPA005785) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 7). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:50; fig 4
In order to analyze triploid breast cancers non-responsive to neoadjuvant therapy by study of aneuploidy and senescence paradoxes, MilliporeSigma CD44 antibody (Sigma, HPA005785) was used in immunohistochemistry on human samples at 1:50 (fig 4). Histochem Cell Biol (2016) ncbi
domestic rabbit polyclonal
MilliporeSigma CD44 antibody (Sigma, HPA005785) was used . PLoS ONE (2015) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:3500; fig 4
In order to characterize human cardiac valve development by endocardial-to-mesenchymal transformation and mesenchymal cell colonization, MilliporeSigma CD44 antibody (Sigma-Aldrich, HPA005785) was used in immunohistochemistry - paraffin section on human samples at 1:3500 (fig 4). Development (2016) ncbi
Bio-Rad
mouse monoclonal (Bu52)
  • immunohistochemistry - frozen section; human; 1:1000; loading ...; fig 5l
Bio-Rad CD44 antibody (Serotec, MCA2504T) was used in immunohistochemistry - frozen section on human samples at 1:1000 (fig 5l). J Histochem Cytochem (2018) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 1
Bio-Rad CD44 antibody (AbD Serotec, MCA2726) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (VFF-7)
  • immunohistochemistry - paraffin section; camel ; 1:200; fig 7a
Bio-Rad CD44 antibody (AbD Serotec, MCA1730) was used in immunohistochemistry - paraffin section on camel samples at 1:200 (fig 7a). Reprod Fertil Dev (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; tbl 2
Bio-Rad CD44 antibody (AbD Serotec, MCA2726) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Mol Carcinog (2015) ncbi
mouse monoclonal (VFF-14)
  • western blot; human
Bio-Rad CD44 antibody (AbD Serotec, VFF14) was used in western blot on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (VFF-8)
  • flow cytometry; human; 1:100
Bio-Rad CD44 antibody (AbD Serotec, clone VFF8) was used in flow cytometry on human samples at 1:100. Stem Cells (2013) ncbi
Abnova
rat monoclonal (RV3)
  • immunocytochemistry; human; 3 ug/ml; loading ...; fig 3c
Abnova CD44 antibody (AB Nova, RV3) was used in immunocytochemistry on human samples at 3 ug/ml (fig 3c). Cancers (Basel) (2020) ncbi
Miltenyi Biotec
human monoclonal (REA690)
  • immunohistochemistry - frozen section; human; loading ...; fig 3e
Miltenyi Biotec CD44 antibody (Miltenyi Biotec, 130-113-906) was used in immunohistochemistry - frozen section on human samples (fig 3e). Cell (2019) ncbi
LifeSpan Biosciences
rat monoclonal (9A4)
  • immunohistochemistry; mouse; loading ...; fig 4d
In order to assess the expression of Lrig1 in senescent atrophic human epidermis and in the epidermis of CD44 knockout mice, LifeSpan Biosciences CD44 antibody (LifeSpan, LS-C44149) was used in immunohistochemistry on mouse samples (fig 4d). PLoS ONE (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (E7K2Y)
  • western blot; human; 1:1000; loading ...; fig 4i
Cell Signaling Technology CD44 antibody (CST, 37259S) was used in western blot on human samples at 1:1000 (fig 4i). J Cancer (2021) ncbi
mouse monoclonal (156-3C11)
  • flow cytometry; human; 1:100; loading ...; fig 3b
  • immunocytochemistry; human; 1:100; loading ...; fig 6e
Cell Signaling Technology CD44 antibody (Cell Signaling, 156-3C11) was used in flow cytometry on human samples at 1:100 (fig 3b) and in immunocytochemistry on human samples at 1:100 (fig 6e). Cancers (Basel) (2020) ncbi
domestic rabbit monoclonal (E7K2Y)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 4g
Cell Signaling Technology CD44 antibody (CST, 37259S) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 4g). Cancer Cell Int (2020) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology CD44 antibody (Cell signaling Technology, 3570) was used in western blot on human samples (fig 3a). Mol Cancer (2020) ncbi
domestic rabbit monoclonal (E7K2Y)
  • western blot; human; fig 1d
Cell Signaling Technology CD44 antibody (cell signaling, 5604) was used in western blot on human samples (fig 1d). Oncogenesis (2020) ncbi
mouse monoclonal (8E2)
  • western blot; human; loading ...; fig 1d, s2d, s2e, s2f
Cell Signaling Technology CD44 antibody (Cell Signaling, 5640) was used in western blot on human samples (fig 1d, s2d, s2e, s2f). Mol Cancer (2019) ncbi
mouse monoclonal (156-3C11)
  • immunocytochemistry; human; loading ...; fig 1b
Cell Signaling Technology CD44 antibody (Cell Signaling, 3570) was used in immunocytochemistry on human samples (fig 1b). EBioMedicine (2019) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology CD44 antibody (CST, 3570) was used in western blot on human samples (fig 3d). Cell Commun Signal (2019) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; loading ...; fig 4h
Cell Signaling Technology CD44 antibody (CST, 3570) was used in western blot on human samples (fig 4h). J Exp Clin Cancer Res (2019) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; loading ...; fig 6b
Cell Signaling Technology CD44 antibody (Cell Signaling, 3570) was used in western blot on human samples (fig 6b). Cancer Cell Int (2019) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; loading ...; fig 5d
Cell Signaling Technology CD44 antibody (Cell Signaling Technology, 3570) was used in western blot on human samples (fig 5d). J Clin Invest (2019) ncbi
mouse monoclonal (156-3C11)
  • other; human; loading ...; fig 4c
Cell Signaling Technology CD44 antibody (Cell Signaling, 3570) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (156-3C11)
  • immunocytochemistry; human; 1:200; loading ...; fig 4b
Cell Signaling Technology CD44 antibody (Cell Signaling Technologies, 3570T) was used in immunocytochemistry on human samples at 1:200 (fig 4b). J Cell Biol (2018) ncbi
mouse monoclonal (8E2)
  • immunohistochemistry - paraffin section; human; fig 6b
  • immunocytochemistry; human; loading ...; fig 1e
In order to investigate Rac1 activity and inhibition in gastric adenocarcinoma cells and mouse xenograft models for epithelial-to-mesenchymal transition and cancer stem-like cell phenotypes, Cell Signaling Technology CD44 antibody (Cell Signaling, 5640) was used in immunohistochemistry - paraffin section on human samples (fig 6b) and in immunocytochemistry on human samples (fig 1e). Mol Cancer Res (2017) ncbi
mouse monoclonal (8E2)
  • flow cytometry; mouse; loading ...; fig 2a
Cell Signaling Technology CD44 antibody (cell signalling, 5640) was used in flow cytometry on mouse samples (fig 2a). J Hepatol (2017) ncbi
mouse monoclonal (156-3C11)
  • immunocytochemistry; human; loading ...; fig 3a
  • western blot; human; loading ...; fig 3c
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Cell Signaling Technology CD44 antibody (cell signalling, 3570) was used in immunocytochemistry on human samples (fig 3a) and in western blot on human samples (fig 3c). Cell Death Dis (2017) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; 1:1000; loading ...; fig 5B
Cell Signaling Technology CD44 antibody (Cell Signaling, 3570S) was used in western blot on human samples at 1:1000 (fig 5B). BMC Med Genomics (2017) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; loading ...; fig 4d
Cell Signaling Technology CD44 antibody (Cell Signaling, CST-3570) was used in western blot on human samples (fig 4d). Oncotarget (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to classify triple-negative breast cancer into subtypes, Cell Signaling Technology CD44 antibody (Cell Signaling, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100; fig 10
In order to determine regulation of AMP-activated protein kinase (AMPK) activation upon matrix deprivation by a calcium-oxidant signaling network, Cell Signaling Technology CD44 antibody (Cell Signaling Technology, 3570S) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 10). J Biol Chem (2016) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 2
Cell Signaling Technology CD44 antibody (Cell Signaling, 3570S) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). PLoS ONE (2016) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; fig 5
Cell Signaling Technology CD44 antibody (Cell Signaling, 3570) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (8E2)
  • immunohistochemistry; human; 1:100; fig 6
Cell Signaling Technology CD44 antibody (Cell Signaling Tech, 5640) was used in immunohistochemistry on human samples at 1:100 (fig 6). Oncotarget (2016) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; 1:1000; fig s3
Cell Signaling Technology CD44 antibody (Cell signaling, 3570) was used in western blot on human samples at 1:1000 (fig s3). Cell Death Dis (2016) ncbi
mouse monoclonal (8E2)
  • western blot; human; 1:1000; loading ...; fig 5C
Cell Signaling Technology CD44 antibody (Cell Sgnaling, 5640) was used in western blot on human samples at 1:1000 (fig 5C). Mol Oncol (2016) ncbi
mouse monoclonal (156-3C11)
  • immunoprecipitation; human; fig 5b
  • western blot; human; fig 5b
In order to study functional receptors for cholera toxin by fucosylation and protein glycosylation, Cell Signaling Technology CD44 antibody (Cell Signaling Technology, 3570) was used in immunoprecipitation on human samples (fig 5b) and in western blot on human samples (fig 5b). elife (2015) ncbi
mouse monoclonal (8E2)
  • western blot; human; fig 1a,b
Cell Signaling Technology CD44 antibody (Cell Signaling Technology., 5640S) was used in western blot on human samples (fig 1a,b). Nucleic Acids Res (2016) ncbi
mouse monoclonal (8E2)
  • immunocytochemistry; rat
In order to study the effect of bile acids on mesenchymal stem cells in liver, Cell Signaling Technology CD44 antibody (Cell Signaling, 5640S) was used in immunocytochemistry on rat samples . Sci Rep (2015) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; fig 3
Cell Signaling Technology CD44 antibody (Cell Signaling, 3570S) was used in western blot on human samples (fig 3). Oncogene (2016) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; fig 6
Cell Signaling Technology CD44 antibody (Cell Signaling, 3570) was used in western blot on human samples (fig 6). PLoS ONE (2015) ncbi
mouse monoclonal (8E2)
  • blocking or activating experiments; mouse
Cell Signaling Technology CD44 antibody (Cell Signaling Technology, 5640) was used in blocking or activating experiments on mouse samples . J Mol Cell Cardiol (2015) ncbi
mouse monoclonal (8E2)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology CD44 antibody (Cell Signaling Technology, 5640) was used in western blot on human samples at 1:1000 (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (156-3C11)
  • western blot; mouse
Cell Signaling Technology CD44 antibody (Cell Signaling, 3570) was used in western blot on mouse samples . J Biol Chem (2015) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology CD44 antibody (Cell Signaling Tech, 3570) was used in western blot on human samples at 1:1000 (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (8E2)
  • immunocytochemistry; human; 1:800
  • western blot; human
Cell Signaling Technology CD44 antibody (Cell Signaling Technology, 5640) was used in immunocytochemistry on human samples at 1:800 and in western blot on human samples . Int J Oncol (2015) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; fig 8
  • western blot; human; fig 5
Cell Signaling Technology CD44 antibody (Cell Signaling, 3570) was used in immunohistochemistry - paraffin section on human samples (fig 8) and in western blot on human samples (fig 5). Sci Rep (2015) ncbi
mouse monoclonal (8E2)
  • immunohistochemistry - free floating section; human; 1:2000
Cell Signaling Technology CD44 antibody (Cell Signaling, #5640) was used in immunohistochemistry - free floating section on human samples at 1:2000. J Cell Physiol (2015) ncbi
mouse monoclonal (8E2)
  • western blot; human; fig 2
Cell Signaling Technology CD44 antibody (Cell Signaling, 5640) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (8E2)
  • western blot; human
In order to investigate the role of TLR3 signaling in breast cancer stem cells, Cell Signaling Technology CD44 antibody (cell signaling, 5640) was used in western blot on human samples . Cell Death Differ (2015) ncbi
mouse monoclonal (156-3C11)
  • western blot; human; 1:2000; fig 3
In order to assess the efficacy of alisertib against glioblastoma neurosphere tumor stem-like cells in vitro and in vivo, Cell Signaling Technology CD44 antibody (Cell Signaling, 3570) was used in western blot on human samples at 1:2000 (fig 3). Cancer Res (2014) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry - paraffin section; human; 1:100
In order to study the claudin expression in fibromatosis-like metaplastic carcinoma of the breast, Cell Signaling Technology CD44 antibody (Cell Signaling Technology, 156-3C11) was used in immunohistochemistry - paraffin section on human samples at 1:100. Virchows Arch (2014) ncbi
mouse monoclonal (8E2)
  • immunohistochemistry; human
Cell Signaling Technology CD44 antibody (Cell Signaling, 5640s) was used in immunohistochemistry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (156-3C11)
  • immunohistochemistry; human
  • western blot; human
Cell Signaling Technology CD44 antibody (Cell Signaling Technology, 3570S) was used in immunohistochemistry on human samples and in western blot on human samples . Neuro Oncol (2014) ncbi
Beckman Coulter
mouse monoclonal (J.173)
  • flow cytometry; human; loading ...; fig st1
Beckman Coulter CD44 antibody (Beckman Coulter, IM1219U) was used in flow cytometry on human samples (fig st1). PLoS ONE (2016) ncbi
mouse monoclonal (J.173)
  • flow cytometry; human; 1:50; fig 1c
In order to report the effects of mesenchymal stem cells derived from the umbilical cord on hepatocellular carcinoma cells, Beckman Coulter CD44 antibody (Beckman Coulter, IM1219U) was used in flow cytometry on human samples at 1:50 (fig 1c). Mol Med Rep (2016) ncbi
mouse monoclonal (J.173)
  • other; human; 200 ug/ml; fig 1
Beckman Coulter CD44 antibody (Beckman Coulter, IM0845) was used in other on human samples at 200 ug/ml (fig 1). J Extracell Vesicles (2016) ncbi
mouse monoclonal (J.173)
  • flow cytometry; human
Beckman Coulter CD44 antibody (Beckman Coulter Inc, IM1219U) was used in flow cytometry on human samples . Cell Death Dis (2015) ncbi
mouse monoclonal (J.173)
  • flow cytometry; human
Beckman Coulter CD44 antibody (Immunotech, IM1219U) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (J.173)
  • flow cytometry; human; fig 2
Beckman Coulter CD44 antibody (Beckman Coulter, IM1219U) was used in flow cytometry on human samples (fig 2). Sci Rep (2015) ncbi
Dako
mouse monoclonal (DF1485)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 6A
Dako CD44 antibody (DAKO, DF1485) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6A). BMC Med Genomics (2017) ncbi
mouse monoclonal (DF1485)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2e
Dako CD44 antibody (Dako, DF1485) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2e). Ann Oncol (2016) ncbi
mouse monoclonal (DF1485)
  • immunohistochemistry - paraffin section; human; 1:150; fig 1
In order to classify familial breast cancer patients and their immunoprofile from tissue microarrays, Dako CD44 antibody (Dako, DF1485) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (DF1485)
  • immunohistochemistry; human; 1:50
In order to evaluate the presence of cancer stem cells and EMT markers as prognostic markers for breast metaplastic carcinoma, Dako CD44 antibody (Dako, M7082) was used in immunohistochemistry on human samples at 1:50. Breast Cancer Res Treat (2015) ncbi
Stemcell Technologies
rat monoclonal (IM7)
  • immunocytochemistry; human; fig 2a
Stemcell Technologies CD44 antibody (StemCell Technologies, 60068) was used in immunocytochemistry on human samples (fig 2a). Cell (2018) ncbi
International Blood Group Reference Laboratory
mouse monoclonal (BRIC 222)
  • flow cytometry; human; 5.7 ug/ml; fig s3a
International Blood Group Reference Laboratory CD44 antibody (IBGRL Research Products, BRIC222) was used in flow cytometry on human samples at 5.7 ug/ml (fig s3a). Nat Commun (2017) ncbi
Genway Biotech
mouse monoclonal
  • flow cytometry; human
Genway Biotech CD44 antibody (GenWay, GWB-1F90D6) was used in flow cytometry on human samples . Oncogene (2015) ncbi
BD Biosciences
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig s1-3a
BD Biosciences CD44 antibody (BD Pharmingen, 561289) was used in flow cytometry on human samples (fig s1-3a). elife (2020) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:50; loading ...; fig s1-1e
BD Biosciences CD44 antibody (BD Bioscience, 559942) was used in flow cytometry on human samples at 1:50 (fig s1-1e). elife (2020) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD44 antibody (BD Biosciences, 560890) was used in flow cytometry on human samples (fig s1). Int J Mol Sci (2020) ncbi
mouse monoclonal (G44-26)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6, t2
BD Biosciences CD44 antibody (BD Pharmingen, G44-26) was used in immunohistochemistry - paraffin section on human samples (fig 6, t2). Cancers (Basel) (2019) ncbi
mouse monoclonal (L178)
  • flow cytometry; human; loading ...; fig 3c
BD Biosciences CD44 antibody (BD Biosciences, 347943) was used in flow cytometry on human samples (fig 3c). Breast Cancer Res (2019) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 1s2, 1s3b
BD Biosciences CD44 antibody (BD, RRID:AB_10645788) was used in flow cytometry on human samples (fig 1s2, 1s3b). elife (2019) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:20; loading ...; fig 2d
BD Biosciences CD44 antibody (BD, G44-26) was used in flow cytometry on human samples at 1:20 (fig 2d). elife (2019) ncbi
mouse monoclonal (515)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD44 antibody (BD Pharmingen, 550989) was used in flow cytometry on human samples (fig 1b). Sci Rep (2019) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; mouse; loading ...; fig s3g
BD Biosciences CD44 antibody (BD, 555479) was used in flow cytometry on mouse samples (fig s3g). Cell (2019) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:100; loading ...; fig 1c
BD Biosciences CD44 antibody (BD Biosciences, 560890) was used in flow cytometry on human samples at 1:100 (fig 1c). elife (2019) ncbi
mouse monoclonal (G44-26)
  • western blot; human; 1:1000; loading ...; fig 4i
BD Biosciences CD44 antibody (BD Biosciences, 555478) was used in western blot on human samples at 1:1000 (fig 4i). EBioMedicine (2019) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:13; loading ...; fig 1s1a
BD Biosciences CD44 antibody (BD Biosciences, 555478) was used in flow cytometry on human samples at 1:13 (fig 1s1a). elife (2019) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 6g
BD Biosciences CD44 antibody (BD, 5599942) was used in flow cytometry on human samples (fig 6g). Cell Death Dis (2019) ncbi
mouse monoclonal (515)
  • flow cytometry; human; fig s2a
BD Biosciences CD44 antibody (BD, 550989) was used in flow cytometry on human samples (fig s2a). Nature (2019) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig s4g
BD Biosciences CD44 antibody (BD, 560531) was used in flow cytometry on human samples (fig s4g). Cell Death Differ (2019) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:300; loading ...; fig 2f
BD Biosciences CD44 antibody (BD, G44-26) was used in flow cytometry on human samples at 1:300 (fig 2f). Nucleic Acids Res (2018) ncbi
mouse monoclonal (515)
  • flow cytometry; human; 1:100; loading ...; fig 6a
BD Biosciences CD44 antibody (BD Biosciences, 550988) was used in flow cytometry on human samples at 1:100 (fig 6a). Nat Commun (2018) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:50; loading ...; fig 8h
BD Biosciences CD44 antibody (BD Biosciences, G44-26) was used in flow cytometry on human samples at 1:50 (fig 8h). Oncotarget (2018) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 2c
BD Biosciences CD44 antibody (BD Biosciences, 561292) was used in flow cytometry on human samples (fig 2c). Sci Rep (2018) ncbi
mouse monoclonal (G44-26)
  • western blot; mouse; 1:100; loading ...; fig s1a
BD Biosciences CD44 antibody (BD Biosciences, 555478) was used in western blot on mouse samples at 1:100 (fig s1a). Nat Commun (2018) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in flow cytometry on human samples (fig 4a). Cancer Res (2018) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig s4c
BD Biosciences CD44 antibody (BD Biosciences, 555478) was used in flow cytometry on human samples (fig s4c). Cell (2018) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, BD Biosciences CD44 antibody (BD Pharmingen, 559942) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:20; fig 3g
BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in flow cytometry on human samples at 1:20 (fig 3g). Neurosci Lett (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:20; loading ...; fig s8b
BD Biosciences CD44 antibody (Becton Dickinson, G44-26) was used in flow cytometry on human samples at 1:20 (fig s8b). Nat Commun (2017) ncbi
mouse monoclonal (515)
  • flow cytometry; human; loading ...; fig 5
BD Biosciences CD44 antibody (BD Pharmingen, 515) was used in flow cytometry on human samples (fig 5). Respir Res (2017) ncbi
mouse monoclonal (G44-26)
  • immunocytochemistry; human; 2 ug/ml; loading ...; fig s1
In order to research the involvement of protein IQGAP1 in the regulation of actin networks, BD Biosciences CD44 antibody (BD Biosciences, BDB550392) was used in immunocytochemistry on human samples at 2 ug/ml (fig s1). Biol Open (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 3a
In order to find a role for IL-4 in promoting breast cancer aggressiveness, BD Biosciences CD44 antibody (BD Biosciences, G44-26) was used in flow cytometry on human samples (fig 3a). Cancer Res (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2b
BD Biosciences CD44 antibody (BD PharmingenTM, 555478) was used in flow cytometry on human samples (fig 2b). Cell J (2017) ncbi
mouse monoclonal (515)
  • blocking or activating experiments; human; loading ...
In order to implicate myeloid differentiation factor-2 as the high-affinity soluble CD83 binding partner, BD Biosciences CD44 antibody (BD Biosciences, 515) was used in blocking or activating experiments on human samples . J Immunol (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CD44 antibody (BD, 562890) was used in flow cytometry on human samples (fig 1d). Sci Rep (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in flow cytometry on human samples (fig s1b). Genome Biol (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 4c
BD Biosciences CD44 antibody (BD Biosciences, 555479) was used in flow cytometry on human samples (fig 4c). Int J Oncol (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 5b
BD Biosciences CD44 antibody (BD Pharmingen, 559942) was used in flow cytometry on human samples (fig 5b). Oncotarget (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2c
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BD Biosciences CD44 antibody (BD Bioscience, 555478) was used in flow cytometry on human samples (fig 2c). Sci Rep (2017) ncbi
mouse monoclonal (515)
  • flow cytometry; African green monkey; fig 1
In order to study cell therapy for intrinsic urinary sphincter deficiency in nonhuman primates, BD Biosciences CD44 antibody (BD Pharmingen, 550989) was used in flow cytometry on African green monkey samples (fig 1). Stem Cell Res Ther (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig s4c
BD Biosciences CD44 antibody (BD Pharmingen, 561289) was used in flow cytometry on human samples (fig s4c). Oncotarget (2017) ncbi
mouse monoclonal (L178)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences CD44 antibody (BD Biosciences, L178) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 3
In order to suggest that synthetic analogues of Theonelladin C are a promising class for development of anticancer agents, BD Biosciences CD44 antibody (BD Pharmigen, 560532) was used in flow cytometry on human samples (fig 3). Chem Biol Drug Des (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 6a
In order to examine a subpopulation of CD44-bright cells in human oral carcinomas that do not overexpress mesenchymal genes, are slow-cycling, and are unique in their ability to initiate metastasis, BD Biosciences CD44 antibody (BD Pharmigen, 560533) was used in flow cytometry on human samples (fig 6a). Nature (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 3c
In order to study the effect of PIK3CA in breast cancer., BD Biosciences CD44 antibody (BD Bioscience, 555479) was used in flow cytometry on human samples (fig 3c). PLoS ONE (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; domestic sheep; loading ...
In order to discuss methods to generate ovine mesenchymal stromal cells, BD Biosciences CD44 antibody (BD Biosciences, G44-26) was used in flow cytometry on domestic sheep samples . J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:100; loading ...; fig 4j
BD Biosciences CD44 antibody (BD Pharmingen, 555477) was used in flow cytometry on human samples at 1:100 (fig 4j). J Clin Invest (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD44 antibody (BD Biosciences, 560977) was used in flow cytometry on human samples (fig 1c). Mol Med Rep (2016) ncbi
mouse monoclonal (515)
  • flow cytometry; human; fig 1b
BD Biosciences CD44 antibody (BD Pharmingen, 550989) was used in flow cytometry on human samples (fig 1b). Sci Rep (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig s10m
BD Biosciences CD44 antibody (BD, G44-26) was used in flow cytometry on human samples (fig s10m). Nature (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2
In order to investigate the contribution of DNA methyltransferase 1 to the epithelial-mesenchymal transition and cancer stem cells, BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in flow cytometry on human samples (fig 2). Neoplasia (2016) ncbi
mouse monoclonal (G44-26)
  • western blot; human; fig s1d
BD Biosciences CD44 antibody (BD Bioscience, 562991) was used in western blot on human samples (fig s1d). Oncotarget (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; tbl 1
BD Biosciences CD44 antibody (Becton-Dickinson, 555476) was used in flow cytometry on human samples (tbl 1). Int J Oncol (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig st1
BD Biosciences CD44 antibody (BD Pharmingen, 555478) was used in flow cytometry on human samples (fig st1). Sci Rep (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig S1D
BD Biosciences CD44 antibody (BD Biosciences, G44-26) was used in flow cytometry on human samples (fig S1D). Oncotarget (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 1a
In order to assess the contribution of cytomorphology and flow cytometry to histopathological studies of brain biopsies, BD Biosciences CD44 antibody (BD Biosciences, G44-26) was used in flow cytometry on human samples (fig 1a). Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 6
BD Biosciences CD44 antibody (BD Pharmingen, 555479) was used in flow cytometry on human samples (fig 6). BMC Cancer (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2
In order to study the role of kif3a in dental mesenchymal stem and precursor cell differentiation, BD Biosciences CD44 antibody (BD Biosciences, 555478) was used in flow cytometry on human samples (fig 2). Mol Med Rep (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2
In order to analyze the contribution to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of formyl peptide receptor pathway by annexin A1, BD Biosciences CD44 antibody (BD Pharmigen, G44-26) was used in flow cytometry on human samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 2
In order to propose that ikarugamycin is a useful reagent to study routes of endocytic trafficking, BD Biosciences CD44 antibody (BD Pharmingen, G44-26) was used in flow cytometry on human samples (fig 2). Traffic (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; mouse; loading ...; fig 7B
In order to propose that lincRNA-RoR and miR10b distinguish aggressive clones from non-aggressive clones of ductal carcinoma in situ-invasive ductal carcinoma, BD Biosciences CD44 antibody (BD Biosciences, 555478) was used in flow cytometry on mouse samples (fig 7B). Oncotarget (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 3f
BD Biosciences CD44 antibody (BD Bioscience, 559942) was used in flow cytometry on human samples (fig 3f). Oncotarget (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:40; loading ...; fig s5b
BD Biosciences CD44 antibody (BD Bioscience, 559942) was used in flow cytometry on human samples at 1:40 (fig s5b). Oncotarget (2016) ncbi
mouse monoclonal (515)
  • flow cytometry; human; 1:100; fig 4
In order to determine mediation of differentiation and cisplatin chemotherapy resistance by biased expression of the FOXP3delta3 isoform in aggressive bladder cancer, BD Biosciences CD44 antibody (BD Biosciences, 550989) was used in flow cytometry on human samples at 1:100 (fig 4). Clin Cancer Res (2016) ncbi
mouse monoclonal (515)
  • flow cytometry; human; fig 4
In order to elucidate regulation of E-cadherin and CD24 by determination of cell fate transition and impeding tumor initiation and progression in breast cancer via HOXA5, BD Biosciences CD44 antibody (BD Pharmigen, 515) was used in flow cytometry on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2
BD Biosciences CD44 antibody (BD Bioscience, 559942) was used in flow cytometry on human samples (fig 2). Toxins (Basel) (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:10; loading ...
BD Biosciences CD44 antibody (BD Bioscience, 555478) was used in flow cytometry on human samples at 1:10. Mol Med Rep (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 4
In order to report the results of the rituximab by intravenous and Intrathecai injection versus placebo in patients with low-inflammatory secondary progressive multiple sclerosis study, BD Biosciences CD44 antibody (BD Biosciences, G44-26) was used in flow cytometry on human samples (fig 4). Ann Clin Transl Neurol (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2
BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in flow cytometry on human samples (fig 2). Oncotarget (2016) ncbi
mouse monoclonal (G44-26)
  • immunohistochemistry; human; 1:250; fig 4
In order to learn mediation of Wnt signaling-induced radioresistance by LIG4, BD Biosciences CD44 antibody (BD Pharmingen, G44-26) was used in immunohistochemistry on human samples at 1:250 (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2
BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in flow cytometry on human samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD44 antibody (BD, 555478) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 4
BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in flow cytometry on human samples (fig 4). Nucleus (2016) ncbi
mouse monoclonal (515)
  • flow cytometry; human; 1:10; fig 1
BD Biosciences CD44 antibody (BD, 550989) was used in flow cytometry on human samples at 1:10 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (515)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BD Biosciences CD44 antibody (BD Pharmingen, BD550989) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig s1
In order to analyze the DUSP family members and their differential roles in epithelial to mesenchymal transition and cancer stem cell regulation in breast cancer, BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in flow cytometry on human samples (fig s1). PLoS ONE (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:100; fig s6
BD Biosciences CD44 antibody (BD, G44-26) was used in flow cytometry on human samples at 1:100 (fig s6). Nat Commun (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; tbl 2
In order to study human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue, BD Biosciences CD44 antibody (BD Pharmingen, 555479) was used in flow cytometry on human samples (tbl 2). Int J Mol Med (2016) ncbi
mouse monoclonal (G44-26)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 2e
  • flow cytometry; human; 1:100; fig 2g
  • immunocytochemistry; human; 1:100; fig 3e
In order to study the differentiation of oral mucosa stromal cells into neural crest stem cells and assess their therapeutic value, BD Biosciences CD44 antibody (BD Pharmingen, G44-26) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2e), in flow cytometry on human samples at 1:100 (fig 2g) and in immunocytochemistry on human samples at 1:100 (fig 3e). Stem Cells Transl Med (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:200; fig 1d
BD Biosciences CD44 antibody (BD Pharmingen, 561858) was used in flow cytometry on human samples at 1:200 (fig 1d). Eur J Immunol (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:100; fig 1
BD Biosciences CD44 antibody (BD Biosciences, G44-26) was used in flow cytometry on human samples at 1:100 (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 1
BD Biosciences CD44 antibody (BD, 559942) was used in flow cytometry on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BD Biosciences CD44 antibody (BD Pharmingen, 555478) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2
BD Biosciences CD44 antibody (BD Biosciences, #559942) was used in flow cytometry on human samples (fig 2). Proteomics (2015) ncbi
mouse monoclonal (515)
  • flow cytometry; human; tbl 1
BD Biosciences CD44 antibody (BD bioscience, 550989) was used in flow cytometry on human samples (tbl 1). PLoS ONE (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2
  • immunocytochemistry; human; fig 1
BD Biosciences CD44 antibody (BD Biosciences, 560531) was used in flow cytometry on human samples (fig 2) and in immunocytochemistry on human samples (fig 1). Stem Cell Res Ther (2015) ncbi
mouse monoclonal (G44-26)
  • immunocytochemistry; human
BD Biosciences CD44 antibody (BD Pharmingen, G44-26) was used in immunocytochemistry on human samples . elife (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:200
BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in flow cytometry on human samples at 1:200. Nat Commun (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2
BD Biosciences CD44 antibody (BD Biosciences, 560532) was used in flow cytometry on human samples (fig 2). J Endod (2015) ncbi
mouse monoclonal (515)
  • flow cytometry; human; fig 2
BD Biosciences CD44 antibody (BD Biosciences, 550988) was used in flow cytometry on human samples (fig 2). Int J Mol Med (2015) ncbi
mouse monoclonal (515)
  • flow cytometry; human; fig 1a
BD Biosciences CD44 antibody (BD PharMingen, 550989) was used in flow cytometry on human samples (fig 1a). Oncotarget (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2
In order to use of estrogen receptor-positive breast cancer lines to study steroid induction of therapy-resistant cytokeratin-5-positive cells through a BCL6-dependent mechanism, BD Biosciences CD44 antibody (BD Biosciences, 562818) was used in flow cytometry on human samples (fig 2). Oncogene (2016) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 4
BD Biosciences CD44 antibody (BD HorizonTM, 561,292) was used in flow cytometry on human samples (fig 4). Cytometry A (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig s4
BD Biosciences CD44 antibody (BD Pharmingen, 555478) was used in flow cytometry on human samples (fig s4). Stem Cell Reports (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 4
BD Biosciences CD44 antibody (BD Bioscience, G44-26) was used in flow cytometry on human samples (fig 4). Nat Commun (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 3G
BD Biosciences CD44 antibody (BD Pharmigen, G44-C26) was used in flow cytometry on human samples (fig 3G). Oncotarget (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig s1
BD Biosciences CD44 antibody (BD Pharmingen, 555478) was used in flow cytometry on human samples (fig s1). Sci Rep (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human
BD Biosciences CD44 antibody (BD Biosciences, 555479) was used in flow cytometry on human samples . Bone (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human
  • western blot; human; fig s2
BD Biosciences CD44 antibody (BD Biosciences, 561858) was used in flow cytometry on human samples and in western blot on human samples (fig s2). Nature (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD44 antibody (BD Pharmingen, 559942) was used in flow cytometry on human samples (fig 4a). Oncotarget (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig s1
BD Biosciences CD44 antibody (BD Pharmingen, G44-26) was used in flow cytometry on human samples (fig s1). Nat Cell Biol (2015) ncbi
mouse monoclonal (G44-26)
  • immunocytochemistry; human
In order to generate patient-derived iPSCs from a Li-Fraumeni syndrome family and assess the role of mutant p53 in the development of osteosarcoma, BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in immunocytochemistry on human samples . Cell (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human
BD Biosciences CD44 antibody (BD, 555478) was used in flow cytometry on human samples . Blood Cancer J (2015) ncbi
mouse monoclonal (G44-26)
  • immunocytochemistry; human; fig 2
BD Biosciences CD44 antibody (BD biosciences, 555476) was used in immunocytochemistry on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (G44-26)
  • immunocytochemistry; human
In order to report a protocol using a non-integrating Sendai virus vector for transduction of Yamanaka factors into urine cells collected from patients with muscular dystrophy, BD Biosciences CD44 antibody (BD Biosciences, 560977) was used in immunocytochemistry on human samples . J Vis Exp (2015) ncbi
mouse monoclonal (G44-26)
  • immunohistochemistry - paraffin section; human; fig 1
  • immunocytochemistry; human
BD Biosciences CD44 antibody (BD Biosciences, 555478) was used in immunohistochemistry - paraffin section on human samples (fig 1) and in immunocytochemistry on human samples . J Transl Med (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human
BD Biosciences CD44 antibody (B.D. Biosciences, 560977) was used in flow cytometry on human samples . World J Stem Cells (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 3
BD Biosciences CD44 antibody (BD Pharmingen, G44-26) was used in flow cytometry on human samples (fig 3). J Immunol (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 2
BD Biosciences CD44 antibody (BD Pharmingen, G44-26) was used in flow cytometry on human samples (fig 2). J Virol (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; domestic sheep
BD Biosciences CD44 antibody (BD Biosciences, G44-26) was used in flow cytometry on domestic sheep samples . Cytotechnology (2016) ncbi
mouse monoclonal (515)
  • flow cytometry; human; fig 1
BD Biosciences CD44 antibody (BD Biosciences, 550989) was used in flow cytometry on human samples (fig 1). Stem Cells Dev (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 4
BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in flow cytometry on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 3
BD Biosciences CD44 antibody (BD Biosciences, 560532) was used in flow cytometry on human samples (fig 3). Int J Oncol (2015) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human
BD Biosciences CD44 antibody (BD Pharmingen, G44-26) was used in flow cytometry on human samples . Oncotarget (2014) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human
BD Biosciences CD44 antibody (BD Biosciences, 555478) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human
BD Biosciences CD44 antibody (BD, 555478) was used in flow cytometry on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; fig 6
In order to analyze cancer cell plasticity autonomous stimulation by human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells, BD Biosciences CD44 antibody (BD Pharmingen, G44-26) was used in flow cytometry on human samples (fig 6). PLoS ONE (2014) ncbi
mouse monoclonal (G44-26)
  • immunocytochemistry; mouse
BD Biosciences CD44 antibody (PharMingen, G44-26) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi
mouse monoclonal (515)
  • flow cytometry; human; 1:500
BD Biosciences CD44 antibody (BD Biosciences, 550989) was used in flow cytometry on human samples at 1:500. PLoS ONE (2014) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human
In order to generate and assess primary pancreatic adenocarcinoma cell lines for colony forming capacity, tumourigenicity, expression of known cancer cell surface markers and cancer stem-like characteristics, BD Biosciences CD44 antibody (Becton Dickinson, clone G44-26) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human
In order to identify the metabolic phenotype associated with breast cancer stem cells, BD Biosciences CD44 antibody (BD Pharmingen, 559942) was used in flow cytometry on human samples . Cell Death Dis (2014) ncbi
mouse monoclonal (L178)
  • flow cytometry; human
BD Biosciences CD44 antibody (BD Biosciences, L178) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (515)
  • flow cytometry; human
BD Biosciences CD44 antibody (BD, 550989) was used in flow cytometry on human samples . Cell Tissue Res (2014) ncbi
mouse monoclonal (515)
  • flow cytometry; human; 1 ug/1x106 cells
BD Biosciences CD44 antibody (BD pharmingen, 550989) was used in flow cytometry on human samples at 1 ug/1x106 cells. J Cell Mol Med (2014) ncbi
mouse monoclonal (L178)
  • flow cytometry; human
BD Biosciences CD44 antibody (BD Biosciences, 347943) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:100
In order to evaluate a cell culture system for long-term passaging of human pluripotent stem cells, BD Biosciences CD44 antibody (BD Biosciences, 559942) was used in flow cytometry on human samples at 1:100. J Neurosci Res (2013) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:100
BD Biosciences CD44 antibody (BD Biosciences, clone G44-26) was used in flow cytometry on human samples at 1:100. Stem Cells (2013) ncbi
mouse monoclonal (G44-26)
  • flow cytometry; human; 1:100
BD Biosciences CD44 antibody (BD biosciences, G44-26) was used in flow cytometry on human samples at 1:100. PLoS ONE (2013) ncbi
Developmental Studies Hybridoma Bank
rat monoclonal (HERMES-1)
  • immunohistochemistry; mouse; 1:40; loading ...; fig s6b
Developmental Studies Hybridoma Bank CD44 antibody (DSHB, HERMES-1) was used in immunohistochemistry on mouse samples at 1:40 (fig s6b). elife (2020) ncbi
mouse monoclonal (H4C4)
  • flow cytometry; human; 1:100; fig 3
Developmental Studies Hybridoma Bank CD44 antibody (DSHB, H4C4) was used in flow cytometry on human samples at 1:100 (fig 3). BMC Musculoskelet Disord (2015) ncbi
mouse monoclonal (H4C4)
  • immunohistochemistry - frozen section; human; 1:200
In order to study the mechanical properties of tissue-engineered cartilage constructs using in vitro culture models incorporating human chondrocytes from osteoarthritis patients, Developmental Studies Hybridoma Bank CD44 antibody (Developmental Studies Hybridoma Bank, H4C4) was used in immunohistochemistry - frozen section on human samples at 1:200. PLoS ONE (2014) ncbi
Cosmo Bio
rat monoclonal (RV3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 3C
  • western blot; human; 1:500; loading ...; fig 1A;4
In order to investigate the roles of CD44s and CD44v in the development of bone metastases, Cosmo Bio CD44 antibody (Cosmo Bio, LKG-M001) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3C) and in western blot on human samples at 1:500 (fig 1A;4). Oncol Lett (2016) ncbi
rat monoclonal (RV3)
  • western blot; human; fig 5
Cosmo Bio CD44 antibody (CosmoBio, CAC-LKG-M003) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
Leica Biosystems
  • immunohistochemistry - paraffin section; human; 1:60
In order to determine the role of Fer in the stromal cells surrounding renal cell carcinoma, Leica Biosystems CD44 antibody (Leica, NCL-CD31-1A10P) was used in immunohistochemistry - paraffin section on human samples at 1:60. Oncol Lett (2017) ncbi
  • immunocytochemistry; human; 1:100
Leica Biosystems CD44 antibody (Leica Biosystems, NCL-CD31-1A10) was used in immunocytochemistry on human samples at 1:100. PLoS ONE (2016) ncbi
Articles Reviewed
  1. Tyagi A, Sharma S, Wu K, Wu S, Xing F, Liu Y, et al. Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung. Nat Commun. 2021;12:474 pubmed publisher
  2. Ye D, Wang S, Huang Y, Wang X, Chi P. USP43 directly regulates ZEB1 protein, mediating proliferation and metastasis of colorectal cancer. J Cancer. 2021;12:404-416 pubmed publisher
  3. Jakob M, Hambrecht M, Spiegel J, Kitz J, Canis M, Dressel R, et al. Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Show Comparable Functionality to Their Autologous Origin. Cells. 2020;10: pubmed publisher
  4. Jensen I, Jensen S, Sjaastad F, Gibson Corley K, Dileepan T, Griffith T, et al. Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells. elife. 2020;9: pubmed publisher
  5. Myers D, Abram C, Wildes D, Belwafa A, Welsh A, Schulze C, et al. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity. Front Immunol. 2020;11:576310 pubmed publisher
  6. Lee H, Park J, Yoo H, Lee H, Lee B, Kim J. The Selenoprotein MsrB1 Instructs Dendritic Cells to Induce T-Helper 1 Immune Responses. Antioxidants (Basel). 2020;9: pubmed publisher
  7. Xu J, Wang Y, Hsu C, Negri S, Tower R, Gao Y, et al. Lysosomal protein surface expression discriminates fat- from bone-forming human mesenchymal precursor cells. elife. 2020;9: pubmed publisher
  8. Kim K, Park T, Cho B, Kim T. Nanoparticles from Equine Fetal Bone Marrow-Derived Cells Enhance the Survival of Injured Chondrocytes. Animals (Basel). 2020;10: pubmed publisher
  9. Lauver M, Goetschius D, Netherby Winslow C, Ayers K, Jin G, Haas D, et al. Antibody escape by polyomavirus capsid mutation facilitates neurovirulence. elife. 2020;9: pubmed publisher
  10. Oliemuller E, Newman R, Tsang S, Foo S, Muirhead G, Noor F, et al. SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells. elife. 2020;9: pubmed publisher
  11. Benavente F, Piltti K, Hooshmand M, Nava A, Lakatos A, Feld B, et al. Novel C1q receptor-mediated signaling controls neural stem cell behavior and neurorepair. elife. 2020;9: pubmed publisher
  12. Lobo S, Pereira C, Oliveira C, Almeida G. Skipping Exon-v6 from CD44v6-Containing Isoforms Influences Chemotherapy Response and Self-Renewal Capacity of Gastric Cancer Cells. Cancers (Basel). 2020;12: pubmed publisher
  13. Fernandes R, Li C, Wang G, Yang X, Savvides C, Glassman C, et al. Discovery of surrogate agonists for visceral fat Treg cells that modulate metabolic indices in vivo. elife. 2020;9: pubmed publisher
  14. Huang F, Zheng C, Huang L, Lin C, Wang J. USP18 directly regulates Snail1 protein through ubiquitination pathway in colorectal cancer. Cancer Cell Int. 2020;20:346 pubmed publisher
  15. Pseftogas A, Xanthopoulos K, Poutahidis T, Ainali C, Dafou D, Panteris E, et al. The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF Signaling. Cancers (Basel). 2020;12: pubmed publisher
  16. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  17. Svensson M, Zoccheddu M, Yang S, Nygaard G, Secchi C, Doody K, et al. Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal. Sci Adv. 2020;6:eaba4353 pubmed publisher
  18. Anthwal N, Fenelon J, Johnston S, Renfree M, Tucker A. Transient role of the middle ear as a lower jaw support across mammals. elife. 2020;9: pubmed publisher
  19. Leelatian N, Sinnaeve J, Mistry A, Barone S, Brockman A, Diggins K, et al. Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells. elife. 2020;9: pubmed publisher
  20. Kim E, Woodruff M, Grigoryan L, Maier B, Lee S, Mandal P, et al. Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway. elife. 2020;9: pubmed publisher
  21. Liao T, Lin C, Jiang J, Yang S, Teng H, Yang M. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer. Theranostics. 2020;10:6095-6112 pubmed publisher
  22. Parray H, Shukla S, Samal S, Shrivastava T, Ahmed S, Sharma C, et al. Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives. Int Immunopharmacol. 2020;85:106639 pubmed publisher
  23. Witschen P, Chaffee T, Brady N, Huggins D, Knutson T, LaRue R, et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers (Basel). 2020;12: pubmed publisher
  24. Yamamoto K, Venida A, Yano J, Biancur D, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100-105 pubmed publisher
  25. Liu G, Yu Y, Feng F, Zhu P, Zhang H, Zhang D, et al. Human CD8+CD28- T suppressor cells expanded by common gamma chain (γc) cytokines retain steady allospecific suppressive capacity in vivo. BMC Immunol. 2020;21:23 pubmed publisher
  26. Zheng D, Gao F, Cheng Q, Bao P, Dong X, Fan J, et al. A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy. Nat Commun. 2020;11:1985 pubmed publisher
  27. Zhu M, Ma Y, Tan K, Zhang L, Wang Z, Li Y, et al. Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts. BMC Immunol. 2020;21:19 pubmed publisher
  28. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  29. von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11:1508 pubmed publisher
  30. Gao M, Wang T, Ji L, Bai S, Tian L, Song H. Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer. Front Immunol. 2020;11:366 pubmed publisher
  31. Aaltonen N, Singha P, Jakupović H, Wirth T, Samaranayake H, Pasonen Seppänen S, et al. High-Resolution Confocal Fluorescence Imaging of Serine Hydrolase Activity in Cryosections - Application to Glioma Brain Unveils Activity Hotspots Originating from Tumor-Associated Neutrophils. Biol Proced Online. 2020;22:6 pubmed publisher
  32. Donaldson D, Bradford B, Else K, Mabbott N. Accelerated onset of CNS prion disease in mice co-infected with a gastrointestinal helminth pathogen during the preclinical phase. Sci Rep. 2020;10:4554 pubmed publisher
  33. Ramstead A, Wallace J, Lee S, Bauer K, Tang W, Ekiz H, et al. Mitochondrial Pyruvate Carrier 1 Promotes Peripheral T Cell Homeostasis through Metabolic Regulation of Thymic Development. Cell Rep. 2020;30:2889-2899.e6 pubmed publisher
  34. Kumar A, Chamoto K, Chowdhury P, Honjo T. Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy. elife. 2020;9: pubmed publisher
  35. Hajaj E, Eisenberg G, Klein S, Frankenburg S, Merims S, Ben David I, et al. SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. elife. 2020;9: pubmed publisher
  36. Wei J, Mattapallil M, Horai R, Jittayasothorn Y, Modi A, Sen H, et al. A novel role for lipoxin A4 in driving a lymph node-eye axis that controls autoimmunity to the neuroretina. elife. 2020;9: pubmed publisher
  37. Martens R, Permanyer M, Werth K, Yu K, Braun A, Halle O, et al. Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance. Nat Commun. 2020;11:1114 pubmed publisher
  38. Si D, Yin F, Peng J, Zhang G. High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas. Cancer Manag Res. 2020;12:769-775 pubmed publisher
  39. Pothuraju R, Rachagani S, Krishn S, Chaudhary S, Nimmakayala R, Siddiqui J, et al. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance. Mol Cancer. 2020;19:37 pubmed publisher
  40. Adams C, Ercolano E, Ferluga S, Sofela A, Dave F, Negroni C, et al. A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours. Int J Mol Sci. 2020;21: pubmed publisher
  41. Chandrasekaran B, Dahiya N, Tyagi A, Kolluru V, Saran U, Baby B, et al. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis. 2020;9:23 pubmed publisher
  42. Moreno Rodríguez M, Perez S, Nadeem M, Malek Ahmadi M, Mufson E. Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer's disease. J Neuroinflammation. 2020;17:58 pubmed publisher
  43. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed publisher
  44. Angenendt A, Steiner R, Knörck A, Schwär G, Konrad M, Krause E, et al. Orai, STIM, and PMCA contribute to reduced calcium signal generation in CD8+ T cells of elderly mice. Aging (Albany NY). 2020;12:3266-3286 pubmed publisher
  45. Lee J, Zhang J, Chung Y, Kim J, Kook C, Gonzalez Navajas J, et al. Inhibition of IRF4 in dendritic cells by PRR-independent and -dependent signals inhibit Th2 and promote Th17 responses. elife. 2020;9: pubmed publisher
  46. Hou K, Li G, Zhao J, Xu B, Zhang Y, Yu J, et al. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway. J Neuroinflammation. 2020;17:46 pubmed publisher
  47. Bell O, Copland D, Ward A, Nicholson L, Lange C, Chu C, et al. Single Eye mRNA-Seq Reveals Normalisation of the Retinal Microglial Transcriptome Following Acute Inflammation. Front Immunol. 2019;10:3033 pubmed publisher
  48. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed publisher
  49. Kim J, Fei L, Yin W, Coquenlorge S, Rao Bhatia A, Zhang X, et al. Single cell and genetic analyses reveal conserved populations and signaling mechanisms of gastrointestinal stromal niches. Nat Commun. 2020;11:334 pubmed publisher
  50. Blagih J, Zani F, Chakravarty P, Hennequart M, Pilley S, Hobor S, et al. Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses. Cell Rep. 2020;30:481-496.e6 pubmed publisher
  51. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  52. Liu Q, Zhou C, Zhang B. Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis. BMC Gastroenterol. 2019;19:230 pubmed publisher
  53. Williford J, Ishihara J, Ishihara A, Mansurov A, Hosseinchi P, Marchell T, et al. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019;5:eaay1357 pubmed publisher
  54. Wei J, Long L, Zheng W, Dhungana Y, Lim S, Guy C, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576:471-476 pubmed publisher
  55. Li A, Herbst R, Canner D, Schenkel J, Smith O, Kim J, et al. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development. Cell Rep. 2019;29:2998-3008.e8 pubmed publisher
  56. Hang S, Paik D, Yao L, Kim E, Jamma T, Lu J, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576:143-148 pubmed publisher
  57. Wang L, Shen E, Luo L, Rabe H, Wang Q, Yin J, et al. Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor. Cell Rep. 2019;29:1848-1861.e6 pubmed publisher
  58. Wang Y, Chiang I, Ohara T, Fujii S, Cheng J, Muegge B, et al. Long-Term Culture Captures Injury-Repair Cycles of Colonic Stem Cells. Cell. 2019;179:1144-1159.e15 pubmed publisher
  59. Leone R, Zhao L, Englert J, Sun I, Oh M, Sun I, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013-1021 pubmed publisher
  60. Lin Q, Chen X, Meng F, Ogawa K, Li M, Song R, et al. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Mol Cancer. 2019;18:156 pubmed publisher
  61. Valentiner U, Knips J, Pries R, Clauditz T, Münscher A, Sauter G, et al. Selectin Binding Sites Are Involved in Cell Adhesive Properties of Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2019;11: pubmed publisher
  62. Lin F, Meng X, Guo Y, Cao W, Liu W, Xia Q, et al. Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1. Sci Adv. 2019;5:eaax1608 pubmed publisher
  63. Mani V, Bromley S, Aijö T, Mora Buch R, Carrizosa E, Warner R, et al. Migratory DCs activate TGF-β to precondition naïve CD8+ T cells for tissue-resident memory fate. Science. 2019;366: pubmed publisher
  64. Shikama Y, Kurosawa M, Furukawa M, Ishimaru N, Matsushita K. Involvement of adiponectin in age-related increases in tear production in mice. Aging (Albany NY). 2019;11:8329-8346 pubmed publisher
  65. Liu Y, Jiang Q, Liu X, Lin X, Tang Z, Liu C, et al. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway. EBioMedicine. 2019;48:386-404 pubmed publisher
  66. Veschi V, Mangiapane L, Nicotra A, Di Franco S, Scavo E, Apuzzo T, et al. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene. 2020;39:987-1003 pubmed publisher
  67. Majer O, Liu B, Kreuk L, Krogan N, Barton G. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575:366-370 pubmed publisher
  68. Ren J, Smid M, Iaria J, Salvatori D, van Dam H, Zhu H, et al. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression. Breast Cancer Res. 2019;21:109 pubmed publisher
  69. Nelson C, Thompson E, Quarnstrom C, Fraser K, Seelig D, Bhela S, et al. Robust Iterative Stimulation with Self-Antigens Overcomes CD8+ T Cell Tolerance to Self- and Tumor Antigens. Cell Rep. 2019;28:3092-3104.e5 pubmed publisher
  70. Piao L, Yang Z, Feng Y, Zhang C, Cui C, Xuan Y. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma. BMC Cancer. 2019;19:898 pubmed publisher
  71. Noguerol J, Roustan P, N Taye M, Delcombel L, Rolland C, Guiraud L, et al. Sexual dimorphism in PAR2-dependent regulation of primitive colonic cells. Biol Sex Differ. 2019;10:47 pubmed publisher
  72. Sang Y, Li Y, Zhang Y, Alvarez A, Yu B, Zhang W, et al. CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity. Nat Commun. 2019;10:4013 pubmed publisher
  73. Xu J, Wang Y, Hsu C, Gao Y, Meyers C, Chang L, et al. Human perivascular stem cell-derived extracellular vesicles mediate bone repair. elife. 2019;8: pubmed publisher
  74. Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
  75. Rasoulouniriana D, Santana Magal N, Gutwillig A, Farhat Younis L, Wine Y, Saperia C, et al. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. J Clin Invest. 2019;129:4151-4164 pubmed publisher
  76. Dong M, Wang G, Chow R, Ye L, Zhu L, Dai X, et al. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. Cell. 2019;178:1189-1204.e23 pubmed publisher
  77. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  78. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  79. Benci J, Johnson L, Choa R, Xu Y, Qiu J, Zhou Z, et al. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. Cell. 2019;178:933-948.e14 pubmed publisher
  80. Katsuda T, Matsuzaki J, Yamaguchi T, Yamada Y, Prieto Vila M, Hosaka K, et al. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes. elife. 2019;8: pubmed publisher
  81. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  82. Li Q, Lai Q, He C, Fang Y, Yan Q, Zhang Y, et al. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 2019;38:334 pubmed publisher
  83. Neftel C, Laffy J, Filbin M, Hara T, Shore M, Rahme G, et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell. 2019;178:835-849.e21 pubmed publisher
  84. Shokri M, Bozorgmehr M, Ghanavatinejad A, Falak R, Aleahmad M, Kazemnejad S, et al. Human menstrual blood-derived stromal/stem cells modulate functional features of natural killer cells. Sci Rep. 2019;9:10007 pubmed publisher
  85. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  86. Wolock S, Krishnan I, Tenen D, Matkins V, Camacho V, Patel S, et al. Mapping Distinct Bone Marrow Niche Populations and Their Differentiation Paths. Cell Rep. 2019;28:302-311.e5 pubmed publisher
  87. Papaioannou E, Yanez D, Ross S, Lau C, Solanki A, Chawda M, et al. Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation. J Clin Invest. 2019;129:3153-3170 pubmed publisher
  88. Wang H, Xiang D, Liu B, He A, Randle H, Zhang K, et al. Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer. Cell. 2019;178:135-151.e19 pubmed publisher
  89. Khanom U, Ohigashi I, Fujimori S, Kondo K, Takada K, Takahama Y. TCR Affinity for In Vivo Peptide-Induced Thymic Positive Selection Fine-Tunes TCR Responsiveness of Peripheral CD8+ T Cells. J Immunol. 2019;: pubmed publisher
  90. Leach S, Shinnakasu R, Adachi Y, Momota M, Makino Okamura C, Yamamoto T, et al. Requirement for memory B cell activation in protection from heterologous influenza virus reinfection. Int Immunol. 2019;: pubmed publisher
  91. Ansaldo E, Slayden L, Ching K, Koch M, Wolf N, Plichta D, et al. Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science. 2019;364:1179-1184 pubmed publisher
  92. Essex A, Pineda J, Acharya G, Xin H, Evans J, Iorns E, et al. Replication Study: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. elife. 2019;8: pubmed publisher
  93. Khan O, Giles J, McDonald S, Manne S, Ngiow S, Patel K, et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature. 2019;: pubmed publisher
  94. Moamer A, Hachim I, Binothman N, Wang N, Lebrun J, Ali S. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis. EBioMedicine. 2019;: pubmed publisher
  95. Oh J, Iijima N, Song E, Lu P, Klein J, Jiang R, et al. Migrant memory B cells secrete luminal antibody in the vagina. Nature. 2019;: pubmed publisher
  96. Wang R, Geng J, Sheng W, Liu X, Jiang M, Zhen Y. The ionophore antibiotic gramicidin A inhibits pancreatic cancer stem cells associated with CD47 down-regulation. Cancer Cell Int. 2019;19:145 pubmed publisher
  97. Sabol R, Bowles A, Côté A, Wise R, O Donnell B, Matossian M, et al. Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Res. 2019;21:67 pubmed publisher
  98. Di Pilato M, Kim E, Cadilha B, Prüßmann J, Nasrallah M, Seruggia D, et al. Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy. Nature. 2019;570:112-116 pubmed publisher
  99. Qiu J, Villa M, Sanin D, Buck M, O Sullivan D, Ching R, et al. Acetate Promotes T Cell Effector Function during Glucose Restriction. Cell Rep. 2019;27:2063-2074.e5 pubmed publisher
  100. Kotov J, Kotov D, Linehan J, Bardwell V, Gearhart M, Jenkins M. BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors. J Exp Med. 2019;216:1450-1464 pubmed publisher
  101. Maji B, Gangopadhyay S, Lee M, Shi M, Wu P, Heler R, et al. A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9. Cell. 2019;177:1067-1079.e19 pubmed publisher
  102. Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells. Cell. 2019;177:1172-1186.e14 pubmed publisher
  103. Lu D, Liao Y, Zhu S, Chen Q, Xie D, Liao J, et al. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction. Stem Cell Res Ther. 2019;10:127 pubmed publisher
  104. Ahmed M, El Sayed A, Chen H, Zhao R, Yusuf M, Zuo Q, et al. Comparison between curcumin and all-trans retinoic acid in the osteogenic differentiation of mouse bone marrow mesenchymal stem cells. Exp Ther Med. 2019;17:4154-4166 pubmed publisher
  105. LaFleur M, Nguyen T, Coxe M, Yates K, Trombley J, Weiss S, et al. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat Commun. 2019;10:1668 pubmed publisher
  106. Chen Z, Wang H, Wang S, Fan L, Feng S, Cai X, et al. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells. J Clin Invest. 2019;130:2043-2055 pubmed publisher
  107. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  108. Wu J, Ma S, Sandhoff R, Ming Y, Hotz Wagenblatt A, Timmerman V, et al. Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness. Immunity. 2019;50:1218-1231.e5 pubmed publisher
  109. Li Y, Tinoco R, Elmén L, Segota I, Xian Y, Fujita Y, et al. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice. Nat Commun. 2019;10:1492 pubmed publisher
  110. Sinclair L, Howden A, Brenes A, Spinelli L, Hukelmann J, Macintyre A, et al. Antigen receptor control of methionine metabolism in T cells. elife. 2019;8: pubmed publisher
  111. Cao Y, Trillo Tinoco J, Sierra R, Anadon C, Dai W, Mohamed E, et al. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat Commun. 2019;10:1280 pubmed publisher
  112. Chakarov S, Lim H, Tan L, Lim S, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363: pubmed publisher
  113. Yan X, Tang B, Chen B, Shan Y, Yang H, Iorns E, et al. Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. elife. 2019;8: pubmed publisher
  114. Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249-252 pubmed publisher
  115. Xing S, Gai K, Li X, Shao P, Zeng Z, Zhao X, et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J Exp Med. 2019;: pubmed publisher
  116. Han Y, Feng H, Sun J, Liang X, Wang Z, Xing W, et al. Lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activation. J Clin Invest. 2019;130: pubmed publisher
  117. Guillon J, Petit C, Moreau M, Toutain B, Henry C, Roche H, et al. Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment. Cell Death Dis. 2019;10:199 pubmed publisher
  118. Michaels Y, Barnkob M, Barbosa H, Baeumler T, Thompson M, Andre V, et al. Precise tuning of gene expression levels in mammalian cells. Nat Commun. 2019;10:818 pubmed publisher
  119. Salerno F, Guislain A, Freen van Heeren J, Nicolet B, Young H, Wolkers M. Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells. Oncoimmunology. 2019;8:e1532762 pubmed publisher
  120. Jin C, Lagoudas G, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell. 2019;176:998-1013.e16 pubmed publisher
  121. Yamamoto T, Lee P, Vodnala S, Gurusamy D, Kishton R, Yu Z, et al. T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019;129:1551-1565 pubmed publisher
  122. Faliti C, Gualtierotti R, Rottoli E, Gerosa M, Perruzza L, Romagnani A, et al. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus. J Exp Med. 2019;216:317-336 pubmed publisher
  123. Wimmer R, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M, et al. Human blood vessel organoids as a model of diabetic vasculopathy. Nature. 2019;565:505-510 pubmed publisher
  124. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  125. Li F, Zeng Z, Xing S, Gullicksrud J, Shan Q, Choi J, et al. Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf. Nat Commun. 2018;9:5452 pubmed publisher
  126. Zhang C, Wang Y. Metformin attenuates cells stemness and epithelial‑mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a/β‑catenin pathway. Mol Med Rep. 2019;19:1203-1209 pubmed publisher
  127. Karmaus P, Chen X, Lim S, Herrada A, Nguyen T, Xu B, et al. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity. Nature. 2019;565:101-105 pubmed publisher
  128. Chorro L, Suzuki M, Chin S, Williams T, Snapp E, Odagiu L, et al. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape. Nat Commun. 2018;9:5368 pubmed publisher
  129. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed publisher
  130. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  131. Poncette L, Chen X, Lorenz F, Blankenstein T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J Clin Invest. 2019;129:324-335 pubmed publisher
  132. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  133. Gejman R, Chang A, Jones H, DiKun K, Hakimi A, Schietinger A, et al. Rejection of immunogenic tumor clones is limited by clonal fraction. elife. 2018;7: pubmed publisher
  134. Atretkhany K, Mufazalov I, Dunst J, Kuchmiy A, Gogoleva V, Andruszewski D, et al. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc Natl Acad Sci U S A. 2018;115:13051-13056 pubmed publisher
  135. Muscate F, Stetter N, Schramm C, Schulze zur Wiesch J, Bosurgi L, Jacobs T. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018;9:2611 pubmed publisher
  136. Ng K, Yui M, Mehta A, Siu S, Irwin B, Pease S, et al. A stochastic epigenetic switch controls the dynamics of T-cell lineage commitment. elife. 2018;7: pubmed publisher
  137. Glal D, Sudhakar J, Lu H, Liu M, Chiang H, Liu Y, et al. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases. Front Immunol. 2018;9:2522 pubmed publisher
  138. Klement J, Paschall A, Redd P, Ibrahim M, Lu C, Yang D, et al. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128:5549-5560 pubmed publisher
  139. Humblet Baron S, Barber J, Roca C, Lenaerts A, Koni P, Liston A. Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells. Blood. 2018;: pubmed publisher
  140. Song M, Sandoval T, Chae C, Chopra S, Tan C, Rutkowski M, et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature. 2018;562:423-428 pubmed publisher
  141. Vuckovic S, Minnie S, Smith D, Gartlan K, Watkins T, Markey K, et al. Bone marrow transplantation generates T cell-dependent control of myeloma in mice. J Clin Invest. 2019;129:106-121 pubmed publisher
  142. Sang A, Danhorn T, Peterson J, Rankin A, O Connor B, Leach S, et al. Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus. Nat Commun. 2018;9:3973 pubmed publisher
  143. Fauster A, Rebsamen M, Willmann K, César Razquin A, Girardi E, Bigenzahn J, et al. Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ. 2019;26:1138-1155 pubmed publisher
  144. Giles D, Duncker P, Wilkinson N, Washnock Schmid J, Segal B. CNS-resident classical DCs play a critical role in CNS autoimmune disease. J Clin Invest. 2018;128:5322-5334 pubmed publisher
  145. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  146. Leng Y, Abdullah A, Wendt M, Calve S. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis. Matrix Biol. 2019;78-79:236-254 pubmed publisher
  147. Olson H, Davis L, Kiianitsa K, Khoo K, Liu Y, Knijnenburg T, et al. Increased levels of RECQ5 shift DNA repair from canonical to alternative pathways. Nucleic Acids Res. 2018;46:9496-9509 pubmed publisher
  148. Cummings M, Arumanayagam A, Zhao P, Kannanganat S, Stuve O, Karandikar N, et al. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. PLoS ONE. 2018;13:e0200752 pubmed publisher
  149. Baens M, Stirparo R, Lampi Y, Verbeke D, Vandepoel R, Cools J, et al. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice. Eur J Immunol. 2018;48:1728-1738 pubmed publisher
  150. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  151. Zhang C, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745 pubmed publisher
  152. Cho S, Lee H, Yu I, Choi Y, Huang H, Hashemifar S, et al. Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b. Nat Commun. 2018;9:2757 pubmed publisher
  153. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  154. Vendetti F, Karukonda P, Clump D, Teo T, Lalonde R, Nugent K, et al. ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation. J Clin Invest. 2018;128:3926-3940 pubmed publisher
  155. Nusse Y, Savage A, Marangoni P, Rosendahl Huber A, Landman T, De Sauvage F, et al. Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature. 2018;559:109-113 pubmed publisher
  156. Murakami T, Kim J, Li Y, Green G, Shikanov A, Ono A. Secondary lymphoid organ fibroblastic reticular cells mediate trans-infection of HIV-1 via CD44-hyaluronan interactions. Nat Commun. 2018;9:2436 pubmed publisher
  157. Espinoza Sánchez N, Enciso J, Pelayo R, Fuentes Panana E. An NF?B-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features. Oncotarget. 2018;9:26679-26700 pubmed publisher
  158. Kirkling M, Cytlak U, Lau C, Lewis K, Resteu A, Khodadadi Jamayran A, et al. Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells. Cell Rep. 2018;23:3658-3672.e6 pubmed publisher
  159. Huang W, Bei L, Eklund E. Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin. Oncotarget. 2018;9:25891-25902 pubmed publisher
  160. Hojo N, Huisken A, Wang H, Chirshev E, Kim N, Nguyen S, et al. Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer. Sci Rep. 2018;8:8704 pubmed publisher
  161. Feng Y, Liao Y, Huang W, Lai X, Luo J, Du C, et al. Mesenchymal stromal cells-derived matrix Gla protein contribute to the alleviation of experimental colitis. Cell Death Dis. 2018;9:691 pubmed publisher
  162. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  163. Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360: pubmed publisher
  164. Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen H, Bastian D, Zhang M, et al. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018;128:2787-2801 pubmed publisher
  165. Hu X, Majchrzak K, Liu X, Wyatt M, Spooner C, Moisan J, et al. In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo. Cancer Res. 2018;78:3888-3898 pubmed publisher
  166. Hsu J, Xia W, Hsu Y, Chan L, Yu W, Cha J, et al. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nat Commun. 2018;9:1908 pubmed publisher
  167. Drobek A, Moudra A, Mueller D, Huranová M, Horková V, Pribikova M, et al. Strong homeostatic TCR signals induce formation of self-tolerant virtual memory CD8 T cells. EMBO J. 2018;37: pubmed publisher
  168. Borlido J, Sakuma S, Raices M, Carrette F, Tinoco R, Bradley L, et al. Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis. Nat Immunol. 2018;19:594-605 pubmed publisher
  169. Ge J, Burnier L, Adamopoulou M, Kwa M, Schaks M, Rottner K, et al. RhoA, Rac1, and Cdc42 differentially regulate αSMA and collagen I expression in mesenchymal stem cells. J Biol Chem. 2018;293:9358-9369 pubmed publisher
  170. Gounder A, Yokoyama C, Jarjour N, Bricker T, Edelson B, Boon A. Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer. PLoS Pathog. 2018;14:e1007001 pubmed publisher
  171. Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. 2018;173:634-648.e12 pubmed publisher
  172. Zhang Y, Tech L, George L, Acs A, Durrett R, Hess H, et al. Plasma cell output from germinal centers is regulated by signals from Tfh and stromal cells. J Exp Med. 2018;215:1227-1243 pubmed publisher
  173. Gaddis D, Padgett L, Wu R, McSkimming C, Romines V, Taylor A, et al. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat Commun. 2018;9:1095 pubmed publisher
  174. Safya H, Mellouk A, Legrand J, Le Gall S, Benbijja M, Kanellopoulos Langevin C, et al. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage. Front Immunol. 2018;9:360 pubmed publisher
  175. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  176. Khan A, Carpenter B, Santos e Sousa P, Pospori C, Khorshed R, Griffin J, et al. Redirection to the bone marrow improves T cell persistence and antitumor functions. J Clin Invest. 2018;128:2010-2024 pubmed publisher
  177. Hailemichael Y, Woods A, Fu T, He Q, Nielsen M, Hasan F, et al. Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018;128:1338-1354 pubmed publisher
  178. Lee C, Zhang H, Singh S, Koo L, Kabat J, Tsang H, et al. C/EBPδ drives interactions between human MAIT cells and endothelial cells that are important for extravasation. elife. 2018;7: pubmed publisher
  179. Kotov D, Kotov J, Goldberg M, Jenkins M. Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential. J Immunol. 2018;200:2004-2012 pubmed publisher
  180. Fahl S, Coffey F, Kain L, Zarin P, Dunbrack R, Teyton L, et al. Role of a selecting ligand in shaping the murine γδ-TCR repertoire. Proc Natl Acad Sci U S A. 2018;115:1889-1894 pubmed publisher
  181. Jung Y, Cackowski F, Yumoto K, Decker A, Wang J, Kim J, et al. CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes. Cancer Res. 2018;78:2026-2039 pubmed publisher
  182. Chen X, Nagai Y, Zhu Z, Ruan H, Peehl D, Greene M, et al. A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77. Oncotarget. 2018;9:3631-3640 pubmed publisher
  183. Ellestad K, Thangavelu G, Haile Y, Lin J, Boon L, Anderson C. Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1. Front Immunol. 2018;9:12 pubmed publisher
  184. Sato M, Kawana K, Adachi K, Fujimoto A, Yoshida M, Nakamura H, et al. Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer. Oncol Lett. 2018;15:1357-1361 pubmed publisher
  185. Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172:841-856.e16 pubmed publisher
  186. Linehan J, Harrison O, Han S, Byrd A, Vujkovic Cvijin I, Villarino A, et al. Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell. 2018;172:784-796.e18 pubmed publisher
  187. Solomon H, Dinowitz N, Pateras I, Cooks T, Shetzer Y, Molchadsky A, et al. Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers. Oncogene. 2018;37:1669-1684 pubmed publisher
  188. Koh A, Miller E, Buenrostro J, Moskowitz D, Wang J, Greenleaf W, et al. Rapid chromatin repression by Aire provides precise control of immune tolerance. Nat Immunol. 2018;19:162-172 pubmed publisher
  189. Ferdinand J, Richard A, Meylan F, Al Shamkhani A, Siegel R. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. J Immunol. 2018;200:1360-1369 pubmed publisher
  190. Freeman S, Vega A, Riedl M, Collins R, Ostrowski P, Woods E, et al. Transmembrane Pickets Connect Cyto- and Pericellular Skeletons Forming Barriers to Receptor Engagement. Cell. 2018;172:305-317.e10 pubmed publisher
  191. Nakashima H, Alayo Q, Penaloza MacMaster P, Freeman G, Kuchroo V, Reardon D, et al. Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells. Sci Rep. 2018;8:208 pubmed publisher
  192. Hira V, Wormer J, Kakar H, Breznik B, van der Swaan B, Hulsbos R, et al. Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins. J Histochem Cytochem. 2018;66:155-173 pubmed publisher
  193. Pleiner T, Bates M, Gorlich D. A toolbox of anti-mouse and anti-rabbit IgG secondary nanobodies. J Cell Biol. 2018;217:1143-1154 pubmed publisher
  194. Burrack A, Malhotra D, Dileepan T, Osum K, Swanson L, Fife B, et al. Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides. J Immunol. 2018;200:477-482 pubmed publisher
  195. Ibitokou S, Dillon B, Sinha M, Szczesny B, Delgadillo A, Reda Abdelrahman D, et al. Early Inhibition of Fatty Acid Synthesis Reduces Generation of Memory Precursor Effector T Cells in Chronic Infection. J Immunol. 2018;200:643-656 pubmed publisher
  196. Ibrahim M, Scozzi D, Toth K, Ponti D, Kreisel D, Menna C, et al. Naive CD4+ T Cells Carrying a TLR2 Agonist Overcome TGF-β-Mediated Tumor Immune Evasion. J Immunol. 2018;200:847-856 pubmed publisher
  197. Zhao B, Mei Y, Cao L, Zhang J, Sumagin R, Yang J, et al. Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms. J Clin Invest. 2018;128:125-140 pubmed publisher
  198. Ruetz T, Pfisterer U, Di Stefano B, Ashmore J, Beniazza M, Tian T, et al. Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming. Cell Stem Cell. 2017;21:791-805.e9 pubmed publisher
  199. Ernszt D, Banfai K, Kellermayer Z, Pap A, Lord J, Pongracz J, et al. PPARgamma Deficiency Counteracts Thymic Senescence. Front Immunol. 2017;8:1515 pubmed publisher
  200. Kwak J, Laskowski J, Li H, McSharry M, Sippel T, Bullock B, et al. Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res. 2018;78:143-156 pubmed publisher
  201. Wasiuk A, Testa J, Weidlick J, Sisson C, Vitale L, Widger J, et al. CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. J Immunol. 2017;199:4110-4123 pubmed publisher
  202. Francis N, Every A, Ayodele B, Pike R, Mackie E, Pagel C. A T cell-specific knockout reveals an important role for protease-activated receptor 2 in lymphocyte development. Int J Biochem Cell Biol. 2017;92:95-103 pubmed publisher
  203. Blanchfield L, Sabatino J, Lawrence L, Evavold B. NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease. J Immunol. 2017;199:2680-2691 pubmed publisher
  204. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed publisher
  205. Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y, et al. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun. 2017;8:254 pubmed publisher
  206. Li L, Labuda J, Imai D, Griffey S, McSorley S. CCR7 Deficiency Allows Accelerated Clearance of Chlamydia from the Female Reproductive Tract. J Immunol. 2017;199:2547-2554 pubmed publisher
  207. Hu J, Guan W, Liu P, Dai J, Tang K, Xiao H, et al. Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells. Stem Cell Reports. 2017;9:464-477 pubmed publisher
  208. Kim M, Yoo S, Kang S, Kwon J, Choi I, Lee C. TNF? and IL-1? in the synovial fluid facilitate mucosal-associated invariant T (MAIT) cell migration. Cytokine. 2017;99:91-98 pubmed publisher
  209. Walker R, Poleszczuk J, Mejia J, Lee J, Pimiento J, Malafa M, et al. Toward early detection of Helicobacter pylori-associated gastric cancer. Gastric Cancer. 2018;21:196-203 pubmed publisher
  210. Wang Y, Yun C, Gao B, Xu Y, Zhang Y, Wang Y, et al. The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation. Cell Rep. 2017;20:600-612 pubmed publisher
  211. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  212. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  213. Sitrin J, Suto E, Wuster A, Eastham Anderson J, Kim J, Austin C, et al. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice. J Immunol. 2017;199:1238-1249 pubmed publisher
  214. Azizi H, Hwang J, Suen V, Kang N, Somvanshi R, Tadavarty R, et al. Sleep deprivation induces changes in 5-HT actions and 5-HT1A receptor expression in the rat hippocampus. Neurosci Lett. 2017;655:151-155 pubmed publisher
  215. Levine A, Mendoza A, Hemmers S, Moltedo B, Niec R, Schizas M, et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature. 2017;546:421-425 pubmed publisher
  216. Seifert H, Benedek G, Liang J, Nguyen H, Kent G, Vandenbark A, et al. Sex differences in regulatory cells in experimental stroke. Cell Immunol. 2017;318:49-54 pubmed publisher
  217. Castella B, Kopecka J, Sciancalepore P, Mandili G, Foglietta M, Mitro N, et al. The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells. Nat Commun. 2017;8:15663 pubmed publisher
  218. Hasan Z, Koizumi S, Sasaki D, Yamada H, Arakaki N, Fujihara Y, et al. JunB is essential for IL-23-dependent pathogenicity of Th17 cells. Nat Commun. 2017;8:15628 pubmed publisher
  219. Lu G, Zhang X, Shen L, Qiao Q, Li Y, Sun J, et al. CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy. PLoS ONE. 2017;12:e0178352 pubmed publisher
  220. Mendoza A, Fang V, Chen C, Serasinghe M, Verma A, Muller J, et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature. 2017;546:158-161 pubmed publisher
  221. Loi A, Hoonhorst S, van Aalst C, Langereis J, Kamp V, Sluis Eising S, et al. Proteomic profiling of peripheral blood neutrophils identifies two inflammatory phenotypes in stable COPD patients. Respir Res. 2017;18:100 pubmed publisher
  222. Lis R, Karrasch C, Poulos M, Kunar B, Redmond D, Duran J, et al. Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature. 2017;545:439-445 pubmed publisher
  223. Kumazoe M, Takai M, Hiroi S, Takeuchi C, Kadomatsu M, Nojiri T, et al. The FOXO3/PGC-1? signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma. J Biol Chem. 2017;292:10813-10823 pubmed publisher
  224. Miao T, Symonds A, Singh R, Symonds J, Ogbe A, Omodho B, et al. Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation. J Exp Med. 2017;214:1787-1808 pubmed publisher
  225. Bagchi S, He Y, Zhang H, Cao L, Van Rhijn I, Moody D, et al. CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J Clin Invest. 2017;127:2339-2352 pubmed publisher
  226. Yoon C, Cho S, Chang K, Park D, Ryeom S, Yoon S. Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma. Mol Cancer Res. 2017;15:1106-1116 pubmed publisher
  227. Samson E, Tsao D, Zimak J, McLaughlin R, Trenton N, Mace E, et al. The coordinating role of IQGAP1 in the regulation of local, endosome-specific actin networks. Biol Open. 2017;6:785-799 pubmed publisher
  228. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  229. Li P, Wang Y, Mao X, Jiang Y, Liu J, Li J, et al. CRB3 downregulation confers breast cancer stem cell traits through TAZ/?-catenin. Oncogenesis. 2017;6:e322 pubmed publisher
  230. Lu P, Shih C, Qi H. Ephrin B1-mediated repulsion and signaling control germinal center T cell territoriality and function. Science. 2017;356: pubmed publisher
  231. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed publisher
  232. Fu G, Xu Q, Qiu Y, Jin X, Xu T, Dong S, et al. Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med. 2017;214:1453-1469 pubmed publisher
  233. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  234. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  235. Lino C, Barros Martins J, Oberdörfer L, Walzer T, Prinz I. Eomes expression reports the progressive differentiation of IFN-?-producing Th1-like ?? T cells. Eur J Immunol. 2017;47:970-981 pubmed publisher
  236. Bouziat R, Hinterleitner R, Brown J, Stencel Baerenwald J, Ikizler M, Mayassi T, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356:44-50 pubmed publisher
  237. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  238. Emadedin M, Labibzadeh N, Fazeli R, Mohseni F, Hosseini S, Moghadasali R, et al. Percutaneous Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Implantation Is Safe for Reconstruction of Human Lower Limb Long Bone Atrophic Nonunion. Cell J. 2017;19:159-165 pubmed
  239. Martinez Jimenez C, Eling N, Chen H, Vallejos C, Kolodziejczyk A, Connor F, et al. Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science. 2017;355:1433-1436 pubmed publisher
  240. Connolly N, Stokum J, Schneider C, Ozawa T, Xu S, Galisteo R, et al. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. PLoS ONE. 2017;12:e0174557 pubmed publisher
  241. Liang G, Li S, Du W, Ke Q, Cai J, Yang J. Hypoxia regulates CD44 expression via hypoxia-inducible factor-1? in human gastric cancer cells. Oncol Lett. 2017;13:967-972 pubmed publisher
  242. Mitsunari K, Miyata Y, Watanabe S, Asai A, Yasuda T, Kanda S, et al. Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survival. Oncol Lett. 2017;13:834-840 pubmed publisher
  243. Briseño C, Gargaro M, Durai V, Davidson J, Theisen D, Anderson D, et al. Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms. Proc Natl Acad Sci U S A. 2017;114:3957-3962 pubmed publisher
  244. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed publisher
  245. Keckesova Z, Donaher J, De Cock J, Freinkman E, Lingrell S, Bachovchin D, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017;543:681-686 pubmed publisher
  246. Patouraux S, Rousseau D, Bonnafous S, Lebeaupin C, Luci C, Canivet C, et al. CD44 is a key player in non-alcoholic steatohepatitis. J Hepatol. 2017;67:328-338 pubmed publisher
  247. Clark K, Fierro F, Ko E, Walker N, Arzi B, Tepper C, et al. Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome. Stem Cell Res Ther. 2017;8:69 pubmed publisher
  248. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  249. Bhattacharyya M, Penaloza MacMaster P. T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells. Immunology. 2017;151:340-348 pubmed publisher
  250. Trakarnsanga K, Griffiths R, Wilson M, Blair A, Satchwell T, Meinders M, et al. An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells. Nat Commun. 2017;8:14750 pubmed publisher
  251. Celiku O, Tandle A, Chung J, Hewitt S, Camphausen K, Shankavaram U. Computational analysis of the mesenchymal signature landscape in gliomas. BMC Med Genomics. 2017;10:13 pubmed publisher
  252. Pishesha N, Bilate A, Wibowo M, Huang N, Li Z, Deshycka R, et al. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proc Natl Acad Sci U S A. 2017;114:3157-3162 pubmed publisher
  253. Chang Y, Lin T, Campbell M, Pan C, Lee S, Lee H, et al. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. Sci Rep. 2017;7:42795 pubmed publisher
  254. Ramos G, van den Berg A, Nunes Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A. 2017;114:E2420-E2429 pubmed publisher
  255. Rubtsova K, Rubtsov A, Thurman J, Mennona J, Kappler J, Marrack P. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest. 2017;127:1392-1404 pubmed publisher
  256. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  257. Vernot J, Bonilla X, Rodriguez Pardo V, Vanegas N. Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment. Int J Mol Sci. 2017;18: pubmed publisher
  258. Horvatinovich J, Grogan E, Norris M, Steinkasserer A, Lemos H, Mellor A, et al. Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes. J Immunol. 2017;198:2286-2301 pubmed publisher
  259. Neganova I, Chichagova V, Armstrong L, Lako M. A critical role for p38MAPK signalling pathway during reprogramming of human fibroblasts to iPSCs. Sci Rep. 2017;7:41693 pubmed publisher
  260. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed publisher
  261. Duhachek Muggy S, Qi Y, Wise R, Alyahya L, Li H, Hodge J, et al. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer. Mol Cancer. 2017;16:32 pubmed publisher
  262. Ritschka B, Storer M, Mas A, Heinzmann F, Ortells M, Morton J, et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev. 2017;31:172-183 pubmed publisher
  263. van Nieuwenhuijze A, Dooley J, Humblet Baron S, Sreenivasan J, Koenders M, Schlenner S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74:2095-2106 pubmed publisher
  264. Litzenburger U, Buenrostro J, Wu B, Shen Y, Sheffield N, Kathiria A, et al. Single-cell epigenomic variability reveals functional cancer heterogeneity. Genome Biol. 2017;18:15 pubmed publisher
  265. Xing X, Zhang Z, Zhong L, Ju G, Zou X, Zhu Y, et al. Differentiation of human umbilical cord mesenchymal stem cells into steroidogenic cells in vitro. Exp Ther Med. 2016;12:3527-3534 pubmed publisher
  266. Chorzalska A, Kim J, Roder K, Tepper A, Ahsan N, Rao R, et al. Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. Stem Cells Dev. 2017;26:656-677 pubmed publisher
  267. Lango Chavarría M, Chimal Ramírez G, Ruiz Tachiquín M, Espinoza Sánchez N, Suárez Arriaga M, Fuentes Pananá E. A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients. Int J Oncol. 2017;50:432-440 pubmed publisher
  268. Barnes L, Saurat J, Kaya G. Senescent Atrophic Epidermis Retains Lrig1+ Stem Cells and Loses Wnt Signaling, a Phenotype Shared with CD44KO Mice. PLoS ONE. 2017;12:e0169452 pubmed publisher
  269. Kechele D, Blue R, Zwarycz B, Espenschied S, Mah A, Siegel M, et al. Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation. J Clin Invest. 2017;127:593-607 pubmed publisher
  270. Pal D, Pertot A, Shirole N, Yao Z, Anaparthy N, Garvin T, et al. TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24- cancer cells. elife. 2017;6: pubmed publisher
  271. Nowyhed H, Chandra S, Kiosses W, Marcovecchio P, Andary F, Zhao M, et al. ATP Binding Cassette Transporter ABCA7 Regulates NKT Cell Development and Function by Controlling CD1d Expression and Lipid Raft Content. Sci Rep. 2017;7:40273 pubmed publisher
  272. Vanegas N, Vernot J. Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche. Exp Hematol Oncol. 2017;6:2 pubmed publisher
  273. Zhong Y, Li X, Ji Y, Li X, Li Y, Yu D, et al. Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers. Oncotarget. 2017;8:13344-13356 pubmed publisher
  274. Rampoldi F, Brunk F, Bonrouhi M, Federico G, Krunic D, Porubsky S, et al. Deficiency of N-myristoylation reveals calcineurin activity as regulator of IFN-?-producing ?? T cells. J Leukoc Biol. 2017;101:1005-1014 pubmed publisher
  275. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  276. Williams J, Dean A, Lankford S, Criswell T, Badlani G, Andersson K. Determinates of muscle precursor cell therapy efficacy in a nonhuman primate model of intrinsic urinary sphincter deficiency. Stem Cell Res Ther. 2017;8:1 pubmed publisher
  277. Chen S, Cai C, Li Z, Liu G, Wang Y, Blonska M, et al. Dissection of SAP-dependent and SAP-independent SLAM family signaling in NKT cell development and humoral immunity. J Exp Med. 2017;214:475-489 pubmed publisher
  278. Marshall N, Vong A, Devarajan P, Brauner M, Kuang Y, Nayar R, et al. NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection. J Immunol. 2017;198:1142-1155 pubmed publisher
  279. Kijewska M, Kocyk M, Kloss M, Stepniak K, Korwek Z, Polakowska R, et al. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma. Oncotarget. 2017;8:16340-16355 pubmed publisher
  280. Xu X, Han L, Zhao G, Xue S, Gao Y, Xiao J, et al. LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis. J Exp Med. 2017;214:209-226 pubmed publisher
  281. Lamprianou S, Gysemans C, Bou Saab J, Pontes H, Mathieu C, Meda P. Glibenclamide Prevents Diabetes in NOD Mice. PLoS ONE. 2016;11:e0168839 pubmed publisher
  282. Griffiths K, Ahmed M, Das S, Gopal R, Horne W, Connell T, et al. Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Nat Commun. 2016;7:13894 pubmed publisher
  283. Jerić I, Maurer G, Cavallo A, Raguz J, Desideri E, Tarkowski B, et al. A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis. Nat Commun. 2016;7:13781 pubmed publisher
  284. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  285. de Lima A, Barbosa C, Gonçalves A, Santos F, Viana G, Varotti F, et al. New 3-alkylpyridine marine alkaloid analogues as promising antitumor agents against the CD44+/high /CD24-/low subset of triple-negative breast cancer cell line. Chem Biol Drug Des. 2017;90:5-11 pubmed publisher
  286. Pascual G, Avgustinova A, Mejetta S, Martin M, Castellanos A, Attolini C, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541:41-45 pubmed publisher
  287. Hashimoto Hill S, Friesen L, Kim M, Kim C. Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7. Mucosal Immunol. 2017;10:912-923 pubmed publisher
  288. Bhagirath D, Zhao X, Mirza S, West W, Band H, Band V. Mutant PIK3CA Induces EMT in a Cell Type Specific Manner. PLoS ONE. 2016;11:e0167064 pubmed publisher
  289. Wei Y, Lu C, Chen J, Cui G, Wang L, Yu T, et al. High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget. 2017;8:70-82 pubmed publisher
  290. Nish S, Zens K, Kratchmarov R, Lin W, Adams W, Chen Y, et al. CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions. J Exp Med. 2017;214:39-47 pubmed publisher
  291. Jacobsen E, Ochkur S, Doyle A, Lesuer W, Li W, Protheroe C, et al. Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation. Am J Respir Crit Care Med. 2017;195:1321-1332 pubmed publisher
  292. Monfared M, Minaee B, Rastegar T, Khrazinejad E, Barbarestani M. Sertoli cell condition medium can induce germ like cells from bone marrow derived mesenchymal stem cells. Iran J Basic Med Sci. 2016;19:1186-1192 pubmed
  293. Morita K, Okamura T, Inoue M, Komai T, Teruya S, Iwasaki Y, et al. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production. Proc Natl Acad Sci U S A. 2016;113:E8131-E8140 pubmed
  294. Angela M, Endo Y, Asou H, Yamamoto T, Tumes D, Tokuyama H, et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR? directs early activation of T cells. Nat Commun. 2016;7:13683 pubmed publisher
  295. Kretzer N, Theisen D, Tussiwand R, Briseño C, Grajales Reyes G, Wu X, et al. RAB43 facilitates cross-presentation of cell-associated antigens by CD8?+ dendritic cells. J Exp Med. 2016;213:2871-2883 pubmed
  296. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  297. Chen Z, Tang C, Zhu Y, Xie M, He D, Pan Q, et al. TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer. Clin Sci (Lond). 2017;131:227-237 pubmed publisher
  298. Kumazoe M, Takai M, Bae J, Hiroi S, Huang Y, Takamatsu K, et al. FOXO3 is essential for CD44 expression in pancreatic cancer cells. Oncogene. 2017;36:2643-2654 pubmed publisher
  299. FINAN G, Realubit R, Chung S, Lutjohann D, Wang N, Cirrito J, et al. Bioactive Compound Screen for Pharmacological Enhancers of Apolipoprotein E in Primary Human Astrocytes. Cell Chem Biol. 2016;23:1526-1538 pubmed publisher
  300. Le Q, Yao W, Chen Y, Yan B, Liu C, Yuan M, et al. GRK6 regulates ROS response and maintains hematopoietic stem cell self-renewal. Cell Death Dis. 2016;7:e2478 pubmed publisher
  301. Yoo S, Leng L, Kim B, Du X, Tilstam P, Kim K, et al. MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2016;113:E7917-E7926 pubmed
  302. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  303. Caminal M, Velez R, Rabanal R, Vivas D, Batlle Morera L, Aguirre M, et al. A reproducible method for the isolation and expansion of ovine mesenchymal stromal cells from bone marrow for use in regenerative medicine preclinical studies. J Tissue Eng Regen Med. 2017;11:3408-3416 pubmed publisher
  304. Galindo Albarrán A, López Portales O, Gutiérrez Reyna D, Rodríguez Jorge O, Sánchez Villanueva J, Ramirez Pliego O, et al. CD8+ T Cells from Human Neonates Are Biased toward an Innate Immune Response. Cell Rep. 2016;17:2151-2160 pubmed publisher
  305. Theisen E, Sauer J. Listeria monocytogenes-Induced Cell Death Inhibits the Generation of Cell-Mediated Immunity. Infect Immun. 2017;85: pubmed publisher
  306. Dallavalle C, Albino D, Civenni G, Merulla J, Ostano P, Mello Grand M, et al. MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression. J Clin Invest. 2016;126:4585-4602 pubmed publisher
  307. Hirako I, Ataide M, Faustino L, Assis P, Sorensen E, Ueta H, et al. Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun. 2016;7:13277 pubmed publisher
  308. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  309. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  310. Zhao H, Tang H, Xiao Q, He M, Zhao L, Fu Y, et al. The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24? phenotype. Mol Med Rep. 2016;14:5261-5270 pubmed publisher
  311. Yu Z, Zou Y, Fan J, Li C, Ma L. Notch1 is associated with the differentiation of human bone marrow?derived mesenchymal stem cells to cardiomyocytes. Mol Med Rep. 2016;14:5065-5071 pubmed publisher
  312. Kwong Chung C, Ronchi F, Geuking M. Detrimental effect of systemic antimicrobial CD4+ T-cell reactivity on gut epithelial integrity. Immunology. 2017;150:221-235 pubmed publisher
  313. Starobinets H, Ye J, Broz M, Barry K, Goldsmith J, Marsh T, et al. Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. J Clin Invest. 2016;126:4417-4429 pubmed publisher
  314. Skowron K, Pitroda S, Namm J, Balogun O, Beckett M, Zenner M, et al. Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers. Sci Rep. 2016;6:35854 pubmed publisher
  315. Horimoto Y, Arakawa A, Sasahara N, Tanabe M, Sai S, Himuro T, et al. Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases. PLoS ONE. 2016;11:e0165253 pubmed publisher
  316. Kotschy A, Szlávik Z, Murray J, Davidson J, Maragno A, Le Toumelin Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477-482 pubmed publisher
  317. Chu V, Graf R, Wirtz T, Weber T, Favret J, Li X, et al. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line. Proc Natl Acad Sci U S A. 2016;113:12514-12519 pubmed
  318. Liu Z, Tian R, Li Y, Zhang L, Shao H, Yang C, et al. SDF-1?-induced dual pairs of E-selectin/ligand mediate endothelial progenitor cell homing to critical ischemia. Sci Rep. 2016;6:34416 pubmed publisher
  319. Hiraga T, Nakamura H. Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model. Oncol Lett. 2016;12:2962-2969 pubmed
  320. Kang S, Wang Y, Reder N, Liu J. Multiplexed Molecular Imaging of Biomarker-Targeted SERS Nanoparticles on Fresh Tissue Specimens with Channel-Compressed Spectrometry. PLoS ONE. 2016;11:e0163473 pubmed publisher
  321. Rothchild A, Sissons J, Shafiani S, Plaisier C, Min D, Mai D, et al. MiR-155-regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2016;113:E6172-E6181 pubmed
  322. Singh S, Zeng X, Zhao J, Liu Y, Hou G, Liu H, et al. The lipolysis pathway sustains normal and transformed stem cells in adult Drosophila. Nature. 2016;538:109-113 pubmed publisher
  323. Lee E, Wang J, Yumoto K, Jung Y, Cackowski F, Decker A, et al. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis. Neoplasia. 2016;18:553-66 pubmed publisher
  324. Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS ONE. 2016;11:e0162209 pubmed publisher
  325. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed publisher
  326. Jung Y, Riven I, Feigelson S, Kartvelishvily E, Tohya K, Miyasaka M, et al. Three-dimensional localization of T-cell receptors in relation to microvilli using a combination of superresolution microscopies. Proc Natl Acad Sci U S A. 2016;113:E5916-E5924 pubmed
  327. Lexmond W, Goettel J, Lyons J, Jacobse J, Deken M, Lawrence M, et al. FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest. 2016;126:4030-4044 pubmed publisher
  328. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  329. Torres A, Vargas Y, Uribe D, Jaramillo C, Gleisner A, Salazar Onfray F, et al. Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells. Oncotarget. 2016;7:67373-67386 pubmed publisher
  330. Chai Y, Lee E, Gubbe J, Brekke J. 3D Cell Culture in a Self-Assembled Nanofiber Environment. PLoS ONE. 2016;11:e0162853 pubmed publisher
  331. Liu Z, Chu S, Yao S, Li Y, Fan S, Sun X, et al. CD74 interacts with CD44 and enhances tumorigenesis and metastasis via RHOA-mediated cofilin phosphorylation in human breast cancer cells. Oncotarget. 2016;7:68303-68313 pubmed publisher
  332. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed publisher
  333. Olofsson P, Steinberg B, Sobbi R, Cox M, Ahmed M, Oswald M, et al. Blood pressure regulation by CD4+ lymphocytes expressing choline acetyltransferase. Nat Biotechnol. 2016;34:1066-1071 pubmed publisher
  334. Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, et al. Ecotropic viral integration site 1, a novel oncogene in prostate cancer. Oncogene. 2017;36:1573-1584 pubmed publisher
  335. Uhde A, Herder V, Akram Khan M, Ciurkiewicz M, Schaudien D, Teich R, et al. Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice. PLoS ONE. 2016;11:e0161883 pubmed publisher
  336. Puvanenthiran S, Essapen S, Seddon A, Modjtahedi H. Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs. Int J Oncol. 2016;49:1825-1838 pubmed publisher
  337. Lewis G, Wehrens E, Labarta Bajo L, Streeck H, Zuniga E. TGF-? receptor maintains CD4 T helper cell identity during chronic viral infections. J Clin Invest. 2016;126:3799-3813 pubmed publisher
  338. Papadaki G, Kambas K, Choulaki C, Vlachou K, Drakos E, Bertsias G, et al. Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation. Eur J Immunol. 2016;46:2542-2554 pubmed publisher
  339. Vishnyakova P, Volodina M, Tarasova N, Marey M, Tsvirkun D, Vavina O, et al. Mitochondrial role in adaptive response to stress conditions in preeclampsia. Sci Rep. 2016;6:32410 pubmed publisher
  340. Proekt I, Miller C, Jeanne M, Fasano K, Moon J, Lowell C, et al. LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity. J Clin Invest. 2016;126:3758-3771 pubmed publisher
  341. Vogel K, Bell L, Galloway A, Ahlfors H, Turner M. The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic ?-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression. J Immunol. 2016;197:2673-2685 pubmed publisher
  342. Drennan M, Govindarajan S, Verheugen E, Coquet J, Staal J, McGuire C, et al. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med. 2016;213:1973-81 pubmed publisher
  343. Greenwood E, Maisel S, Ebertz D, Russ A, Pandey R, SCHROEDER J. Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration. Oncotarget. 2016;7:60776-60792 pubmed publisher
  344. Valle Y, Almalki S, Agrawal D. Vitamin D machinery and metabolism in porcine adipose-derived mesenchymal stem cells. Stem Cell Res Ther. 2016;7:118 pubmed publisher
  345. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  346. Damgaard R, Walker J, Marco Casanova P, Morgan N, Titheradge H, Elliott P, et al. The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity. Cell. 2016;166:1215-1230.e20 pubmed publisher
  347. Zhang P, He D, Chen Z, Pan Q, Du F, Zang X, et al. Chemotherapy enhances tumor vascularization via Notch signaling-mediated formation of tumor-derived endothelium in breast cancer. Biochem Pharmacol. 2016;118:18-30 pubmed publisher
  348. Camilleri E, Gustafson M, Dudakovic A, Riester S, Garces C, Paradise C, et al. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production. Stem Cell Res Ther. 2016;7:107 pubmed publisher
  349. Ilmer M, Mazurek N, Byrd J, Ramirez K, Hafley M, Alt E, et al. Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics. Cell Death Dis. 2016;7:e2337 pubmed publisher
  350. Carow B, Gao Y, Coquet J, Reilly M, Rottenberg M. lck-Driven Cre Expression Alters T Cell Development in the Thymus and the Frequencies and Functions of Peripheral T Cell Subsets. J Immunol. 2016;197:2261-8 pubmed publisher
  351. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed publisher
  352. Oh B, Kim S, Lee Y, Hong H, Kim T, Kim S, et al. Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells. Oncotarget. 2016;7:57066-57076 pubmed publisher
  353. Di Franco S, Turdo A, Benfante A, Colorito M, Gaggianesi M, Apuzzo T, et al. ?Np63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis. Oncotarget. 2016;7:54157-54173 pubmed publisher
  354. Shi Y, Wu W, Chai Q, Li Q, Hou Y, Xia H, et al. LTβR controls thymic portal endothelial cells for haematopoietic progenitor cell homing and T-cell regeneration. Nat Commun. 2016;7:12369 pubmed publisher
  355. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  356. Tang Y, Bao W, Yang J, Ma L, Yang J, Xu Y, et al. Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells. Mol Med Rep. 2016;14:2717-24 pubmed publisher
  357. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  358. Hwang S, Cobb D, Bhadra R, Youngblood B, Khan I. Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis. J Exp Med. 2016;213:1799-818 pubmed publisher
  359. Liu W, Kang S, Huang Z, Wu C, Jin H, Maine C, et al. A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells. J Exp Med. 2016;213:1901-19 pubmed publisher
  360. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed publisher
  361. Martinez L, Thames E, Kim J, Chaudhuri G, Singh R, Pervin S. Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis. BMC Cancer. 2016;16:559 pubmed publisher
  362. Barin J, Talor M, Schaub J, Diny N, Hou X, Hoyer M, et al. Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol. 2016;186:2337-52 pubmed publisher
  363. Stanly T, Fritzsche M, Banerji S, Garcia E, Bernardino de la Serna J, Jackson D, et al. Critical importance of appropriate fixation conditions for faithful imaging of receptor microclusters. Biol Open. 2016;5:1343-50 pubmed publisher
  364. Liu Y, Wang K, Xing H, Zhai X, Wang L, Wang W. Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers. Oncol Lett. 2016;12:1240-1256 pubmed
  365. Di Scala M, Otano I, Gil Farina I, Vanrell L, Hommel M, Olague C, et al. Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice. J Virol. 2016;90:8563-74 pubmed publisher
  366. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  367. Jiang S, Chen G, Feng L, Jiang Z, Yu M, Bao J, et al. Disruption of kif3a results in defective osteoblastic differentiation in dental mesenchymal stem/precursor cells via the Wnt signaling pathway. Mol Med Rep. 2016;14:1891-900 pubmed publisher
  368. Baptista M, Keszei M, Oliveira M, Sunahara K, Andersson J, Dahlberg C, et al. Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells. Nat Commun. 2016;7:12175 pubmed publisher
  369. Belvedere R, Bizzarro V, Forte G, Dal Piaz F, Parente L, Petrella A. Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway. Sci Rep. 2016;6:29660 pubmed publisher
  370. Riedel A, Shorthouse D, Haas L, Hall B, Shields J. Tumor-induced stromal reprogramming drives lymph node transformation. Nat Immunol. 2016;17:1118-27 pubmed publisher
  371. Elkin S, Oswald N, Reed D, Mettlen M, Macmillan J, Schmid S. Ikarugamycin: A Natural Product Inhibitor of Clathrin-Mediated Endocytosis. Traffic. 2016;17:1139-49 pubmed publisher
  372. Bellerby R, Smith C, Kyme S, Gee J, Gunthert U, Green A, et al. Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance. Front Oncol. 2016;6:145 pubmed publisher
  373. Duru N, Gernapudi R, Lo P, Yao Y, Wolfson B, Zhang Y, et al. Characterization of the CD49f+/CD44+/CD24- single-cell derived stem cell population in basal-like DCIS cells. Oncotarget. 2016;7:47511-47525 pubmed publisher
  374. Ichimaru S, Nakagawa S, Arai Y, Kishida T, Shin Ya M, Honjo K, et al. Hypoxia Potentiates Anabolic Effects of Exogenous Hyaluronic Acid in Rat Articular Cartilage. Int J Mol Sci. 2016;17: pubmed publisher
  375. Nkwe D, Pelchen Matthews A, Burden J, Collinson L, Marsh M. The intracellular plasma membrane-connected compartment in the assembly of HIV-1 in human macrophages. BMC Biol. 2016;14:50 pubmed publisher
  376. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed publisher
  377. Toneff M, Sreekumar A, Tinnirello A, Hollander P, Habib S, Li S, et al. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states. BMC Biol. 2016;14:47 pubmed publisher
  378. Zhang Y, Cabarcas S, Zheng J, Sun L, Mathews L, Zhang X, et al. Cryptotanshinone targets tumor-initiating cells through down-regulation of stemness genes expression. Oncol Lett. 2016;11:3803-3812 pubmed
  379. Nasri I, Bonnet D, Zwarycz B, d Aldebert E, Khou S, Mezghani Jarraya R, et al. PAR2-dependent activation of GSK3? regulates the survival of colon stem/progenitor cells. Am J Physiol Gastrointest Liver Physiol. 2016;311:G221-36 pubmed publisher
  380. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed publisher
  381. Tisza M, Zhao W, Fuentes J, Prijic S, Chen X, Levental I, et al. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Oncotarget. 2016;7:51553-51568 pubmed publisher
  382. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  383. Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck M, et al. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Oncotarget. 2016;7:51107-51123 pubmed publisher
  384. Kwak J, Lee N, Lee H, Hong I, Nam J. HIF2?/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy. Oncotarget. 2016;7:43518-43533 pubmed publisher
  385. Abdel Mohsen M, Chavez L, Tandon R, Chew G, Deng X, Danesh A, et al. Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation. PLoS Pathog. 2016;12:e1005677 pubmed publisher
  386. Sundararaman A, Amirtham U, Rangarajan A. Calcium-Oxidant Signaling Network Regulates AMP-activated Protein Kinase (AMPK) Activation upon Matrix Deprivation. J Biol Chem. 2016;291:14410-29 pubmed publisher
  387. Onzi G, Ledur P, Hainzenreder L, Bertoni A, Silva A, Lenz G, et al. Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment. Cytotherapy. 2016;18:828-37 pubmed publisher
  388. Stein S, Mack E, Rome K, Pajcini K, Ohtani T, Xu L, et al. Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL. PLoS ONE. 2016;11:e0155408 pubmed publisher
  389. Zhang H, Prado K, Zhang K, Peek E, Lee J, Wang X, et al. Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance. Clin Cancer Res. 2016;22:5349-5361 pubmed
  390. Contreras F, Prado C, Gonzalez H, Franz D, Osorio Barrios F, Osorio F, et al. Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity. J Immunol. 2016;196:4143-9 pubmed publisher
  391. Nieves W, Hung L, Oniskey T, Boon L, Foretz M, Viollet B, et al. Myeloid-Restricted AMPK?1 Promotes Host Immunity and Protects against IL-12/23p40-Dependent Lung Injury during Hookworm Infection. J Immunol. 2016;196:4632-40 pubmed publisher
  392. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed publisher
  393. Boareto M, Jolly M, Goldman A, Pietila M, Mani S, Sengupta S, et al. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface. 2016;13: pubmed publisher
  394. Xu A, Bhanumathy K, Wu J, Ye Z, Freywald A, Leary S, et al. IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia. Cell Biosci. 2016;6:30 pubmed publisher
  395. Teo W, Merino V, Cho S, Korangath P, Liang X, Wu R, et al. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24. Oncogene. 2016;35:5539-5551 pubmed publisher
  396. Wen S, Dooner M, Cheng Y, Papa E, Del Tatto M, Pereira M, et al. Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells. Leukemia. 2016;30:2221-2231 pubmed publisher
  397. Lu K, Wang B, Chi W, Chang Chien J, Yang J, Lee H, et al. Ovatodiolide Inhibits Breast Cancer Stem/Progenitor Cells through SMURF2-Mediated Downregulation of Hsp27. Toxins (Basel). 2016;8: pubmed publisher
  398. Silva S, Levy D, Ruiz J, de Melo T, Isaac C, Fidelis M, et al. Oxysterols in adipose tissue-derived mesenchymal stem cell proliferation and death. J Steroid Biochem Mol Biol. 2017;169:164-175 pubmed publisher
  399. Rialdi A, Campisi L, Zhao N, Lagda A, Pietzsch C, Ho J, et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science. 2016;352:aad7993 pubmed publisher
  400. Kayamori K, Katsube K, Sakamoto K, Ohyama Y, Hirai H, Yukimori A, et al. NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma. PLoS ONE. 2016;11:e0154112 pubmed publisher
  401. Wang X, Zhu Y, Xu B, Wang J, Liu X. Identification of TLR2 and TLR4?induced microRNAs in human mesenchymal stem cells and their possible roles in regulating TLR signals. Mol Med Rep. 2016;13:4969-80 pubmed publisher
  402. Seo A, Lee H, Kim E, Jang M, Kim Y, Kim J, et al. Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer. Br J Cancer. 2016;114:1109-16 pubmed publisher
  403. Carofino B, Ayanga B, Tracey L, Brooke Bisschop T, Justice M. PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL. Biol Open. 2016;5:645-53 pubmed publisher
  404. Sato K, Suda K, Shimizu S, Sakai K, Mizuuchi H, Tomizawa K, et al. Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression. PLoS ONE. 2016;11:e0154186 pubmed publisher
  405. O Leary C, Riling C, Spruce L, Ding H, Kumar S, Deng G, et al. Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. Nat Commun. 2016;7:11226 pubmed publisher
  406. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed publisher
  407. Sadeghian Nodoushan F, Aflatoonian R, Borzouie Z, Akyash F, Fesahat F, Soleimani M, et al. Pluripotency and differentiation of cells from human testicular sperm extraction: An investigation of cell stemness. Mol Reprod Dev. 2016;83:312-23 pubmed publisher
  408. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  409. Verbist K, Guy C, Milasta S, Liedmann S, Kaminski M, Wang R, et al. Metabolic maintenance of cell asymmetry following division in activated T lymphocytes. Nature. 2016;532:389-93 pubmed publisher
  410. Mall C, Sckisel G, Proia D, Mirsoian A, Grossenbacher S, Pai C, et al. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016;5:e1075114 pubmed
  411. Seifert L, Werba G, Tiwari S, Giao Ly N, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245-9 pubmed publisher
  412. Komori M, Lin Y, Cortese I, Blake A, Ohayon J, Cherup J, et al. Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis. Ann Clin Transl Neurol. 2016;3:166-79 pubmed publisher
  413. Jung Y, Decker A, Wang J, Lee E, Kana L, Yumoto K, et al. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow. Oncotarget. 2016;7:25698-711 pubmed publisher
  414. Ando K, Fujino N, Mitani K, Ota C, Okada Y, Kondo T, et al. Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis. Am J Physiol Lung Cell Mol Physiol. 2016;310:L899-908 pubmed publisher
  415. Morrow C, Trapani F, Metcalf R, Bertolini G, Hodgkinson C, Khandelwal G, et al. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study. Ann Oncol. 2016;27:1155-60 pubmed publisher
  416. Braun J, Meixner A, Brachner A, Foisner R. The GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse Hematopoiesis. PLoS ONE. 2016;11:e0152278 pubmed publisher
  417. Jun S, Jung Y, Suh H, Wang W, Kim M, Oh Y, et al. LIG4 mediates Wnt signalling-induced radioresistance. Nat Commun. 2016;7:10994 pubmed publisher
  418. Mathewson N, Jenq R, Mathew A, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17:505-513 pubmed publisher
  419. Park S, Kim J, Kim N, Yang K, Shim J, Heo K. Estradiol, TGF-?1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migration. Oncol Lett. 2016;11:1895-1902 pubmed
  420. Lee T, Liu C, Chang Y, Nieh S, Lin Y, Jao S, et al. Increased chemoresistance via Snail-Raf kinase inhibitor protein signaling in colorectal cancer in response to a nicotine derivative. Oncotarget. 2016;7:23512-20 pubmed publisher
  421. Zou L, Chen Q, Quanbeck Z, Bechtold J, Kaufman D. Angiogenic activity mediates bone repair from human pluripotent stem cell-derived osteogenic cells. Sci Rep. 2016;6:22868 pubmed publisher
  422. Apostolidis S, Rodríguez Rodríguez N, Suárez Fueyo A, Dioufa N, Ozcan E, Crispín J, et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;17:556-64 pubmed publisher
  423. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  424. Hardy K, Wu F, Tu W, Zafar A, Boulding T, McCuaig R, et al. Identification of chromatin accessibility domains in human breast cancer stem cells. Nucleus. 2016;7:50-67 pubmed publisher
  425. Leeth C, Racine J, Chapman H, Arpa B, Carrillo J, Carrascal J, et al. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes. 2016;65:1977-1987 pubmed publisher
  426. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed publisher
  427. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  428. Pattabiraman D, Bierie B, Kober K, Thiru P, Krall J, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016;351:aad3680 pubmed publisher
  429. Pokharel D, Padula M, Lu J, Jaiswal R, Djordjevic S, Bebawy M. The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells. Molecules. 2016;21:290 pubmed publisher
  430. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed publisher
  431. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  432. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed publisher
  433. Sancho Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, et al. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat Commun. 2016;7:10743 pubmed publisher
  434. Haraguchi T, Kondo M, Uchikawa R, Kobayashi K, Hiramatsu H, Kobayashi K, et al. Dynamics and plasticity of the epithelial to mesenchymal transition induced by miR-200 family inhibition. Sci Rep. 2016;6:21117 pubmed publisher
  435. Chen L, Huang J, Ji Y, Zhang X, Wang P, Deng K, et al. Tripartite motif 32 prevents pathological cardiac hypertrophy. Clin Sci (Lond). 2016;130:813-28 pubmed publisher
  436. Gradiz R, Silva H, Carvalho L, Botelho M, Mota Pinto A. MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors. Sci Rep. 2016;6:21648 pubmed publisher
  437. Pelly V, Kannan Y, Coomes S, Entwistle L, Rückerl D, Seddon B, et al. IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol. 2016;9:1407-1417 pubmed publisher
  438. Li X, Wu J, Li Q, Shigemura K, Chung L, Huang W. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer. Oncotarget. 2016;7:12869-84 pubmed publisher
  439. D Amato Brito C, Cipriano D, Colin D, Germain S, Seimbille Y, Robert J, et al. Role of MIF/CD74 signaling pathway in the development of pleural mesothelioma. Oncotarget. 2016;7:11512-25 pubmed publisher
  440. Gehlot P, Shukla V, Gupta S, Makidon P. Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells. J Transl Med. 2016;14:49 pubmed publisher
  441. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  442. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  443. Gerashchenko B, Salmina K, Eglitis J, Huna A, Grjunberga V, Erenpreisa J. Disentangling the aneuploidy and senescence paradoxes: a study of triploid breast cancers non-responsive to neoadjuvant therapy. Histochem Cell Biol. 2016;145:497-508 pubmed publisher
  444. Boulding T, Wu F, McCuaig R, Dunn J, Sutton C, Hardy K, et al. Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer. PLoS ONE. 2016;11:e0148065 pubmed publisher
  445. Roffê E, Marino A, Weaver J, Wan W, de Araújo F, Hoffman V, et al. Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice. Infect Immun. 2016;84:1123-1136 pubmed publisher
  446. Vieyra Garcia P, Wei T, Naym D, Fredholm S, Fink Puches R, Cerroni L, et al. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides. Clin Cancer Res. 2016;22:3328-39 pubmed publisher
  447. Wang X, Jung Y, Jun S, Lee S, Wang W, Schneider A, et al. PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. Nat Commun. 2016;7:10633 pubmed publisher
  448. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  449. Bulla R, Tripodo C, Rami D, Ling G, Agostinis C, Guarnotta C, et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346 pubmed publisher
  450. Tubo N, Fife B, Pagán A, Kotov D, Goldberg M, Jenkins M. Most microbe-specific naïve CD4? T cells produce memory cells during infection. Science. 2016;351:511-4 pubmed publisher
  451. Atkinson S, Hoffmann U, Hamann A, Bach E, Danneskiold Samsøe N, Kristiansen K, et al. Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade. Dis Model Mech. 2016;9:427-40 pubmed publisher
  452. Binmadi N, Elsissi A, Elsissi N. Expression of cell adhesion molecule CD44 in mucoepidermoid carcinoma and its association with the tumor behavior. Head Face Med. 2016;12:8 pubmed publisher
  453. Qiu L, Wu J, Pan C, Tan X, Lin J, Liu R, et al. Downregulation of CDC27 inhibits the proliferation of colorectal cancer cells via the accumulation of p21Cip1/Waf1. Cell Death Dis. 2016;7:e2074 pubmed publisher
  454. Lee B, Koo J, Yun Jun J, Gavrilova O, Lee Y, Seo A, et al. A mouse model for a partially inactive obesity-associated human MC3R variant. Nat Commun. 2016;7:10522 pubmed publisher
  455. Aloulou M, Carr E, Gador M, Bignon A, Liblau R, Fazilleau N, et al. Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells. Nat Commun. 2016;7:10579 pubmed publisher
  456. Hattermann K, Gebhardt H, Krossa S, Ludwig A, Lucius R, Held Feindt J, et al. Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling. elife. 2016;5:e10820 pubmed publisher
  457. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed publisher
  458. Quattrocelli M, Giacomazzi G, Broeckx S, Ceelen L, Bolca S, Spaas J, et al. Equine-Induced Pluripotent Stem Cells Retain Lineage Commitment Toward Myogenic and Chondrogenic Fates. Stem Cell Reports. 2016;6:55-63 pubmed publisher
  459. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  460. Metz P, Lopez J, Kim S, Akimoto K, Ohno S, Chang J. Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates. Sci Rep. 2016;6:19182 pubmed publisher
  461. Zhang X, Ma Y, Fu X, Liu Q, Shao Z, Dai L, et al. Runx2-Modified Adipose-Derived Stem Cells Promote Tendon Graft Integration in Anterior Cruciate Ligament Reconstruction. Sci Rep. 2016;6:19073 pubmed publisher
  462. Shu S, Lin C, He H, Witwicki R, Tabassum D, Roberts J, et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. 2016;529:413-417 pubmed publisher
  463. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  464. Heo J, Choi Y, Kim H, Kim H. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med. 2016;37:115-25 pubmed publisher
  465. McCubbrey A, Nelson J, Stolberg V, Blakely P, McCloskey L, Janssen W, et al. MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1. J Immunol. 2016;196:1366-75 pubmed publisher
  466. Mikyšková R, Štěpánek I, Indrová M, Bieblová J, Šímová J, Truxová I, et al. Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy. Int J Oncol. 2016;48:953-64 pubmed publisher
  467. Schneck H, Gierke B, Uppenkamp F, Behrens B, Niederacher D, Stoecklein N, et al. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer. PLoS ONE. 2015;10:e0144535 pubmed publisher
  468. Cheung S, Chuang P, Huang H, Hwang Verslues W, Cho C, Yang W, et al. Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells. Proc Natl Acad Sci U S A. 2016;113:960-5 pubmed publisher
  469. Monaghan M, Linneweh M, Liebscher S, Van Handel B, Layland S, Schenke Layland K. Endocardial-to-mesenchymal transformation and mesenchymal cell colonization at the onset of human cardiac valve development. Development. 2016;143:473-82 pubmed publisher
  470. Ren Y, Wang N, Hu W, Zhang X, Xu J, Wan Y. Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination. Sci Rep. 2015;5:18099 pubmed publisher
  471. Kiermaier E, Moussion C, Veldkamp C, Gerardy Schahn R, de Vries I, Williams L, et al. Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science. 2016;351:186-90 pubmed publisher
  472. Traka M, Podojil J, McCarthy D, Miller S, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016;19:65-74 pubmed publisher
  473. Lindemans C, Calafiore M, Mertelsmann A, O Connor M, Dudakov J, Jenq R, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature. 2015;528:560-564 pubmed publisher
  474. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  475. Vishnoi M, Peddibhotla S, Yin W, T Scamardo A, George G, Hong D, et al. The isolation and characterization of CTC subsets related to breast cancer dormancy. Sci Rep. 2015;5:17533 pubmed publisher
  476. Kaplan J, Marshall M, C McSkimming C, Harmon D, Garmey J, Oldham S, et al. Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue. Mol Metab. 2015;4:779-94 pubmed publisher
  477. Gururajan M, Cavassani K, Sievert M, Duan P, Lichterman J, Huang J, et al. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer. Oncotarget. 2015;6:44072-83 pubmed publisher
  478. Assayag Asherie N, Sever D, Bogdani M, Johnson P, Weiss T, Ginzberg A, et al. Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes. PLoS ONE. 2015;10:e0143589 pubmed publisher
  479. Moretto M, Khan I. IL-21 Is Important for Induction of KLRG1+ Effector CD8 T Cells during Acute Intracellular Infection. J Immunol. 2016;196:375-84 pubmed publisher
  480. Pinheiro C, Granja S, Longatto Filho A, Faria A, Fragoso M, Lovisolo S, et al. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors. Oncotarget. 2015;6:44403-21 pubmed publisher
  481. Abe S, Yamaguchi S, Sato Y, Harada K. Sphere-Derived Multipotent Progenitor Cells Obtained From Human Oral Mucosa Are Enriched in Neural Crest Cells. Stem Cells Transl Med. 2016;5:117-28 pubmed publisher
  482. Arzi B, Mills Ko E, Verstraete F, Kol A, Walker N, Badgley M, et al. Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats. Stem Cells Transl Med. 2016;5:75-86 pubmed publisher
  483. Hu Y, Zhang Y, Tian K, Xun C, Wang S, Lv D. Effects of nerve growth factor and basic fibroblast growth factor dual gene modification on rat bone marrow mesenchymal stem cell differentiation into neuron-like cells in vitro. Mol Med Rep. 2016;13:49-58 pubmed publisher
  484. Schminke B, Trautmann S, Mai B, Miosge N, Blaschke S. Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage. Eur J Immunol. 2016;46:440-5 pubmed publisher
  485. Pai P, Rachagani S, Lakshmanan I, Macha M, Sheinin Y, Smith L, et al. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Mol Oncol. 2016;10:224-39 pubmed publisher
  486. Wands A, Fujita A, McCombs J, Cervin J, Dedic B, Rodriguez A, et al. Fucosylation and protein glycosylation create functional receptors for cholera toxin. elife. 2015;4:e09545 pubmed publisher
  487. Cifuentes F, Valenzuela R, Contreras H, Castellón E. Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer. Oncol Rep. 2015;34:2837-44 pubmed
  488. Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16:1235-44 pubmed publisher
  489. Acikgoz E, Guven U, Duzagac F, Uslu R, Kara M, Soner B, et al. Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells. PLoS ONE. 2015;10:e0141090 pubmed publisher
  490. Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, et al. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med. 2015;21:1272-9 pubmed publisher
  491. Wu V, Smith A, You H, Nguyen T, Ferguson R, Taylor M, et al. Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice. Mucosal Immunol. 2016;9:777-86 pubmed publisher
  492. Yun J, Song S, Kang J, Park J, Kim H, Han S, et al. Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability. Nucleic Acids Res. 2016;44:558-72 pubmed publisher
  493. AbdElazeem M, El Sayed M. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia. Ann Diagn Pathol. 2015;19:369-74 pubmed publisher
  494. Ladell K, Hazenberg M, Fitch M, Emson C, McEvoy Hein Asgarian B, Mold J, et al. Continuous Antigenic Stimulation of DO11.10 TCR Transgenic Mice in the Presence or Absence of IL-1?: Possible Implications for Mechanisms of T Cell Depletion in HIV Disease. J Immunol. 2015;195:4096-105 pubmed publisher
  495. Vlachou K, Mintzas K, Glymenaki M, Ioannou M, Papadaki G, Bertsias G, et al. Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation. Arthritis Rheumatol. 2016;68:449-61 pubmed publisher
  496. Secundino I, Lizcano A, Roupé K, Wang X, Cole J, Olson J, et al. Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation. J Mol Med (Berl). 2016;94:219-33 pubmed publisher
  497. McCormack R, de Armas L, Shiratsuchi M, Fiorentino D, Olsson M, Lichtenheld M, et al. Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria. elife. 2015;4: pubmed publisher
  498. Wei T, Zhang N, Guo Z, Chi F, Song Y, Zhu X. Wnt4 signaling is associated with the decrease of proliferation and increase of apoptosis during age-related thymic involution. Mol Med Rep. 2015;12:7568-76 pubmed publisher
  499. Iriondo O, Rábano M, Domenici G, Carlevaris O, López Ruiz J, Zabalza I, et al. Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions. Oncotarget. 2015;6:31721-39 pubmed publisher
  500. Beckmann R, Lippross S, Hartz C, Tohidnezhad M, Ferreira M, Neuss Stein S, et al. Abrasion arthroplasty increases mesenchymal stem cell content of postoperative joint effusions. BMC Musculoskelet Disord. 2015;16:250 pubmed publisher
  501. Martin Blondel G, Pignolet B, Tietz S, Yshii L, Gebauer C, Périnat T, et al. Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the α4β1-integrin. Eur J Immunol. 2015;45:3302-12 pubmed publisher
  502. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  503. Andersson K, Brisslert M, Cavallini N, Svensson M, Welin A, Erlandsson M, et al. Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6. Oncotarget. 2015;6:20043-57 pubmed
  504. Ceyran A, Şenol S, Güzelmeriç F, Tunçer E, Tongut A, Özbek B, et al. Effects of hypoxia and its relationship with apoptosis, stem cells, and angiogenesis on the thymus of children with congenital heart defects: a morphological and immunohistochemical study. Int J Clin Exp Pathol. 2015;8:8038-47 pubmed
  505. Nie S, McDermott S, Deol Y, Tan Z, Wicha M, Lubman D. A quantitative proteomics analysis of MCF7 breast cancer stem and progenitor cell populations. Proteomics. 2015;15:3772-83 pubmed publisher
  506. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed publisher
  507. Schirosi L, De Summa S, Tommasi S, Paradiso A, Sambiasi D, Popescu O, et al. Immunoprofile from tissue microarrays to stratify familial breast cancer patients. Oncotarget. 2015;6:27865-79 pubmed publisher
  508. Pearce V, Bouabe H, MacQueen A, Carbonaro V, Okkenhaug K. PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes. J Immunol. 2015;195:3206-17 pubmed publisher
  509. Sawitza I, Kordes C, Götze S, Herebian D, Häussinger D. Bile acids induce hepatic differentiation of mesenchymal stem cells. Sci Rep. 2015;5:13320 pubmed publisher
  510. KapucuoÄŸlu N, Bozkurt K, BaÅŸpınar Å, Koçer M, EroÄŸlu H, Akdeniz R, et al. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Pathol Res Pract. 2015;211:740-7 pubmed publisher
  511. Monteiro Carvalho Mori da Cunha M, Zia S, Oliveira Arcolino F, Carlon M, Beckmann D, Pippi N, et al. Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats. PLoS ONE. 2015;10:e0136145 pubmed publisher
  512. Kang R, Zhou Y, Tan S, Zhou G, Aagaard L, Xie L, et al. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Res Ther. 2015;6:144 pubmed publisher
  513. Chantzoura E, Skylaki S, Menendez S, Kim S, Johnsson A, Linnarsson S, et al. Reprogramming Roadblocks Are System Dependent. Stem Cell Reports. 2015;5:350-64 pubmed publisher
  514. Liu X, Chen X, Rycaj K, Chao H, Deng Q, Jeter C, et al. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 2015;6:23959-86 pubmed
  515. Karakas D, Cevatemre B, Aztopal N, Ari F, Yilmaz V, Ulukaya E. Addition of niclosamide to palladium(II) saccharinate complex of terpyridine results in enhanced cytotoxic activity inducing apoptosis on cancer stem cells of breast cancer. Bioorg Med Chem. 2015;23:5580-6 pubmed publisher
  516. Li J, Lam M. Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. elife. 2015;4:e06434 pubmed publisher
  517. Wu M, Lee W, Hua K, Kuo M, Lin M. Macrophage Infiltration Induces Gastric Cancer Invasiveness by Activating the β-Catenin Pathway. PLoS ONE. 2015;10:e0134122 pubmed publisher
  518. Choi Y, Gullicksrud J, Xing S, Zeng Z, Shan Q, Li F, et al. LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nat Immunol. 2015;16:980-90 pubmed publisher
  519. Ngiow S, Young A, Jacquelot N, Yamazaki T, Enot D, Zitvogel L, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75:3800-11 pubmed publisher
  520. Cho M, Park J, Choi H, Park M, Won H, Park Y, et al. DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression. Nat Commun. 2015;6:7821 pubmed publisher
  521. Ducret M, Fabre H, Farges J, Degoul O, Atzeni G, McGuckin C, et al. Production of Human Dental Pulp Cells with a Medicinal Manufacturing Approach. J Endod. 2015;41:1492-9 pubmed publisher
  522. Riordan D, Varma S, West R, Brown P. Automated Analysis and Classification of Histological Tissue Features by Multi-Dimensional Microscopic Molecular Profiling. PLoS ONE. 2015;10:e0128975 pubmed publisher
  523. Lowe K, Navarro Núñez L, Bénézech C, Nayar S, Kingston B, Nieswandt B, et al. The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state. Eur J Immunol. 2015;45:2484-93 pubmed publisher
  524. O Carroll S, Kho D, Wiltshire R, Nelson V, Rotimi O, Johnson R, et al. Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. J Neuroinflammation. 2015;12:131 pubmed publisher
  525. Bian Y, Qian W, Li H, Zhao R, Shan W, Weng X. Pathogenesis of glucocorticoid-induced avascular necrosis: A microarray analysis of gene expression in vitro. Int J Mol Med. 2015;36:678-84 pubmed publisher
  526. de Carvalho J, Zonari A, de Paula A, Martins T, Gomes D, Goes A. Production of Human Endothelial Cells Free from Soluble Xenogeneic Antigens for Bioartificial Small Diameter Vascular Graft Endothelization. Biomed Res Int. 2015;2015:652474 pubmed publisher
  527. Li C, Wu S, Wang H, Bi X, Yang Z, Du Y, et al. The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer. Oncotarget. 2015;6:19542-51 pubmed
  528. Liang Y, Hu J, Li J, Liu Y, Yu J, Zhuang X, et al. Epigenetic Activation of TWIST1 by MTDH Promotes Cancer Stem-like Cell Traits in Breast Cancer. Cancer Res. 2015;75:3672-80 pubmed publisher
  529. Ju S, Huang C, Huang W, Su Y. Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells. Cell Death Dis. 2015;6:e1801 pubmed publisher
  530. Zhu S, Chen Z, Katsha A, Hong J, Belkhiri A, el Rifai W. Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis. Oncogene. 2016;35:1847-56 pubmed publisher
  531. Thieme R, Kurz S, Kolb M, Debebe T, Holtze S, Morhart M, et al. Analysis of Alpha-2 Macroglobulin from the Long-Lived and Cancer-Resistant Naked Mole-Rat and Human Plasma. PLoS ONE. 2015;10:e0130470 pubmed publisher
  532. Goodman C, Sato T, Peck A, Girondo M, Yang N, Liu C, et al. Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism. Oncogene. 2016;35:1373-85 pubmed publisher
  533. Kamimura D, Katsunuma K, Arima Y, Atsumi T, Jiang J, Bando H, et al. KDEL receptor 1 regulates T-cell homeostasis via PP1 that is a key phosphatase for ISR. Nat Commun. 2015;6:7474 pubmed publisher
  534. Baradez M, Lekishvili T, Marshall D. Rapid phenotypic fingerprinting of cell products by robust measurement of ubiquitous surface markers. Cytometry A. 2015;87:624-35 pubmed publisher
  535. James S, Fox J, Afsari F, Lee J, Clough S, Knight C, et al. Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes. Stem Cell Reports. 2015;4:1004-15 pubmed publisher
  536. Conde P, Rodriguez M, van der Touw W, Jimenez A, Burns M, Miller J, et al. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. Immunity. 2015;42:1143-58 pubmed publisher
  537. Takahashi R, Miyazaki H, Takeshita F, Yamamoto Y, Minoura K, Ono M, et al. Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1. Nat Commun. 2015;6:7318 pubmed publisher
  538. Ayadi M, Bouygues A, Ouaret D, Ferrand N, Chouaib S, Thiery J, et al. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors. Oncotarget. 2015;6:18518-33 pubmed
  539. Wei X, Dou X, Bai J, Luo X, Qiu S, Xi D, et al. ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer. Oncotarget. 2015;6:21704-17 pubmed
  540. Cioffi M, D Alterio C, Camerlingo R, Tirino V, Consales C, Riccio A, et al. Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer. Sci Rep. 2015;5:10357 pubmed publisher
  541. Deberge M, Ely K, Wright P, Thorp E, Enelow R. Shedding of TNF receptor 2 by effector CD8⁺ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection. J Leukoc Biol. 2015;98:423-34 pubmed publisher
  542. Chen H, Sun J, Huang Z, Hou H, Arcilla M, Rakhilin N, et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat Biotechnol. 2015;33:656-60 pubmed publisher
  543. Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, et al. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Int J Mol Med. 2015;36:113-22 pubmed publisher
  544. McCully M, Collins P, Hughes T, Thomas C, Billen J, O Donnell V, et al. Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. J Immunol. 2015;195:96-104 pubmed publisher
  545. Liang X, Ding Y, Zhang Y, Chai Y, He J, Chiu S, et al. Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction. Cell Death Dis. 2015;6:e1765 pubmed publisher
  546. Seo K, Lee S, Ye B, Kim Y, Bae S, Kim C. Mechanical stretch enhances the expression and activity of osteopontin and MMP-2 via the Akt1/AP-1 pathways in VSMC. J Mol Cell Cardiol. 2015;85:13-24 pubmed publisher
  547. Takeuchi M, Higashino A, Takeuchi K, Hori Y, Koshiba Takeuchi K, Makino H, et al. Transcriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation. PLoS ONE. 2015;10:e0126562 pubmed publisher
  548. Higuchi A, Wang C, Ling Q, Lee H, Kumar S, Chang Y, et al. A hybrid-membrane migration method to isolate high-purity adipose-derived stem cells from fat tissues. Sci Rep. 2015;5:10217 pubmed publisher
  549. Peske J, Thompson E, Gemta L, Baylis R, Fu Y, Engelhard V. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015;6:7114 pubmed publisher
  550. Kahra D, Mondol T, Niemiec M, Wittung Stafshede P. Human Copper Chaperone Atox1 Translocates to the Nucleus but does not Bind DNA In Vitro. Protein Pept Lett. 2015;22:532-8 pubmed
  551. Zhou F, Gao S, Wang L, Sun C, Chen L, Yuan P, et al. Human adipose-derived stem cells partially rescue the stroke syndromes by promoting spatial learning and memory in mouse middle cerebral artery occlusion model. Stem Cell Res Ther. 2015;6:92 pubmed publisher
  552. Lee J, Park J, Kim T, Jung B, Lee Y, Shim E, et al. Human bone marrow stem cells cultured under hypoxic conditions present altered characteristics and enhanced in vivo tissue regeneration. Bone. 2015;78:34-45 pubmed publisher
  553. Sadowski S, Boufraqech M, Zhang L, Mehta A, Kapur P, Zhang Y, et al. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis. Oncotarget. 2015;6:18038-49 pubmed
  554. Wang W, Runkle K, Terkowski S, Ekaireb R, Witze E. Protein Depalmitoylation Is Induced by Wnt5a and Promotes Polarized Cell Behavior. J Biol Chem. 2015;290:15707-16 pubmed publisher
  555. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed publisher
  556. Pei B, Zhao M, Miller B, Véla J, Bruinsma M, Virgin H, et al. Invariant NKT cells require autophagy to coordinate proliferation and survival signals during differentiation. J Immunol. 2015;194:5872-84 pubmed publisher
  557. Moguche A, Shafiani S, Clemons C, Larson R, Dinh C, Higdon L, et al. ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis. J Exp Med. 2015;212:715-28 pubmed publisher
  558. Olguín J, Fernández J, Salinas N, Juárez I, Rodriguez Sosa M, Campuzano J, et al. Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated Th1 immune response. Microbes Infect. 2015;17:586-95 pubmed publisher
  559. Berkovits B, Mayr C. Alternative 3' UTRs act as scaffolds to regulate membrane protein localization. Nature. 2015;522:363-7 pubmed publisher
  560. Sharon C, Baranwal S, Patel N, Rodriguez Agudo D, Pandak W, Majumdar A, et al. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo. Oncotarget. 2015;6:15332-47 pubmed
  561. ORELLANA R, Kato S, Erices R, Bravo M, Gonzalez P, Oliva B, et al. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer. 2015;15:290 pubmed publisher
  562. Sanguinetti A, Santini D, Bonafè M, Taffurelli M, Avenia N. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment. World J Surg Oncol. 2015;13:129 pubmed publisher
  563. Jung K, Gupta N, Wang P, Lewis J, Gopal K, Wu F, et al. Triple negative breast cancers comprise a highly tumorigenic cell subpopulation detectable by its high responsiveness to a Sox2 regulatory region 2 (SRR2) reporter. Oncotarget. 2015;6:10366-73 pubmed
  564. Ross J, Huh D, Noble L, Tavazoie S. Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer. Nat Cell Biol. 2015;17:651-64 pubmed publisher
  565. Hayashi Y, Bardsley M, Toyomasu Y, Milosavljevic S, Gajdos G, Choi K, et al. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1. Gastroenterology. 2015;149:420-32.e16 pubmed publisher
  566. Lee D, Su J, Kim H, Chang B, Papatsenko D, Zhao R, et al. Modeling familial cancer with induced pluripotent stem cells. Cell. 2015;161:240-54 pubmed publisher
  567. Rouhani S, Eccles J, Riccardi P, Peske J, Tewalt E, Cohen J, et al. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat Commun. 2015;6:6771 pubmed publisher
  568. Li C, Li W, Xiao J, Jiao S, Teng F, Xue S, et al. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. EMBO Mol Med. 2015;7:754-69 pubmed publisher
  569. Ali H, Al Yatama M, Abu Farha M, Behbehani K, Al Madhoun A. Multi-lineage differentiation of human umbilical cord Wharton's Jelly Mesenchymal Stromal Cells mediates changes in the expression profile of stemness markers. PLoS ONE. 2015;10:e0122465 pubmed publisher
  570. Westcott J, Prechtl A, Maine E, Dang T, Esparza M, Sun H, et al. An epigenetically distinct breast cancer cell subpopulation promotes collective invasion. J Clin Invest. 2015;125:1927-43 pubmed publisher
  571. Lujan E, Zunder E, Ng Y, Goronzy I, Nolan G, Wernig M. Early reprogramming regulators identified by prospective isolation and mass cytometry. Nature. 2015;521:352-6 pubmed publisher
  572. Cheah M, Chen J, Sahoo D, Contreras Trujillo H, Volkmer A, Scheeren F, et al. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proc Natl Acad Sci U S A. 2015;112:4725-30 pubmed publisher
  573. Dong F, Eibach M, Bartsch J, Dolga A, Schlomann U, Conrad C, et al. The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells. Neuro Oncol. 2015;17:1474-85 pubmed publisher
  574. Campos D, Freitas D, Gomes J, Magalhães A, Steentoft C, Gomes C, et al. Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery. Mol Cell Proteomics. 2015;14:1616-29 pubmed publisher
  575. Saland E, Boutzen H, Castellano R, Pouyet L, Griessinger E, Larrue C, et al. A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia. Blood Cancer J. 2015;5:e297 pubmed publisher
  576. Yang Y, Gomez J, Herrera M, Perez Marco R, Repenning P, Zhang Z, et al. Salt restriction leads to activation of adult renal mesenchymal stromal cell-like cells via prostaglandin E2 and E-prostanoid receptor 4. Hypertension. 2015;65:1047-54 pubmed publisher
  577. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  578. Rappa G, Green T, Karbanová J, Corbeil D, Lorico A. Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells. Oncotarget. 2015;6:7970-91 pubmed
  579. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  580. Yang H, Ma Y, Zhou Y, Xu L, Chen X, Ding W, et al. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment. Cancer Lett. 2015;361:128-36 pubmed publisher
  581. Costabile V, Duraturo F, Delrio P, Rega D, Pace U, Liccardo R, et al. Lithium chloride induces mesenchymal‑to‑epithelial reverting transition in primary colon cancer cell cultures. Int J Oncol. 2015;46:1913-23 pubmed publisher
  582. Rogler A, Kendziorra E, Giedl J, Stoehr C, Taubert H, Goebell P, et al. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer. J Cancer Res Clin Oncol. 2015;141:1779-90 pubmed publisher
  583. Wensveen F, Jelenčić V, Valentić S, Šestan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed publisher
  584. Koo D, Lee H, Ahn J, Yoon D, Kim S, Gong G, et al. Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer. Tumour Biol. 2015;36:5865-71 pubmed publisher
  585. Sharivkin R, Walker M, Soen Y. Functional proteomics screen enables enrichment of distinct cell types from human pancreatic islets. PLoS ONE. 2015;10:e0115100 pubmed publisher
  586. Srivastava M, Duan G, Kershaw N, Athanasopoulos V, Yeo J, Ose T, et al. Roquin binds microRNA-146a and Argonaute2 to regulate microRNA homeostasis. Nat Commun. 2015;6:6253 pubmed publisher
  587. Hsiao H, Hsu T, Liu W, Hsieh W, Chou T, Wu Y, et al. Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo. Nat Commun. 2015;6:6353 pubmed publisher
  588. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed publisher
  589. Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed publisher
  590. Kobayashi K, Sakurai K, Hiramatsu H, Inada K, Shiogama K, Nakamura S, et al. The miR-199a/Brm/EGR1 axis is a determinant of anchorage-independent growth in epithelial tumor cell lines. Sci Rep. 2015;5:8428 pubmed publisher
  591. Gong J, Weng D, Eguchi T, Murshid A, Sherman M, Song B, et al. Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis. Oncogene. 2015;34:5460-71 pubmed publisher
  592. Bertaux Skeirik N, Feng R, Schumacher M, Li J, Mahé M, Engevik A, et al. CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation. PLoS Pathog. 2015;11:e1004663 pubmed publisher
  593. Li Y, Wu Y, Abbatiello T, Wu W, Kim J, Sarkissyan M, et al. Slug contributes to cancer progression by direct regulation of ERα signaling pathway. Int J Oncol. 2015;46:1461-72 pubmed publisher
  594. Afzal M, Strande J. Generation of induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells. J Vis Exp. 2015;:52032 pubmed publisher
  595. Santhana Kumar K, Tripolitsioti D, Ma M, Grählert J, Egli K, Fiaschetti G, et al. The Ser/Thr kinase MAP4K4 drives c-Met-induced motility and invasiveness in a cell-based model of SHH medulloblastoma. Springerplus. 2015;4:19 pubmed publisher
  596. Ghiabi P, Jiang J, Pasquier J, Maleki M, Abu Kaoud N, Halabi N, et al. Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche. J Transl Med. 2015;13:27 pubmed publisher
  597. Huang Y, Clarke F, Karimi M, Roy N, Williamson E, Okumura M, et al. CRK proteins selectively regulate T cell migration into inflamed tissues. J Clin Invest. 2015;125:1019-32 pubmed publisher
  598. Lankford L, Selby T, Becker J, Ryzhuk V, Long C, Farmer D, et al. Early gestation chorionic villi-derived stromal cells for fetal tissue engineering. World J Stem Cells. 2015;7:195-207 pubmed publisher
  599. Srivastava R, Khan A, Spencer D, Vahed H, Lopes P, Thai N, et al. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic. J Immunol. 2015;194:2232-48 pubmed publisher
  600. Khan A, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, et al. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol. 2015;89:3776-92 pubmed publisher
  601. Cabrera Perez J, Condotta S, James B, Kashem S, Brincks E, Rai D, et al. Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. J Immunol. 2015;194:1609-20 pubmed publisher
  602. Caminal M, Peris D, Fonseca C, Barrachina J, Codina D, Rabanal R, et al. Cartilage resurfacing potential of PLGA scaffolds loaded with autologous cells from cartilage, fat, and bone marrow in an ovine model of osteochondral focal defect. Cytotechnology. 2016;68:907-19 pubmed publisher
  603. Hwang H, Lee T, Jang Y. Cell proliferation-inducing protein 52/mitofilin is a surface antigen on undifferentiated human dental pulp stem cells. Stem Cells Dev. 2015;24:1309-19 pubmed publisher
  604. Singh K, Hjort M, Thorvaldson L, Sandler S. Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naïve mice. Sci Rep. 2015;5:7767 pubmed publisher
  605. Long P, Tighe S, Driscoll H, Fortner K, Viapiano M, Jaworski D. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest. J Cell Physiol. 2015;230:1929-43 pubmed publisher
  606. Jonchère B, Vétillard A, Toutain B, Lam D, Bernard A, Henry C, et al. Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1. Oncotarget. 2015;6:409-26 pubmed
  607. Mohey Elsaeed O, Marei W, Fouladi Nashta A, El Saba A. Histochemical structure and immunolocalisation of the hyaluronan system in the dromedary oviduct. Reprod Fertil Dev. 2016;28:936-947 pubmed publisher
  608. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  609. Van de Laar E, Clifford M, Hasenoeder S, Kim B, Wang D, Lee S, et al. Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas. Respir Res. 2014;15:160 pubmed publisher
  610. Mouraret N, Houssaïni A, Abid S, Quarck R, Marcos E, Parpaleix A, et al. Role for telomerase in pulmonary hypertension. Circulation. 2015;131:742-755 pubmed publisher
  611. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed publisher
  612. Skripuletz T, Manzel A, Gropengießer K, Schäfer N, Gudi V, Singh V, et al. Pivotal role of choline metabolites in remyelination. Brain. 2015;138:398-413 pubmed publisher
  613. LUCAS B, White A, Ulvmar M, Nibbs R, Sitnik K, Agace W, et al. CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. Eur J Immunol. 2015;45:574-83 pubmed publisher
  614. Dalla Pozza E, Dando I, Biondani G, Brandi J, Costanzo C, Zoratti E, et al. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells. Int J Oncol. 2015;46:1099-108 pubmed publisher
  615. Dong X, Lin Q, Aihara A, Li Y, Huang C, Chung W, et al. Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype. Oncotarget. 2015;6:1231-48 pubmed
  616. Naik A, Hawwari A, Krangel M. Specification of Vδ and Vα usage by Tcra/Tcrd locus V gene segment promoters. J Immunol. 2015;194:790-4 pubmed publisher
  617. Ohmura M, Hishiki T, Yamamoto T, Nakanishi T, Kubo A, Tsuchihashi K, et al. Impacts of CD44 knockdown in cancer cells on tumor and host metabolic systems revealed by quantitative imaging mass spectrometry. Nitric Oxide. 2015;46:102-13 pubmed publisher
  618. Guo X, Tanaka Y, Kondo M. Thymic precursors of TCRαβ(+)CD8αα(+) intraepithelial lymphocytes are negative for CD103. Immunol Lett. 2015;163:40-8 pubmed publisher
  619. Levett P, Hutmacher D, Malda J, Klein T. Hyaluronic acid enhances the mechanical properties of tissue-engineered cartilage constructs. PLoS ONE. 2014;9:e113216 pubmed publisher
  620. Fahl S, Harris B, Coffey F, Wiest D. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint. J Immunol. 2015;194:200-9 pubmed
  621. Peters A, Burkett P, Sobel R, Buckley C, Watson S, Bettelli E, et al. Podoplanin negatively regulates CD4+ effector T cell responses. J Clin Invest. 2015;125:129-40 pubmed publisher
  622. Baptista A, Roozendaal R, Reijmers R, Koning J, Unger W, Greuter M, et al. Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation. elife. 2014;3: pubmed publisher
  623. BURKHART C, Fleyshman D, Kohrn R, Commane M, Garrigan J, Kurbatov V, et al. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer. Oncotarget. 2014;5:11038-53 pubmed
  624. Mehta P, Nuotio Antar A, Smith C. γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. J Leukoc Biol. 2015;97:121-34 pubmed publisher
  625. Ghotra V, He S, van der Horst G, Nijhoff S, de Bont H, Lekkerkerker A, et al. SYK is a candidate kinase target for the treatment of advanced prostate cancer. Cancer Res. 2015;75:230-40 pubmed publisher
  626. Mouchacca P, Chasson L, Frick M, Foray C, Schmitt Verhulst A, Boyer C. Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes. Immunology. 2015;145:24-33 pubmed publisher
  627. Backer R, Helbig C, Gentek R, Kent A, Laidlaw B, Dominguez C, et al. A central role for Notch in effector CD8(+) T cell differentiation. Nat Immunol. 2014;15:1143-51 pubmed publisher
  628. Chandrasekaran S, Marshall J, Messing J, Hsu J, King M. TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroids. PLoS ONE. 2014;9:e111487 pubmed publisher
  629. Soncini D, Caffa I, Zoppoli G, Cea M, Cagnetta A, Passalacqua M, et al. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. J Biol Chem. 2014;289:34189-204 pubmed publisher
  630. Kim W, Barron D, San Martin R, Chan K, Tran L, Yang F, et al. RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation. Proc Natl Acad Sci U S A. 2014;111:16389-94 pubmed publisher
  631. Cai X, Dai Z, Reeves R, Caballero Benítez A, Duran K, Delrow J, et al. Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. PLoS ONE. 2014;9:e108942 pubmed publisher
  632. Afonso J, Santos L, Miranda Gonçalves V, Morais A, Amaro T, Longatto Filho A, et al. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance. Mol Carcinog. 2015;54:1451-66 pubmed publisher
  633. Maneva Radicheva L, Amatya C, Parker C, Ellefson J, Radichev I, Raghavan A, et al. Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1. PLoS ONE. 2014;9:e107213 pubmed publisher
  634. Jia D, Yang W, Li L, Liu H, Tan Y, Ooi S, et al. β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer. Cell Death Differ. 2015;22:298-310 pubmed publisher
  635. Bray A, Cevallos R, Gazarian K, Lamas M. Human dental pulp stem cells respond to cues from the rat retina and differentiate to express the retinal neuronal marker rhodopsin. Neuroscience. 2014;280:142-55 pubmed publisher
  636. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed publisher
  637. Mizukami T, Kamachi H, Mitsuhashi T, Tsuruga Y, Hatanaka Y, Kamiyama T, et al. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy. BMC Cancer. 2014;14:687 pubmed publisher
  638. Bertin S, Lozano Ruiz B, Bachiller V, García Martínez I, Herdman S, Zapater P, et al. Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice. Mucosal Immunol. 2015;8:505-15 pubmed publisher
  639. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed publisher
  640. Carty S, Koretzky G, Jordan M. Interleukin-4 regulates eomesodermin in CD8+ T cell development and differentiation. PLoS ONE. 2014;9:e106659 pubmed publisher
  641. Chatterjee S, Thyagarajan K, Kesarwani P, Song J, Soloshchenko M, Fu J, et al. Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014;74:6048-59 pubmed publisher
  642. Tsai H, Deng W, Lai W, Chiu W, Yang C, Tsai Y, et al. Wnts enhance neurotrophin-induced neuronal differentiation in adult bone-marrow-derived mesenchymal stem cells via canonical and noncanonical signaling pathways. PLoS ONE. 2014;9:e104937 pubmed publisher
  643. Wennerström A, Lothe I, Sandhu V, Kure E, Myklebost O, Munthe E. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. PLoS ONE. 2014;9:e103873 pubmed publisher
  644. Kaygusuz E. Immunohistochemical expression of CD44 standard and E-cadherin in atypical leiomyoma and leiomyosarcoma of the uterus. J Obstet Gynaecol. 2015;35:279-82 pubmed publisher
  645. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed publisher
  646. Van Brocklyn J, Wojton J, Meisen W, Kellough D, Ecsedy J, Kaur B, et al. Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Res. 2014;74:5364-70 pubmed publisher
  647. Denton A, Roberts E, Linterman M, Fearon D. Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells. Proc Natl Acad Sci U S A. 2014;111:12139-44 pubmed publisher
  648. Gwak J, Kim H, Kim E, Chung Y, Yun S, Seo A, et al. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Breast Cancer Res Treat. 2014;147:39-49 pubmed publisher
  649. Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014;74:5057-69 pubmed publisher
  650. Bailon E, Ugarte Berzal E, Amigo Jiménez I, Van den Steen P, Opdenakker G, Garcia Marco J, et al. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen. J Leukoc Biol. 2014;96:185-99 pubmed publisher
  651. Senturk S, Yao Z, Camiolo M, Stiles B, Rathod T, Walsh A, et al. p53? is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state. Proc Natl Acad Sci U S A. 2014;111:E3287-96 pubmed publisher
  652. Reeh K, Cardenas K, Bain V, Liu Z, LAURENT M, Manley N, et al. Ectopic TBX1 suppresses thymic epithelial cell differentiation and proliferation during thymus organogenesis. Development. 2014;141:2950-8 pubmed publisher
  653. McNally A, Anderson J. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties. J Biomed Mater Res A. 2015;103:1380-90 pubmed publisher
  654. Ciavardelli D, Rossi C, Barcaroli D, Volpe S, Consalvo A, Zucchelli M, et al. Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment. Cell Death Dis. 2014;5:e1336 pubmed publisher
  655. Boyoglu Barnum S, Chirkova T, Todd S, Barnum T, Gaston K, Jorquera P, et al. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. J Virol. 2014;88:10569-83 pubmed publisher
  656. Cowan J, McCarthy N, Parnell S, White A, Bacon A, Serge A, et al. Differential requirement for CCR4 and CCR7 during the development of innate and adaptive ??T cells in the adult thymus. J Immunol. 2014;193:1204-12 pubmed publisher
  657. Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, et al. YAP/TAZ incorporation in the ?-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158:157-70 pubmed publisher
  658. Li M, Zhang B, Zhang Z, Liu X, Qi X, Zhao J, et al. Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer. Biomed Res Int. 2014;2014:981261 pubmed publisher
  659. Vogelzang A, Perdomo C, Zedler U, Kuhlmann S, Hurwitz R, Gengenbacher M, et al. Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ?ureC::hly vaccine's superior protection against tuberculosis. J Infect Dis. 2014;210:1928-37 pubmed publisher
  660. Chen K, Li Z, Jiang P, Zhang X, Zhang Y, Jiang Y, et al. Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma. Oncol Rep. 2014;32:755-63 pubmed publisher
  661. Rito M, Schmitt F, Pinto A, André S. Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype. Virchows Arch. 2014;465:185-91 pubmed publisher
  662. Rossi E, Chang C, Goldenberg D. Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus. PLoS ONE. 2014;9:e98315 pubmed publisher
  663. Kitagawa K, Shibata K, Matsumoto A, Matsumoto M, Ohhata T, Nakayama K, et al. Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development. Mol Cell Biol. 2014;34:2732-44 pubmed
  664. Mukonoweshuro B, Brown C, Fisher J, Ingham E. Immunogenicity of undifferentiated and differentiated allogeneic mouse mesenchymal stem cells. J Tissue Eng. 2014;5:2041731414534255 pubmed publisher
  665. Smolarchuk C, Zhu L, Chan W, Anderson C. T cells generated in the absence of a thoracic thymus fail to establish homeostasis. Eur J Immunol. 2014;44:2263-73 pubmed publisher
  666. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed publisher
  667. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed publisher
  668. Pei M, Li J, Zhang Y, Liu G, Wei L, Zhang Y. Expansion on a matrix deposited by nonchondrogenic urine stem cells strengthens the chondrogenic capacity of repeated-passage bone marrow stromal cells. Cell Tissue Res. 2014;356:391-403 pubmed publisher
  669. Cochain C, Chaudhari S, Koch M, Wiendl H, Eckstein H, Zernecke A. Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS ONE. 2014;9:e93280 pubmed publisher
  670. Diessner J, Bruttel V, Stein R, Horn E, Häusler S, Dietl J, et al. Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1). Cell Death Dis. 2014;5:e1149 pubmed publisher
  671. Harland K, Day E, Apte S, Russ B, Doherty P, Turner S, et al. Epigenetic plasticity of Cd8a locus during CD8(+) T-cell development and effector differentiation and reprogramming. Nat Commun. 2014;5:3547 pubmed publisher
  672. Shao Z, Zhang X, Pi Y, Yin L, Li L, Chen H, et al. Surface modification on polycaprolactone electrospun mesh and human decalcified bone scaffold with synovium-derived mesenchymal stem cells-affinity peptide for tissue engineering. J Biomed Mater Res A. 2015;103:318-29 pubmed publisher
  673. Yan J, Villarreal D, Racine T, Chu J, Walters J, Morrow M, et al. Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine. Vaccine. 2014;32:2833-42 pubmed publisher
  674. Fu H, Kishore M, Gittens B, Wang G, Coe D, Komarowska I, et al. Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation. Nat Commun. 2014;5:3436 pubmed publisher
  675. Ahmed N, Iu J, Brown C, Taylor D, Kandel R. Serum- and growth-factor-free three-dimensional culture system supports cartilage tissue formation by promoting collagen synthesis via Sox9-Col2a1 interaction. Tissue Eng Part A. 2014;20:2224-33 pubmed publisher
  676. Zhao J, Lin J, Zhu D, Wang X, Brooks D, Chen M, et al. miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/?-catenin/BCL9 pathway. Cancer Res. 2014;74:1801-13 pubmed publisher
  677. Lee J, Walsh M, Hoehn K, James D, Wherry E, Choi Y. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J Immunol. 2014;192:3190-9 pubmed publisher
  678. Hwang W, Jiang J, Yang S, Huang T, Lan H, Teng H, et al. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol. 2014;16:268-80 pubmed publisher
  679. Feng C, Zhang Y, Yin J, Li J, Abounader R, Zuo Z. Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma. Neuro Oncol. 2014;16:1078-85 pubmed publisher
  680. Hirokawa Y, Yip K, Tan C, Burgess A. Colonic myofibroblast cell line stimulates colonoid formation. Am J Physiol Gastrointest Liver Physiol. 2014;306:G547-56 pubmed publisher
  681. Cyr A, Kulak M, Park J, Bogachek M, Spanheimer P, Woodfield G, et al. TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis. Oncogene. 2015;34:436-44 pubmed publisher
  682. Torii D, Konishi K, Watanabe N, Goto S, Tsutsui T. Cementogenic potential of multipotential mesenchymal stem cells purified from the human periodontal ligament. Odontology. 2015;103:27-35 pubmed publisher
  683. Costa R, Bergwerf I, Santermans E, De Vocht N, Praet J, Daans J, et al. Distinct in vitro properties of embryonic and extraembryonic fibroblast-like cells are reflected in their in vivo behavior following grafting in the adult mouse brain. Cell Transplant. 2015;24:223-33 pubmed publisher
  684. Zhou J, Lu P, Ren H, Zheng Z, Ji J, Liu H, et al. 17?-estradiol protects human eyelid-derived adipose stem cells against cytotoxicity and increases transplanted cell survival in spinal cord injury. J Cell Mol Med. 2014;18:326-43 pubmed publisher
  685. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  686. Huang A, Zhou H, Zhao H, Quan Y, Feng B, Zheng M. TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability. Cancer Biol Ther. 2014;15:297-304 pubmed publisher
  687. Hsieh C, Chen H, Chang Y, Pang S, Kuo M, Chuang C, et al. Co-existence of epithelioid and fibroblastoid subsets in a sarcomatoid renal carcinoma cell line revealed by clonal studies. Anticancer Res. 2013;33:4875-89 pubmed
  688. Fuentes T, Appleby N, Tsay E, Martinez J, Bailey L, Hasaniya N, et al. Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability. PLoS ONE. 2013;8:e77464 pubmed publisher
  689. Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G, et al. Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS ONE. 2013;8:e71412 pubmed publisher
  690. Yu P, Yan M, Lai H, Huang R, Chou Y, Lin W, et al. Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells. Int J Cancer. 2014;134:542-51 pubmed publisher
  691. Stover A, Brick D, Nethercott H, Banuelos M, Sun L, O Dowd D, et al. Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling. J Neurosci Res. 2013;91:1247-62 pubmed publisher
  692. Redecke V, Wu R, Zhou J, Finkelstein D, Chaturvedi V, High A, et al. Hematopoietic progenitor cell lines with myeloid and lymphoid potential. Nat Methods. 2013;10:795-803 pubmed publisher
  693. Wu X, Satpathy A, Kc W, Liu P, Murphy T, Murphy K. Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo. PLoS ONE. 2013;8:e64800 pubmed publisher
  694. Yockey L, Demehri S, Turkoz M, Turkoz A, Ahern P, Jassim O, et al. The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation. J Invest Dermatol. 2013;133:2714-2721 pubmed publisher
  695. Shigeishi H, Biddle A, Gammon L, Emich H, Rodini C, Gemenetzidis E, et al. Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3? influenced by CD44 and RHAMM. Stem Cells. 2013;31:2073-83 pubmed publisher
  696. Gammon L, Biddle A, Heywood H, Johannessen A, Mackenzie I. Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism. PLoS ONE. 2013;8:e62493 pubmed publisher
  697. Roehrich M, Spicher A, Milano G, Vassalli G. Characterization of cardiac-resident progenitor cells expressing high aldehyde dehydrogenase activity. Biomed Res Int. 2013;2013:503047 pubmed publisher
  698. Koning J, Kooij G, de Vries H, Nolte M, Mebius R. Mesenchymal stem cells are mobilized from the bone marrow during inflammation. Front Immunol. 2013;4:49 pubmed publisher
  699. Szabo A, Fong S, Yue L, Zhang K, Strachan L, Scalapino K, et al. The CD44+ ALDH+ population of human keratinocytes is enriched for epidermal stem cells with long-term repopulating ability. Stem Cells. 2013;31:786-99 pubmed publisher
  700. Goodison S, Chang M, Dai Y, Urquidi V, Rosser C. A multi-analyte assay for the non-invasive detection of bladder cancer. PLoS ONE. 2012;7:e47469 pubmed publisher
  701. Mathew R, Seiler M, Scanlon S, Mao A, Constantinides M, Bertozzi Villa C, et al. BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature. 2012;491:618-21 pubmed publisher
  702. Bonuccelli G, Castello Cros R, Capozza F, Martinez Outschoorn U, Lin Z, Tsirigos A, et al. The milk protein ?-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis. Cell Cycle. 2012;11:3972-82 pubmed publisher
  703. Zhang N, Bevan M. TGF-? signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol. 2012;13:667-73 pubmed publisher
  704. Chevrier S, Genton C, Malissen B, Malissen M, Acha Orbea H. Dominant Role of CD80-CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells. Front Immunol. 2012;3:27 pubmed publisher
  705. Kodama K, Horikoshi M, Toda K, Yamada S, Hara K, Irie J, et al. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci U S A. 2012;109:7049-54 pubmed publisher
  706. Caserta S, Nausch N, Sawtell A, Drummond R, Barr T, MacDonald A, et al. Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells. PLoS ONE. 2012;7:e35466 pubmed publisher
  707. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed publisher
  708. Ruckwardt T, Malloy A, Gostick E, Price D, Dash P, McClaren J, et al. Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice. PLoS Pathog. 2011;7:e1002377 pubmed publisher
  709. Perdomo Arciniegas A, Vernot J. Co-culture of hematopoietic stem cells with mesenchymal stem cells increases VCAM-1-dependent migration of primitive hematopoietic stem cells. Int J Hematol. 2011;94:525-32 pubmed publisher
  710. Randall K, Chan S, Ma C, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208:2305-20 pubmed publisher
  711. Quere R, Andradottir S, Brun A, Zubarev R, Karlsson G, Olsson K, et al. High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event. Leukemia. 2011;25:515-26 pubmed publisher
  712. Mokry J, Soukup T, Micuda S, Karbanova J, Visek B, Brcakova E, et al. Telomere attrition occurs during ex vivo expansion of human dental pulp stem cells. J Biomed Biotechnol. 2010;2010:673513 pubmed publisher
  713. Hubert S, Rissiek B, Klages K, Huehn J, Sparwasser T, Haag F, et al. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J Exp Med. 2010;207:2561-8 pubmed publisher
  714. da Cunha C, Oliveira C, Wen X, Gomes B, Sousa S, Suriano G, et al. De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Lab Invest. 2010;90:1604-14 pubmed publisher
  715. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  716. Yuan F, Li X, Lin J, Schwabe C, Bullesbach E, Rao C, et al. The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice. Reproduction. 2010;139:759-69 pubmed publisher
  717. Sadri N, Lu J, Badura M, Schneider R. AUF1 is involved in splenic follicular B cell maintenance. BMC Immunol. 2010;11:1 pubmed publisher
  718. Fahl S, Crittenden R, Allman D, Bender T. c-Myb is required for pro-B cell differentiation. J Immunol. 2009;183:5582-92 pubmed publisher
  719. Rajasagi N, Kassim S, Kollias C, Zhao X, Chervenak R, Jennings S. CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1. J Virol. 2009;83:5256-68 pubmed publisher
  720. Hamada H, Garcia Hernandez M, Reome J, Misra S, Strutt T, McKinstry K, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469-81 pubmed publisher
  721. Ahonen C, Wasiuk A, Fuse S, Turk M, Ernstoff M, Suriawinata A, et al. Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood. 2008;111:3116-25 pubmed publisher
  722. Park S, Han Y, Aleyas A, George J, Yoon H, Lee J, et al. Low-dose antigen-experienced CD4+ T cells display reduced clonal expansion but facilitate an effective memory pool in response to secondary exposure. Immunology. 2008;123:426-37 pubmed
  723. Bliss S, Bliss S, Beiting D, Alcaraz A, Appleton J. IL-10 regulates movement of intestinally derived CD4+ T cells to the liver. J Immunol. 2007;178:7974-83 pubmed
  724. Stephens G, Andersson J, Shevach E. Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J Immunol. 2007;178:6901-11 pubmed
  725. Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T, Samuel J. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A. 2007;81:652-62 pubmed
  726. Hofmann M, Brinkmann V, Zerwes H. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Int Immunopharmacol. 2006;6:1902-10 pubmed
  727. Chen B, Deoliveira D, Cui X, Le N, Son J, Whitesides J, et al. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood. 2007;109:3115-23 pubmed
  728. Kolar G, Mehta D, Pelayo R, Capra J. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood. 2007;109:2545-52 pubmed
  729. Lim H, Broxmeyer H, Kim C. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol. 2006;177:840-51 pubmed
  730. Hale J, Boursalian T, Turk G, Fink P. Thymic output in aged mice. Proc Natl Acad Sci U S A. 2006;103:8447-52 pubmed
  731. Hofmann M, Zerwes H. Identification of organ-specific T cell populations by analysis of multiparameter flow cytometry data using DNA-chip analysis software. Cytometry A. 2006;69:533-40 pubmed
  732. Campioni D, Moretti S, Ferrari L, Punturieri M, Castoldi G, Lanza F. Immunophenotypic heterogeneity of bone marrow-derived mesenchymal stromal cells from patients with hematologic disorders: correlation with bone marrow microenvironment. Haematologica. 2006;91:364-8 pubmed
  733. Matsuda J, Zhang Q, Ndonye R, Richardson S, Howell A, Gapin L. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood. 2006;107:2797-805 pubmed
  734. Irwin S, Izzo A, Dow S, Skeiky Y, Reed S, Alderson M, et al. Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun. 2005;73:5809-16 pubmed
  735. Yasumi T, Katamura K, Okafuji I, Yoshioka T, Meguro T, Nishikomori R, et al. Limited ability of antigen-specific Th1 responses to inhibit Th2 cell development in vivo. J Immunol. 2005;174:1325-31 pubmed
  736. Nasir A, Catalano E, Calafati S, Cantor A, Kaiser H, Coppola D. Role of p53, CD44V6 and CD57 in differentiating between benign and malignant follicular neoplasms of the thyroid. In Vivo. 2004;18:189-95 pubmed
  737. Suskind D, Muench M. Searching for common stem cells of the hepatic and hematopoietic systems in the human fetal liver: CD34+ cytokeratin 7/8+ cells express markers for stellate cells. J Hepatol. 2004;40:261-8 pubmed
  738. Fisson S, Darrasse Jèze G, Litvinova E, Septier F, Klatzmann D, Liblau R, et al. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med. 2003;198:737-46 pubmed
  739. Radoja S, Saio M, Frey A. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. J Immunol. 2001;166:6074-83 pubmed
  740. Attinger A, MacDonald H, Acha Orbea H. Lymphoid environment limits superantigen and antigen-induced T cell proliferation at high precursor frequency. Eur J Immunol. 2001;31:884-93 pubmed
  741. Ylagan L, Scholes J, Demopoulos R. Cd44: a marker of squamous differentiation in adenosquamous neoplasms. Arch Pathol Lab Med. 2000;124:212-5 pubmed
  742. Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade P. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med. 1992;175:257-66 pubmed